
<html lang="en"     class="pb-page"  data-request-id="c37c6ebd-dbd8-4986-86fb-4b642c405de6"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b00513;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-3;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2" /></meta><meta name="dc.Creator" content="Xiaoqin  Wu" /></meta><meta name="dc.Creator" content="Gang  Xu" /></meta><meta name="dc.Creator" content="Xiaobo  Li" /></meta><meta name="dc.Creator" content="Weiren  Xu" /></meta><meta name="dc.Creator" content="Qianjin  Li" /></meta><meta name="dc.Creator" content="Wei  Liu" /></meta><meta name="dc.Creator" content="Karen A.  Kirby" /></meta><meta name="dc.Creator" content="Mignon L.  Loh" /></meta><meta name="dc.Creator" content="Jun  Li" /></meta><meta name="dc.Creator" content="Stefan G.  Sarafianos" /></meta><meta name="dc.Creator" content="Cheng-Kui  Qu" /></meta><meta name="dc.Description" content="Genetic mutations in the phosphatase PTPN11 (SHP2) are associated with childhood leukemias. These mutations cause hyperactivation of SHP2 due to the disruption of the autoinhibitory conformation. B..." /></meta><meta name="Description" content="Genetic mutations in the phosphatase PTPN11 (SHP2) are associated with childhood leukemias. These mutations cause hyperactivation of SHP2 due to the disruption of the autoinhibitory conformation. B..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 20, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00513" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00513" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00513" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00513" /></link>
        
    
    

<title>Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00513" /></meta><meta property="og:title" content="Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0008.jpeg" /></meta><meta property="og:description" content="Genetic mutations in the phosphatase PTPN11 (SHP2) are associated with childhood leukemias. These mutations cause hyperactivation of SHP2 due to the disruption of the autoinhibitory conformation. By targeting the activation-associated protein conformational change, we have identified an SHP2 inhibitor (E)-1-(1-(5-(3-(2,4-dichlorophenyl)acryloyl)-2-ethoxy-4-hydroxybenzyl)-1,2,5,6-tetrahydropyridin-3-yl)-1H-benzo[d]imidazol-2(3H)-one (LY6, 1) using computer-aided drug design database screening combined with cell-based assays. This compound inhibited SHP2 with an IC50 value of 9.8 μM, 7-fold more selective for SHP2 than the highly related SHP1. Fluorescence titration, thermal shift, and microscale thermophoresis quantitative binding assays confirmed its direct binding to SHP2. This compound was further verified to effectively inhibit SHP2-mediated cell signaling and proliferation. Furthermore, mouse and patient leukemia cells with PTPN11 activating mutations were more sensitive to this inhibitor than wild-type cells. This small molecule SHP2 inhibitor has a potential to serve as a lead compound for further optimization studies to develop novel anti-SHP2 therapeutic agents." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Genetic mutations in the phosphatase PTPN11 (SHP2) are associated with childhood leukemias. These mutations cause hyperactivation of SHP2 due to the disruption of the autoinhibitory conformation. By targeting the activation-associated protein conformational change, we have identified an SHP2 inhibitor (E)-1-(1-(5-(3-(2,4-dichlorophenyl)acryloyl)-2-ethoxy-4-hydroxybenzyl)-1,2,5,6-tetrahydropyridin-3-yl)-1H-benzo[d]imidazol-2(3H)-one (LY6, 1) using computer-aided drug design database screening combined with cell-based assays. This compound inhibited SHP2 with an IC50 value of 9.8 μM, 7-fold more selective for SHP2 than the highly related SHP1. Fluorescence titration, thermal shift, and microscale thermophoresis quantitative binding assays confirmed its direct binding to SHP2. This compound was further verified to effectively inhibit SHP2-mediated cell signaling and proliferation. Furthermore, mouse and patient leukemia cells with PTPN11 activating mutations were more sensitive to this inhibitor than wild-type cells. This small molecule SHP2 inhibitor has a potential to serve as a lead compound for further optimization studies to develop novel anti-SHP2 therapeutic agents." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0008.jpeg" /></meta><meta name="twitter:title" content="Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00513"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00513">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00513&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00513&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00513&amp;href=/doi/10.1021/acs.jmedchem.8b00513" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1125-1137</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01048" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01090" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Xiaoqin Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoqin Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoqin++Wu">Xiaoqin Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gang Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gang Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicine, Division of Hematology and Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gang++Xu">Gang Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaobo Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaobo Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30322, United States</div><div class="loa-info-affiliations-info">Department of Medicine, Division of Hematology and Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaobo++Li">Xiaobo Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Weiren Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Weiren Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicine, Division of Hematology and Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Weiren++Xu">Weiren Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qianjin Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qianjin Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qianjin++Li">Qianjin Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wei Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wei Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Medicine, Division of Hematology and Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Liu">Wei Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karen A. Kirby</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karen A. Kirby</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karen+A.++Kirby">Karen A. Kirby</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mignon L. Loh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mignon L. Loh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Division of Pediatric Hematology-Oncology, University of California, San Francisco, San Francisco, California 94122, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mignon+L.++Loh">Mignon L. Loh</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jun Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jun Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Anhui Medical University, Hefei 230032, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Li">Jun Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan G. Sarafianos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan G. Sarafianos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan+G.++Sarafianos">Stefan G. Sarafianos</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Cheng-Kui Qu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cheng-Kui Qu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30322, United States</div><div class="loa-info-affiliations-info">Department of Medicine, Division of Hematology and Oncology, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Tel:404-727-5037. Fax: 404-727-4455. E-mail: <a href="/cdn-cgi/l/email-protection#2a49424f444d07415f43045b5f6a4f47455853044f4e5f"><span class="__cf_email__" data-cfemail="b5d6ddd0dbd298dec0dc9bc4c0f5d0d8dac7cc9bd0d1c0">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cheng-Kui++Qu">Cheng-Kui Qu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4256-8652" title="Orcid link">http://orcid.org/0000-0002-4256-8652</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00513&amp;href=/doi/10.1021%2Facs.jmedchem.8b00513" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1125–1137</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 20, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 April 2018</li><li><span class="item_label"><b>Published</b> online</span>20 November 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 February 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00513" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00513</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1125%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DXiaoqin%2BWu%252C%2BGang%2BXu%252C%2BXiaobo%2BLi%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D3%26contentID%3Dacs.jmedchem.8b00513%26title%3DSmall%2BMolecule%2BInhibitor%2Bthat%2BStabilizes%2Bthe%2BAutoinhibited%2BConformation%2Bof%2Bthe%2BOncogenic%2BTyrosine%2BPhosphatase%2BSHP2%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1137%26publicationDate%3DFebruary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00513"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3418</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">21</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00513" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Xiaoqin&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Gang&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Xiaobo&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Weiren&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Qianjin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Karen&quot;,&quot;last_name&quot;:&quot;A. Kirby&quot;},{&quot;first_name&quot;:&quot;Mignon&quot;,&quot;last_name&quot;:&quot;L. Loh&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;G. Sarafianos&quot;},{&quot;first_name&quot;:&quot;Cheng-Kui&quot;,&quot;last_name&quot;:&quot;Qu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;1125-1137&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00513&quot;},&quot;abstract&quot;:&quot;Genetic mutations in the phosphatase PTPN11 (SHP2) are associated with childhood leukemias. These mutations cause hyperactivation of SHP2 due to the disruption of the autoinhibitory conformation. By targeting the activation-associated protein conformational change, we have identified an SHP2 inhibitor (E)-1-(1-(5-(3-(2,4-dichlorophenyl)acryloyl)-2-ethoxy-4-hydroxybenzyl)-1,2,5,6-tetrahydropyridin-3-yl)-1H-benzo[d]imidazol-2(3H)-one (LY6, 1) using computer-aided drug design database screening combined with cell-based assays. This compound inhibited SHP2 with an IC50 value of 9.8 μM, 7-fold more selective for SHP2 than the highly related SHP1. Fluorescence titration, thermal shift, and microscale thermophoresis quantitative binding assays confirmed its direct binding to SHP2. This compound was further verified to effectively inhibit SHP2-mediated cell signaling and proliferation. Furthermore, mouse and patient leukemia cells with PTPN11 activating mutations were more sensitive to this inhibitor than wild-type c&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00513&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00513" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00513&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00513" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00513&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00513" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00513&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00513&amp;href=/doi/10.1021/acs.jmedchem.8b00513" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00513" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00513" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (6 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00513%26sid%3Dliteratum%253Aachs%26pmid%3D30457860%26genre%3Darticle%26aulast%3DWu%26date%3D2019%26atitle%3DSmall%2BMolecule%2BInhibitor%2Bthat%2BStabilizes%2Bthe%2BAutoinhibited%2BConformation%2Bof%2Bthe%2BOncogenic%2BTyrosine%2BPhosphatase%2BSHP2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D3%26spage%3D1125%26epage%3D1137%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/3" title="Go to Volume 62, Issue 3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/jmcmar.2019.62.issue-3/20190214/jmcmar.2019.62.issue-3.largecover.jpg" alt="Go to Volume 62, Issue 3"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Genetic mutations in the phosphatase <i>PTPN11</i> (SHP2) are associated with childhood leukemias. These mutations cause hyperactivation of SHP2 due to the disruption of the autoinhibitory conformation. By targeting the activation-associated protein conformational change, we have identified an SHP2 inhibitor (<i>E</i>)-1-(1-(5-(3-(2,4-dichlorophenyl)acryloyl)-2-ethoxy-4-hydroxybenzyl)-1,2,5,6-tetrahydropyridin-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (LY6, <b>1</b>) using computer-aided drug design database screening combined with cell-based assays. This compound inhibited SHP2 with an IC<sub>50</sub> value of 9.8 μM, 7-fold more selective for SHP2 than the highly related SHP1. Fluorescence titration, thermal shift, and microscale thermophoresis quantitative binding assays confirmed its direct binding to SHP2. This compound was further verified to effectively inhibit SHP2-mediated cell signaling and proliferation. Furthermore, mouse and patient leukemia cells with <i>PTPN11</i> activating mutations were more sensitive to this inhibitor than wild-type cells. This small molecule SHP2 inhibitor has a potential to serve as a lead compound for further optimization studies to develop novel anti-SHP2 therapeutic agents.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span></span> Note</h4><p class="last">After this paper was published ASAP December 5, 2018, ref 43 was added to the reference list. The revised version was reposted February 4, 2019.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87734" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87734" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">SHP2 (encoded by <i>PTPN11</i>), a widely expressed nonreceptor-type protein tyrosine phosphatase (PTP), plays an essential role in several intracellular signal transduction processes, such as Ras-Erk, PI3K-Akt, Jak-Stat, NF-κB, and mTOR pathways.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> It contains two Src homology 2 (SH2) domains at the N-terminus and a PTP domain at the C-terminus. The 2.0 Å X-ray crystal structure of SHP2 reveals that in the basal state the catalytic site of SHP2 is autoinhibited by the N-terminal SH2 (N-SH2) domain. The N-SH2 domain of SHP2 functions as a conformational switch, which either binds to the PTP domain and directly blocks the active site, or binds to phospho-tyrosine (pY)-containing signaling partners and activates the enzyme by disrupting the intramolecular inhibitory interaction.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The C-SH2 also plays an important role in recognition of bisphosphorylated ligands and contributes to binding energy and specificity, being an integral element of the switch.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> Although SHP2 dephosphorylates tyrosine phosphorylated signaling proteins, this phosphatase plays an overall positive role in transduction of the signals initiated from growth factors, cytokines, and extracellular matrix proteins,<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> in sharp contrast to hematopoietic cell-specific SHP1 phosphatase, which shares a similar overall structure and a high homology with SHP2 but plays a negative role in cell signaling. The molecular mechanism for SHP2 function is not completely understood and is an area of intensive research. Both the SH2 domains and the PTP domains of SHP2 and SHP1 determine the signaling and thus functional specificities of these two highly related PTPs.</div><div class="NLM_p">The critical role of SHP2 in cell signaling and other cellular activities is further underscored by its direct association with human diseases. Germline or somatic mutations in the <i>PTPN11</i> gene that cause hyperactivation of SHP2 catalytic activity have been identified in 50% of patients with the developmental disorder Noonan Syndrome (NS) and various childhood leukemias, including juvenile myelomonocytic leukemia (JMML) (∼35%), myelodysplastic syndrome (∼10%), B cell acute lymphoblastic leukemia (∼7%), and acute myeloid leukemia (∼4%).<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11">(7−11)</a> In addition, activating mutations of <i>PTPN11</i> have been found in sporadic solid tumors.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a><i>PTPN11</i> mutations, found in NS, leukemias, and solid tumors, disrupt the intramolecular interaction of SHP2, leading to a partially open conformation and thus activation of SHP2 due to greatly increased accessibility of the catalytic site.<a onclick="showRef(event, 'ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref11 ref13">(11,13)</a> Several studies have demonstrated that a single <i>PTPN11</i> activating mutation is sufficient to induce NS, JMML-like myeloproliferative neoplasm, and acute leukemias in mice,<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> suggesting that <i>PTPN11</i> mutations play a causative role in these diseases.</div><div class="NLM_p last">The direct connection between activating mutations of <i>PTPN11</i> and human diseases makes SHP2 an attractive target for developing mechanism-based therapeutic drugs. Identification of SHP2 inhibitors with high bioactivity will not only be helpful for drug discovery but also for understanding SHP2 function in cell signaling. However, it is extremely challenging to identify SHP2 selective inhibitors given the high homology in the catalytic site of SHP2 to those in other tyrosine phosphatases, especially the highly related SHP1 phosphatase. Over the past decade, several SHP2 inhibitors have been reported.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref43'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref43">(17−23,43)</a> However, their cross reactivity for other PTPs, off-target effects, or biological functions in <i>PTPN11</i> mutated tumor cells have not been well characterized. More recently, a potent and selective inhibitor of SHP2 was identified through high throughput screening.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> This inhibitor concurrently binds to the interface of the N-SH2, C-SH2, and PTP domains, inhibiting SHP2 activity through an allosteric mechanism. In the present study, we have chosen to target a different SHP2 surface pocket to identify small molecule compounds that suppress activation-associated conformational changes to functionally inhibit SHP2. Using computer-aided drug design (CADD) screening of a virtual database of compounds followed by experimental assays, we have identified a new low molecular weight compound that inhibits SHP2 activity. It is more than 7-fold selective for SHP2 over the closest homologue SHP1. Moreover, biological assays have verified that it is effective in blocking SHP2-mediated signaling and cellular functions in mouse and patient cells.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45176" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45176" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Determination of a Drug Binding Pocket in SHP2 for CADD Database Screening</h3><div class="NLM_p">To identify small molecule inhibitors that are selective for SHP2 over SHP1, we performed thorough sequence and structural analyses for SHP2 and SHP1. The active site of SHP2 is almost identical to that of the SHP1 phosphatase. Compounds that target the catalytic core of SHP2 often inhibit SHP1. Therefore, our structure-based approach was aimed to target the allosteric change required for activation of SHP2, instead of the catalytic site. SiteMap was used to explore a potential drug-binding site in SHP2 for inhibitor discovery. Five possible binding sites in SHP2 were identified in this study (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A). The characters of these potential binding sites were assessed by calculating various properties, such as size, volume, amino acid exposure, enclosure, contact, hydrophobicity, hydrophilicity, and donor/acceptor ratio. Site 1 had the largest internal space, and it was located at the interface between C-SH2 and PTP domains of SHP2. Site 4 was close to Site 1 and sat at the interface between N-SH2 and PTP domains. Site 3 was also located between N-SH2 and PTP domains. Both Site 2 and Site 5 were parts of the PTP domain. Site 3 and Site 5 were subsequently eliminated due to their low scores in the Sitemap algorithm. By analyzing chemical environments and structural conformations of Site 1 and the other two binding pockets, we thought that compounds binding to Site 1 might tighten the connection of C-SH2 and PTP domains and stabilize the “closed” autoinhibited conformation of SHP2. More importantly, Site 1 of SHP2 showed specific features, as compared to the corresponding region of the homology SHP1 (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). This pocket in SHP2 may confer biological selectivity to small molecule compounds that bind to and potentially stabilize the inhibitory conformation of SHP2. Therefore, Site 1 was selected as the docking site for database screening.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Identification of a drug docking site in SHP2 that has unique features in both amino acid composition and structure. (A) SiteMap was used to explore potential binding sites in the SHP2 receptor for computational docking studies. Five possible binding sites were identified. The characters of potential binding sites were assessed by calculating various properties, such as size, volume, amino acid exposure, enclosure, contact, hydrophobicity, hydrophilicity, and donor/acceptor ratio. Site 1 in SHP2 was chosen for subsequent CADD <i>in silico</i> database screening. (B) Comparison between Site 1 in SHP2 and a corresponding site in SHP1. Different amino acid sequences between SHP2 and SHP1 are shown as green cartoons, and key residues are shown as green carbon sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> CADD <i>in Silico</i> Screening and Structural Optimization</h3><div class="NLM_p last">To identify small molecular compounds that bind to and stabilize the autoinhibited conformation to functionally inhibit SHP2, virtual chemical structure database screening and core-hopping procedures were performed. The drug-like structure database of the National Cancer Institute (NCI), USA, was screened by using Glide of Schrödinger 2010 based on the conformation of the Site 1 pocket in SHP2. NSC681129, ranked 21st in the positive hits from the screening, was considered as the most promising lead compound (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S1</a>). NSC681129-based structural optimization was then performed to identify chemical structures that can potentially better stabilize the intramolecular interaction between SH2 and PTP domains in SHP2 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S1</a>). NSC681129 was divided into three parts: Fragment 1, Core, and Fragment 2. The Core structure and the two fragments were replaced with chemical segments from a fragment database to fill up Site 1 and keep SHP2 in a closed autoinhibited state. As a result, top 10 derivatives (LY1-LY10) with high docking scores were selected (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S2</a>). These derivatives along with the top 100 hits from the initial database screening were subjected to PAINS (Pan Assay Interference Compounds) and aggregator examination.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Forty-seven structures, including NSC681129, were identified as potential PAINS-group containing structures (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Supplementary PAINS Results</a>). However, the 10 derivatives passed PAINS and aggregator tests and therefore were synthesized (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figures S3 and S9</a>). These molecular candidates were redocked into Site 1 to estimate their SHP2-binding affinities. The docking results showed that (<i>E</i>)-1-(1-(5-(3-(2,4-dichlorophenyl)acryloyl)-2-ethoxy-4-hydroxybenzyl)-1,2,5,6-tetrahydropyridin-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (LY6, <b>1</b>) had the best docking score (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S2</a>). The Glide scoring was conducted based on the sum of the Coulomb interaction energy, van der Waals energy, lipophilic and hydrogen-bonding terms, and penalty, which included factors that hindered binding. van der Waals interactions dominated all interactions between the ligands and the receptor. Compound <b>1</b> was identified to have the strongest van der Waals interaction energy among all candidates, and it formed a strong H-bond with Glu250 and Thr218, indicating that <b>1</b> occupied the pocket better than other derivatives. The amino acids involved at the binding site in SHP2 included Arg111, Phe113, His114, Gly115, His116, Leu117, Leu125, Lys129, Leu136, Arg138, Thr218, Thr219, Arg220, Ile221, Ser228, Arg229, Glu232, Val243, Lys244, Gln245, Gly246, Glu249, Glu250, and Thr253.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Identification of <b>1</b> as a Novel SHP2 Inhibitor</h3><div class="NLM_p">The ten candidate compounds were then subjected to SHP2 enzymatic assays with a tyrosine phosphorylated peptide as the substrate, which also served as an allosteric activator. These compounds inhibited SHP2 phosphatase activity to various extents (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S4</a>). LY1 and LY7 were subsequently eliminated due to acute toxicity in cells. Compound <b>1</b> was identified as the most active compound among the remaining compounds that inhibited SHP2 activity (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S4</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A). As <i>PTPN11</i> (SHP2) activating mutations are mainly associated with JMML, which is characterized by hypersensitity of myeloid progenitors to GM-CSF and IL-3;<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> it is critically important to determine the inhibitory activity of <b>1</b> against the homologous SHP1 phosphatase because SHP2 and SHP1 play opposing roles in these cytokine signaling pathways (due to the functional specificity determined by their SH2 domains). As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B, <b>1</b> inhibited SHP2-catalyzed hydrolysis of the phospho-peptide substrate with an IC<sub>50</sub> value of 9.8 μM, whereas the IC<sub>50</sub> of <b>1</b> for SHP1 was 72.7 μM. Although LY3 and LY5 showed good effects on SHP2, they inhibited the SHP1 phosphatase to a similar extent (i.e., no selectivity between SHP2 and SHP1; data not shown). Therefore, LY3 and LY5 were eliminated.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Identification of <b>1</b> as a novel inhibitor of SHP2. (A) Chemical structure of <b>1</b>. (B) Phosphatase assays were carried out using full length SHP2 or SHP1 as the enzyme and a phospho-peptide as the substrate in the presence of various concentrations of <b>1</b>, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. For IC<sub>50</sub> determinations, six concentrations of <b>1</b> were tested. Results shown are the mean ± SD of three independent experiments. (C) Phosphatase activities of full length WT SHP2, full length SHP2 E76K, and the SHP2 PTP domain were assessed in the presence of <b>1</b> at various concentrations as above. IC<sub>50</sub> values were then determined. Experiments were repeated independently three times, similar results were obtained in each experiment. Results shown are the mean ± SD of triplicates from one experiment. (D) Phosphatase activities of full length WT SHP2, full length SHP2 E76K, and the SHP2 PTP domain were determined in the presence of <b>1</b> (10 μM) using a phospho-peptide or <i>p</i>NPP as the substrate, as detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Experiments were repeated independently three times, similar results were obtained in each experiment. Results shown are the mean ± SD of triplicates from one experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Docking simulation analyses demonstrated that <b>1</b> created three hydrogen bonds with Arg111, Lys129, and Arg229 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S5A</a>). Moreover, the dichloro-phenyl ring of <b>1</b> occupied the hydrophobic pocket made up of Leu117, Leu125, Leu136, and Leu216. Compound <b>1</b> possessed an L-shaped structure and fitted well in the pocket of SHP2, connecting C-SH2 and PTP domains through hydrogen bonds and hydrophobic interactions. Binding energy calculation showed that <b>1</b> occupied Site 1 with high binding energy (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S6A</a>), similar to the binding energy of the newly identified allosteric SHP-2 inhibitor SHP099<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> when docking into its binding site (<a href="http://www.RCSB.org" class="extLink">http://www.RCSB.org</a>; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>). While <b>1</b> docked into Site 1 with docking score of −7.3, it could not dock into the SHP099 binding site due to limited space. Interestingly, <b>1</b> gained more binding energy when docking into Site 1 than did SHP099 when docking into its binding site (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S6B</a>).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Molecular Dynamics (MD) Simulation of the <b>1</b>/SHP2 Binding Interaction</h3><div class="NLM_p">Many biological functions of proteins and their profound dynamic mechanisms, such as switching between active and inactive states,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> cooperative effects,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> allosteric transition,<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and intercalations with drugs can be revealed by studying their internal motions. In order to understand the allosteric mechanism of a ligand with its receptor, both the static structures and the dynamics information should be considered. Therefore, MD simulations were performed to further define the <b>1</b>/SHP2 interaction. The root-mean-square deviation (RMSD) as compared with the initial conformation is a crucial criterion for evaluating the reliability and stability of drug/protein systems. The RMSD of four complexes (SHP2-<b>1</b>, SHP1-<b>1</b>, SHP2 alone, and SHP1 alone) versus the simulation times is illustrated in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S7A</a>, in which the RMSD of the SHP2-<b>1</b> interaction is lower than those of the other systems, indicating that the movement of SHP2 might be circumscribed when binding with <b>1</b>, which would reduce the activity of SHP2 because activation of SHP2 requires protein conformational changes from the closed autoinhibited conformation to the open conformation. In contrast, the motion of SHP1 could hardly be suppressed by <b>1</b> during the simulation process.</div><div class="NLM_p last">In order to evaluate the motion of the key residues interacting with <b>1</b> at the binding site in SHP2 defined in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S5A</a>, the root-mean-square fluctuations (RMSF) for all residues of the SHP2 protein were calculated. The most flexible region for SHP2 is made up of residues 111–206, corresponding to the C-SH2 domain. Compound <b>1</b> was designed to concurrently bind to the C-SH2 domain and the PTP domain. The interaction between <b>1</b> and the receptor SHP2 made the whole system stable, decreasing the flexibility of the C-SH2 domain in the meantime. The fluctuating magnitude of SHP2 decreased when binding to <b>1</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S7B</a>), indicating that SHP2 is more stable when bonded with <b>1</b>. In contrast, <b>1</b> could hardly lower the movement of key residues in SHP1 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S7A,B</a>), further supporting that <b>1</b> is selective for SHP2 over SHP1. Ten nanosecond MD simulation of the <b>1</b>/SHP2 binding (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S5B</a>) predicts that <b>1</b> creates three hydrogen bonds with Thr218, Arg220, and Arg229 of SHP2. The dichloro-phenyl ring of <b>1</b> is still in the hydrophobic region of the pocket consisting of Leu117, Leu125, Leu136, and Leu216. The hydrogen bond between Arg111 and <b>1</b> is broken under MD simulation, while Arg111 forms a salt bridge with Glu250. By comparing the binding modes of <b>1</b> after and before MD simulations, it appears that <b>1</b> stays tightly in the binding pocket of SHP2, indicating that the interaction between <b>1</b> and SHP2 is stable.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Compound <b>1</b> Also Inhibits Leukemia-Associated Mutant SHP2</h3><div class="NLM_p">The E76K mutation, localized in the N-SH2 domain, is the most common and active <i>PTPN11</i> mutation found in leukemias. This mutation causes a partially open conformation in SHP2 due to the disruption of the intramolecular interaction. To further characterize the acting mechanisms of <b>1</b>, we purified GST fusion proteins of wild-type (WT) full-length SHP2 and the full-length SHP2 E76K mutant, and compared sensitivities of these SHP2 proteins to <b>1</b>. Compound <b>1</b> inhibited the full length SHP2 E76K mutant in a dose-dependent manner, with an IC<sub>50</sub> value of 7.67 μM, which is slightly lower than that for full length WT SHP2 (9.8 μM) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). The fact that the IC<sub>50</sub> values of <b>1</b> for WT SHP2 and SHP2 E76K were in a similar range suggests that <b>1</b> was able to “close” WT SHP2 and SHP2 E76K, regardless of the status of their basal conformations. Another possibility is that the phospho-peptide substrate used in the phosphatase assay also functioned as an allosteric activator “opening up” protein conformations of WT SHP2 and SHP2 E76K, regardless of the basal status, and similarly opened conformations resulted in similar <b>1</b> concentrations required to achieve 50% inhibition of SHP2 enzymatic activity.</div><div class="NLM_p">We also tested the inhibitory effect of <b>1</b> on GST-SHP2 PTP domain without SH2 domains. It inhibited the phosphatase activity of SHP2 PTP, although SHP2 PTP had a completely open conformation. This result indicates that the binding of <b>1</b> with SHP2 PTP somehow interfered with the peptide substrate–enzyme interaction. However, the fact that the IC<sub>50</sub> value (20.87 μM) of <b>1</b> for the SHP2 PTP domain was >2-fold higher than that for full length WT SHP2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C) supports that <b>1</b> functions by stabilizing the inhibitory closed conformation of full length SHP2. To further characterize the acting mechanisms of <b>1</b>, we also tested its effect on SHP2 catalytic activity using <i>para</i>-nitrophenylphosphate (<i>p</i>NPP), a general small compound substrate for all PTPs. <i>p</i>NPP is much smaller than the phospho-peptide substrate and can easily get access to SHP2 catalytic core. Dephosphorylation of this small interrogate substrate does not require a substantial conformational change in SHP2. Indeed, <b>1</b> did not affect the capability of SHP2 to dephosphorylate <i>p</i>NPP (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D), regardless of what form of SHP2 protein was used as the enzyme, suggesting that <b>1</b> binding does not interfere with the access of this small substrate to SHP2 catalytic core.</div><div class="NLM_p">Furthermore, we performed enzymatic kinetic studies (Lineweaver–Burk plot) in the absence or presence of <b>1</b>. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, <i>V</i><sub>max</sub> decreased, while <i>K</i><sub>m</sub> increased when the <b>1</b>/SHP2 binding increased with increasing concentrations of <b>1</b>, suggesting that <b>1</b> is a mixed type inhibitor against SHP2 (not a competitive or noncompetitive inhibitor). We also tested the inhibitory effect of <b>1</b> on SHP2 by extensively washing the enzyme–inhibitor complex. The results indicated that the <b>1</b>/SHP2 binding was stable (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S8A</a>). In addition, to exclude the possibility that the inhibition of SHP2 by <b>1</b> was a promiscuous effect, we tested the activity of <b>1</b> in the presence of the detergent Triton X-100 and found that the <b>1</b>-SHP2 complex was stable and that the inhibitory function of <b>1</b> was not decreased by 0.001% Triton X-100 in the assay buffer (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S8B</a>). However, the inhibition of SHP2 by <b>1</b> was diminished by 0.01% Triton X-100, suggesting that the <b>1</b>/SHP2 binding affinity is low. To further determine whether <b>1</b> directly bonds to the SHP2 protein, we performed the SHP2 fluorescence quenching assay, taking advantage of the seven tryptophans in the protein. As demonstrated in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B, this drug exhibited strong quenching of SHP2 fluorescence in a dose-dependent manner. Thermal shift assays also verified the binding of <b>1</b> and SHP2, as evidenced by dose-dependent right shifts in melting temperature (<i>T</i><sub>m</sub>) (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). Furthermore, quantitative MicroScale Thermophoresis (MST) binding affinity assays demonstrated specific binding between <b>1</b> and His-tagged SHP2 and that their interaction was not irreversible. The equilibrium dissociation constant (<i>K</i><sub>d</sub>) of the <b>1</b>/SHP2 complex was 69 ± 3 μM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). The <i>K</i><sub>d</sub> value of <b>1</b> derived from the MST assay was much lower than its IC<sub>50</sub> value from the phosphatase assay, likely because the buffer conditions, e.g., chemical components and their concentrations, pH, etc., were significantly different in the two assays (different solution conditions could effectively modify the strength of any intermolecular interactions holding a particular ligand–protein complex together).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>1</b> directly binds to the SHP2 protein and functions as an inhibitor. (A) Enzymatic kinetic analyses in the presence or absence of <b>1</b> were performed using full length WT SHP2 (0.1 μg) as the enzyme. Compound <b>1</b> concentrations used in this experiment were 0, 10, and 20 μM. Lineweaver–Burk plot was generated to show <b>1</b>-mediated SHP2 inhibition. Experiments were repeated independently three times. Results shown are the mean ± SD of three independent experiments. (B) Fluorescence titration of SHP2 was performed by increasing the concentrations of <b>1</b> while maintaining the WT SHP2 protein concentration at 3.0 μM. The fluorescence intensity is plotted against the log concentration in mol/L (Log[M]). Experiments were repeated independently three times, similar results were obtained in each experiment. Data shown are the mean ± SD of triplicates from one representative experiment. (C) Thermal shift assays were performed as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Representative dose response melting curves of His-tagged SHP2 in the presence of <b>1</b> are shown. <i>T</i><sub>m</sub> data shown are the mean ± SD of three independent experiments. (D) MST binding affinity assays were performed as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. One representative dose–response curve of <b>1</b> binding to His-tagged SHP2 is shown. Fnorm, normalized fluorescence. Experiments were repeated independently three times. Reported <i>K</i><sub>d</sub> is the mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Compound <b>1</b> Inhibits SHP2-Mediated Cell Signaling and Cellular Function</h3><div class="NLM_p"><i>PTPN11</i> (SHP2) activating mutation-associated JMML exhibits hypersensitivity to GM-CSF and IL-3,<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> and previous studies have demonstrated that SHP2 promotes IL-3-stimulated cell proliferation by enhancing activation of Erk, Akt, and Jak2,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> in sharp contrast to the SHP1 phosphatase, which negatively regulates these cytokine signals. It is critically important to test the effects of any potential SHP2 inhibitors in these cytokine-induced signals and cellular responses. Ba/F<sub>3</sub>, an IL-3 dependent murine pro-B lymphoma cell line, was utilized to determine the effects of <b>1</b> on SHP2-mediated cell signaling and cellular functions. This compound significantly suppressed cell growth (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), in agreement with the overall positive role of SHP2 catalytic activity in cellular response to IL-3. To determine whether <b>1</b> functioned by inhibiting SHP2-mediated cell signaling, we examined the effects of <b>1</b> on IL-3-induced signaling processes. Following IL-3 stimulation, activation of Erk, Akt, Jak2, and Stat5, determined by their phosphorylation levels, was inhibited by <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B,C), and this effect was clearly <b>1</b> dose-dependent, consistent with the previous finding that SHP2 catalytic activity was required for optimal activation of IL-3-induced signaling pathways.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> These results suggest that <b>1</b> suppresses IL-3 signaling and cellular responses through a mechanism involving inhibition of SHP2 catalytic activity.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>1</b> inhibits IL-3-induced signaling and cell proliferation. (A) Ba/F<sub>3</sub> cells were cultured in IL-3 (1.0 ng/mL) containing medium supplemented with <b>1</b> at the indicated concentrations or DMSO. Cell numbers were determined 48 h later using a One Solution Cell Proliferation Assay kit. Experiments were performed three times with similar results obtained in each. Data shown are the mean ± SD of triplicates from one representative experiment. (B) Ba/F<sub>3</sub> cells were deprived of IL-3 overnight. Cells were treated with <b>1</b> (20 μM) for 4 h and then stimulated with IL-3 (2.0 ng/mL) for the indicated times. (C) Ba/F<sub>3</sub> cells were deprived of IL-3 overnight. Cells were treated with <b>1</b> at the indicated concentrations for 4 h and then stimulated with IL-3 (2.0 ng/mL) for 10 min. Whole cell lysates were prepared. Levels of p-Erk, p-Akt, p-Jak2, and p-Stat5 were determined by immunoblotting analyses. Blots were striped and reprobed with anti-Erk, anti-Akt, anti-Jak2, and anti-Stat5 antibodies to check for protein loading. Experiments were repeated independently three times. Representative results from one experiment are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Compound <b>1</b> Has Minimal Off-target Effects</h3><div class="NLM_p">To confirm that the cellular effects of <b>1</b> were mediated by acting on SHP2, <i>PTPN11</i> (SHP2) knockout cells were treated with <b>1</b>. <i>PTPN11</i> conditional knockout (<i>PTPN11</i><sup><i>fl/fl</i></sup><i>/Ade-Cre</i><sup><i>+</i></sup>) and WT control (<i>PTPN11</i><sup><i>+/+</i></sup><i>/Ade-Cre</i><sup><i>+</i></sup>) mouse embryonic fibroblast (MEFs) were treated with <b>1</b> or vehicle. Proliferation of WT cells was markedly decreased by this inhibitor, consistent with the positive role that SHP2 plays in growth factor signaling.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> In contrast, <b>1</b> did not show a significant effect on <i>PTPN11</i>-depleted MEFs (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A). The observation that cells lacking SHP2 were insensitive to <b>1</b> suggests that SHP2 is the main target of this compound.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of <b>1</b> are diminished in SHP2 knockout cells while cells harboring hyperactivated SHP2 are more sensitive to <b>1</b>. (A) <i>Ptpn11</i> conditional knockout (<i>Ptpn11</i><sup><i>fl/fl</i></sup>/Ade-Cre<sup>+</sup>) mouse embryonic fibroblasts (MEFs) and WT (<i>Ptpn11</i><sup><i>+/+</i></sup>/Ade-Cre<sup>+</sup>) control cells were infected with adeno-Cre viruses and then treated with <b>1</b> at 6 μM or DMSO. Cell growth rates were determined at 24, 48, and 72 h using a One Solution Cell Proliferation Assay kit. SHP2 levels in knockout and control cells were analyzed by immunoblotting analyses with anti-SHP2 antibody. Blots were striped and reprobed with anti-β-actin antibody to monitor protein loading. Experiments were performed three times. Similar results were obtained in each. Data shown are the mean ± SD of triplicates from one representative experiment. (B) <i>Ptpn11</i><sup><i>E76K/+</i></sup> and <i>Ptpn11</i><sup><i>+/+</i></sup> control MEFs were treated with <b>1</b> (6 μM). Cell numbers were determined using a One Solution Cell Proliferation Assay kit. Experiments were performed three times. Similar results were obtained in each. Data shown are the mean ± SD of triplicates from one representative experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Tumor Cells Carrying SHP2 Activating Mutations Are More Sensitive to <b>1</b> than Control Cells with WT SHP2</h3><div class="NLM_p">We next assessed the effect of <b>1</b> on mutant cells with a tumor-associated <i>PTPN11</i> activating mutation (<i>PTPN11</i><sup><i>E76K</i></sup>). Treatment of both WT and <i>PTPN11</i><sup><i>E76K/+</i></sup> MEFs with <b>1</b> significantly decreased cell growth (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B). Interestingly, <i>PTPN11</i><sup><i>E76K/+</i></sup> mutant cells were much more sensitive than WT cells to SHP2 inhibition, although the IC<sub>50</sub> value of <b>1</b> for the SHP2 E76K mutant was only slightly lower than that for WT SHP2. Additionally, human lung cancer cells H661 carrying the activating mutation (N58S) in <i>PTPN11</i> and human lung cancer cells H596 with WT <i>PTPN11</i> were treated with <b>1</b>. This compound inhibited proliferation of both two cell lines in a dose-dependent manner. Importantly, H661 cells were more sensitive to <b>1</b> than H596 cells (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Moreover, <b>1</b>-treated H661 cells showed pronounced G2/M arrest (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B), consistent with the positive role of SHP2 in cell cycle progression.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Lung cancer cells harboring hyperactivated SHP2 are more sensitive to <b>1</b> than lung cancer cells expressing WT SHP2. (A) Human lung cancer cell line H661 carrying the <i>PTPN11</i><sup><i>N58S/+</i></sup> mutation and H596 with WT <i>PTPN11</i> were treated with <b>1</b> at the indicated concentrations for 48 h. DMSO-treated cells were included as negative controls. Cell numbers were determined using a One Solution Cell Proliferation Assay kit. Experiments were repeated three times, similar results were obtained in each experiment. Data are presented as the mean ± SD of triplicates from one representative experiment. (B) H661 cells were treated with <b>1</b> at 0, 10, and 20 μM. Apoptotic cells were quantified 24 h later by FACS using an Annexin V staining kit. Cell cycle changes were determined by propidium iodide staining followed by FACS analyses. Experiments were performed three times. Apoptosis data presented are the mean ± SD of three experiments. Cell cycle profiles are representatives of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We next determined whether <b>1</b> could suppress colony formation and proliferation of mouse and human leukemic cells with <i>PTPN11</i> activating mutations. Myeloid progenitors from <i>PTPN11</i><sup><i>E76K/+</i></sup> mice showed greatly increased responses to GM-CSF as compared to WT counterparts. These SHP2 E76K-expressing progenitors were much more sensitive than control cells to <b>1</b> inhibition of colony-forming capabilities over a range of concentrations (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). Consistent with this data, colony formation of myeloid blasts from JMML patients with the <i>PTPN11</i><sup><i>E76K/+</i></sup> mutation was exquisitely sensitive to <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Overall, these results suggest that <b>1</b> is able to overcome the dominant effects of SHP2 activating mutations in primary mouse and patient cells, and that SHP2 is a useful therapeutic target for <i>PTPN11</i> mutation-associated hematological malignancies.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Mouse and JMML patient leukemic cells are more sensitive to <b>1</b> than normal control cells. (A) Bone marrow cells harvested from <i>Ptpn11</i><sup><i>E76K/+</i></sup><i>/Mx1-Cre</i><sup><i>+</i></sup> and <i>Ptpn11</i><sup><i>+/+</i></sup><i>/Mx1-Cre</i><sup><i>+</i></sup> mice were plated in methylcellulose medium containing GM-CSF (1.0 ng/mL) and <b>1</b> at the indicated concentrations or DMSO. Hematopoietic colonies that were generated were enumerated 7 days later and normalized against the number of colonies derived from WT control cells treated with DMSO. Data are presented as the mean ± SD of three independent experiments. (B) Splenocytes/marrow cells/blood cells from JMML patients with the <i>PTPN11</i><sup><i>E76K/+</i></sup> mutation and apheresis samples from healthy donors were plated in methylcellulose medium containing GM-CSF (1.0 ng/mL) and <b>1</b> at the indicated concentrations or control DMSO. Leukemic colonies that were produced were enumerated 14 days later and normalized against the number of colonies derived from the cells treated with DMSO. Three patient samples and three apheresis samples were tested in three independent experiments. Similar results were obtained in each. Data are presented as the mean ± SD of triplicates from one patient sample.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, by using CADD <i>in silico</i> database screening in combination with experimental assays, we have identified a new SHP2 inhibitor. SHP2, encoded by <i>PTPN11</i>, is an important signaling component downstream of growth factor/cytokine receptors and cell adhesion molecules. Activating mutations of <i>PTPN11</i> that cause enhanced catalytic activity are associated with human diseases, such as Noonan syndrome and childhood leukemias.<a onclick="showRef(event, 'ref7 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref7 ref10 ref11 ref12">(7,10−12)</a> Importantly, these mutations play a causative role in the pathogenesis of these diseases.<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> Therefore, identification of highly selective SHP2 inhibitors is greatly needed and would facilitate the development of therapeutic drugs for these diseases. However, it has been challenging to develop SHP2 selective inhibitors that directly target the active site due to a high homology in these sites among tyrosine phosphatases. To circumvent this problem, a few allosteric inhibitors of SHP2 that inhibit the conformational change required for activation of this enzyme have recently been successfully developed.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23−25)</a> Our structure-based approach in this study was also targeting the activation-associated conformational change, but a different surface pocket formed between C-SH2 and PTP domains. We have identified a novel SHP2 inhibitor (<b>1</b>) through CADD database screening, structural optimization, and cell-based assays.</div><div class="NLM_p">Structure–activity relationship analyses of optimized derivatives suggest that three parts of <b>1</b> function cooperatively in keeping the “closed” autoinhibited conformation of SHP2. (1) The Core part of <b>1</b> is responsible for an interaction with the PTP domain. The hydroxyl group of the Core part (beta-methyloxygenly phenol group) forms firm connections with key residues of the PTP domain via H-bond interactions. The methoxyl group and benzene ring interact with Lys129 and Tyr515 via intermolecular forces. (2) R1 of Fragment 1 acts as a linker of the SH2 domain to stabilize its position by hydrophobic effects and VDW interactions. (3) R2 and R3 of Fragment 2 provide benzene ring effects and possibly other molecular interactions with the SH2 domain. In addition, PTP and SH2 domains are firmly connected via two Cl atoms of Fragment 2. Compound <b>1</b> inhibits SHP2 activity toward a pY-peptide substrate, but not the small compound substrate <i>p</i>NPP (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>D). This is because pY-peptide substrates rely more on SHP2 protein conformational changes than <i>p</i>NPP in order to get access to the catalytic core to be dephosphorylated. It is likely that <b>1</b> functions by inhibiting the activation-associated allosteric change of SHP2, as designed, not targeting the active site. Computational modeling shows that the structure of <b>1</b> complements very well the binding pocket in SHP2 in docking simulation. In addition, MD simulation demonstrates that movement of the SHP2 protein is suppressed upon binding with <b>1</b>, further supporting that the autoinhibitory protein conformation of SHP2 is stabilized by <b>1</b>.</div><div class="NLM_p"><i>PTPN11</i> (SHP2) activating mutations are associated with JMML, which display a characteristic hypersensitive growth pattern in response to GM-CSF and IL-3.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Compound <b>1</b> inhibited IL-3-stimulated cell proliferation and suppressed IL-3-induced Ras-Erk, PI3K-Akt, and Jak2-Stat5 pathways. Given the positive roles that the SHP2 phosphatase plays in these signaling pathways, the function of <b>1</b> in this context is likely mediated by inhibition of the catalytic activity of SHP2. Interestingly, mouse and human leukemia cells carrying the activating mutation SHP2 E76K were much more sensitive than control cells with WT SHP2 to the inhibition by <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), although the SHP2 E76K protein was only slightly more sensitive to <b>1</b> than WT SHP2 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C). Part of the reason for this might be the addiction of leukemic cells to this disease causing oncoprotein. The differential sensitivity of <i>PTPN11</i> activated leukemia cells and normal control cells to SHP2 inhibition provides proof of concept that SHP2 is a “druggable” target for the treatment of <i>PTPN11</i>-associated malignancies.</div><div class="NLM_p last">Compound <b>1</b> appears to function as an allosteric inhibitor of SHP2, despite a low SHP2-binding affinity. This inhibitor and the allosteric SHP-2 inhibitor SHP099 recently identified<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> have different binding sites and activities. Compound <b>1</b> was designed to bind to the surface pocket of SHP2 formed between C-SH2 and PTP domains. This drug docking site (Site 1) is different from the binding site of SHP099,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> which concomitantly binds to N-SH2, C-SH2, and PTP domains (<a href="http://www.RCSB.org" class="extLink">http://www.RCSB.org</a>; PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>). Given that the structures and the SHP2-binding sites of these two inhibitors are completely different, they have distinct biochemical activities in inhibiting the function of WT SHP2 and SHP2 variants. This is especially the case when different phospho-peptides or interrogate compounds were used as the substrate in phosphatase assays. More biochemical/biological studies with tumor-associated mutant SHP2 and SHP2-mutated tumor cells will be necessary to further compare the functions of these two inhibitors. It is important to point out that, while <b>1</b> is a drug-like small molecule that is bioavailable in cells, <b>1</b>/SHP2 binding affinity is low. Further structure–activity relationship analysis for this compound is needed to establish independent intellectual property positions that will allow pharmacological validation of its effect on SHP2 inhibition for the development of analogues for further preclinical and clinical studies. In addition, cocrystallization of <b>1</b> and SHP2 is required to reveal the structural bases of their binding interaction, which will be essential for structural optimization of <b>1</b>. The structural bases of the <b>1</b>/SHP2 binding can also address the mechanisms of action of this inhibitor and other related questions regarding the biochemical activities of this inhibitor.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Reagents and Chemicals</h3><div class="NLM_p last">The CellTiter 96 AQueous One Solution Cell Proliferation Assay kit was purchased from Promega (Madison, WI, USA). Antibodies specific for p-Erk (E-4), Erk (C-16), Jak2 (C-20), and SHP2 (C-18) were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Antibodies against p-Akt (S473), Akt, and p-Stat5 (Y694) were obtained from Cell Signaling Technology (Beverly, MA, USA). Stat5 antibody was purchased from BD Biosciences (San Jose, CA, USA). Antibodies specific for p-Jak2 (Y1007/1008) and phosphor-tyrosine (pY) were purchased from Millipore Corporation (Temecula, CA, USA). Horseradish peroxidase conjugated goat-antirabbit and antimouse IgG were purchased from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA, USA). Dimethyl sulfoxide and other chemicals used for buffer solutions were provided by Fisher Scientific (Pittsburgh, PA, USA). LY series compounds, including <b>1</b>, were obtained from Tianjin Institute of Pharmaceutical Research. (Tianjin, China) and dissolved in DMSO to prepare a stock solution (20 mM) for subsequent experiments. The purity of all test compounds was ≥98% by HPLC.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Compound Synthesis and Characterization</h3><div class="NLM_p">Compound <b>1</b> was synthesized using 1-(2,4-dihydroxyphenyl) ethan-1-one and diethyl sulfate as starting materials with four-step reactions (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S3</a>). The synthesis of other derivatives is described in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Figure S9</a>.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 1-(4-Ethoxy-2-hydroxyphenyl) Ethan-1-one</h4><div class="NLM_p last">A mixture of 1-(2,4-dihydroxyphenyl) ethan-1-one (19.8 g, 130 mmol) and diethyl sulfate (40.5 g, 520 mmol) was stirred in 300 mL of acetone at room temperature for 24 h. The solution was heated to reflux for 1 h and then filtered. Desolventized mixture was washed by 50 mL of water three times and extracted by 100 mL of ethyl acetoacetate three times. A crude product [(Building block (2)] was obtained. The product was used in the next step without any further purification.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 1-(5-(Chloromethyl)-4-ethoxy-2-hydroxyphenyl) Ethan-1-one</h4><div class="NLM_p last">Building block (2) (15.0 g, 83 mmol) was dissolved in chloromethyl methyl ether (14.0 g, 122 mmol). The solution was diluted in 100 mL of acetic acid and stirred at ambient temperature for 24 h. After removing the solvent under reduced pressure, the product [(Building block (3)] (7.7 g, 33.6 mmol) was obtained with yield of 27.5%.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-(1-(5-Acetyl-2-ethoxy-4-hydroxybenzyl)-1,2,5,6-tetrahydropyridin-3-yl)-1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2-one</h4><div class="NLM_p last">K<sub>2</sub>CO<sub>3</sub> (1.74g, 12.6 mmol) and 1-(1,2,5,6- tetrahydropyridin-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one (11g, 50.4 mmol) were added into the solution of Building block (3) (7.7 g, 33.6 mmol) in 30 mL of ethyl acetoacetate at room temperature and stirred for 24 h. The solvent was removed under reduced pressure and then washed by brine and 1 M hydrochloric acid three times, respectively. The solution was extracted by ethyl acetoacetate after adjusting pH to 8–9 by 1 M K<sub>2</sub>CO<sub>3</sub>. After the volatile solvent of the reaction was evaporated, 15.3 g of yellow pale oily raw product [(Building block (4)] was obtained.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (<i>E</i>)-1-(1-(5-(3-(2,4-Dichlorophenyl)acryloyl)-2-ethoxy-4-hydroxybenzyl)-1,2,5,6-tetrahydropyridin-3-yl)-1<i>H</i>-benzo[<i>d</i>]imidazol-2(3<i>H</i>)-one</h4><div class="NLM_p last">Building block (4) (1.12g, 2.5 mmol), 2,4-dichlorobenzaldehyde (0.88g, 5 mmol), and 0.7 g KOH (0.7 g, 12 mmol) were mixed and stirred in 9 mL of ethanol and 2 mL of water at room temperature for 24 h. The product was recrystallized in 15 mL of ethanol after discarding the volatile solvent. Then, 0.3 g of compound (22.4%) was obtained as the final product (LY6, <b>1</b>). The purity and the structure of this final product were determined by high-performance liquid chromatography (HPLC) and nuclear magnetic resonance (NMR), respectively (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">Supplementary HPLC and NMR results</a>).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Virtual Screening and Core-Hopping Procedure <i>in Silico</i></h3><div class="NLM_p last">The database of small structures from NCI, USA was screened by the Glide docking package of the Schrödinger suite 2010<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> based on the 3D structure of residues in the designated binding pocket in SHP2. Protein and small compound structures were geared up by Protein Preparation Wizard and LigPrep modules embedded in Schrödinger suite 2010 (<a href="http://www.schrodinger.com" class="extLink">www.schrodinger.com</a>),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> respectively. All investigated structures in the NCI database were docked into the defined pocket using the rigid docking model with the stand-precision scoring function<a onclick="showRef(event, 'ref34 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref36">(34,36)</a> to estimate the binding affinities. In order to enhance binding affinity, the program Core-Hopping<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> in Schrödinger suite 2010 was utilized in this study, which had dual functions (including fragment-based replacing and molecular docking). OPLS2005 force field<a onclick="showRef(event, 'ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref37 ref38">(37,38)</a> was recruited in all assays performed <i>in silico</i>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Molecular Dynamics (MD) Simulation</h3><div class="NLM_p last">To examine whether the inhibitor remains bound in the presence of explicit solvent from a dynamic point of view, the MD simulation was performed with GROMACS 96–53a6 force fields<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> with the periodic boundary conditions by using the GROMACS 4.5 package for Linux. The topology files and charges for the ligand atoms were generated by the Dundee PRODRG2.5 Server.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> After minimization of the potential energy of the whole system, 10 ns MD simulations were carried out with a time interval of 2 fs; corresponding coordinates were stored every 10 fs. The PME algorithm was used to calculate the electrostatic interactions. All simulations were run under the periodic boundary condition with NVT ensemble by using the V-rescale coupling algorithm to keep the temperature at 310 K and pressure at 1 atm. All bonds were constrained by using the LINCS algorithm. The GROMACS 4.5 package was utilized to analyze the results. The initial complex structures of <b>1</b>-SHP1 and <b>1</b>-SHP2 for MD simulation were from docking calculations (<a class="ref internalNav" href="#notes1" aria-label="Supplementary PDB Files 1 and 2">Supplementary PDB Files 1 and 2</a>).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Protein–Ligand Binding Energy Calculation</h3><div class="NLM_p">The binding energy was calculated as follows. The coulomb interaction energies between protein and ligand were computed by <a class="ref internalNav" href="#eq1" aria-label="eq 1">eq 1</a> where <i>q</i><sub><i>i</i></sub> and <i>q</i><sub><i>j</i></sub> are the formal charge associated with atomic centers <i>i</i> and <i>j</i>, which were the residues in the C-SH2 and PTP domain, respectively. <i>R</i><sub><i>ij</i></sub> is the distance between them. <i>F</i> = 138.935 and ε<sub>r</sub> is the dielectric constant.<span class="NLM_disp-formula" id="eq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_m001.gif" alt="" id="_i24" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">The van der Waals interaction energies between protein and ligand equals<span class="NLM_disp-formula" id="eq2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_m002.gif" alt="" id="_i25" /></img><span class="labelSpan">(2)</span></span><span class="NLM_disp-formula" id="eq3"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_m003.gif" alt="" id="_i26" /></img><span class="labelSpan">(3)</span></span><span class="NLM_disp-formula" id="eq4"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_m004.gif" alt="" id="_i27" /></img><span class="labelSpan">(4)</span></span></div><div class="NLM_p last">As the parameters <i>C<sub>ij</sub></i><sup>(6)</sup> and <i>C<sub>ij</sub></i><sup>(12)</sup> depend on pairs of atom types, they were taken from a matrix of Lennard-Jones parameters. <i>R<sub>ij</sub></i> was the distance between them.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>In Vitro</i> Phosphatase Activity Assay</h3><div class="NLM_p last">Purified SHP2 and SHP1 phosphatases purchased from Enzo Life Sciences (Farmingdale, NY, USA) were used as enzymes, and a phospho-peptide (H-Glu-Phe-<b>pTyr</b>-Ala-Glu-Val-Gly-Arg-Ser-Pro-Pro-Asp-Pro-Ala-Lys) (BML-P157, Enzo Life Sciences Inc., NY, USA) was used as the substrate, which also functions as an activator of SHP2 by binding to the N-SH2 domain. The assay determines free phosphate generated by dephosphorylation of the substrate by using the Malachite Green reagent (Sigma, St. Louis, MO, USA). In brief, 0.1 μg of SHP2 or SHP1 was incubated in 40 μL of the assay buffer (25 mM Tris-HCl, pH 7.4, 50 mM NaCl, 5 mM DTT, and 2.5 mM EDTA) with test compounds at various concentrations at room temperature for 30 min. The substrate was then added to a final concentration of 50 μM. The mixture was incubated at 30 °C for 30 min. Finally, 50 μL of Malachite Green solution was added and OD<sub>620</sub> was measured after 10 min. Under these conditions, the absorbance readings of the phosphatase assays with SHP2 E76K or SHP2 PTP as the enzyme were still within the linear calibration range. For the phosphatase assay with <i>p</i>NPP as the substrate, 0.1 μg of SHP2 or its mutants was incubated in 60 μL of the assay buffer as above with <b>1</b> at various concentrations at 37 °C for 15 min, followed by addition of 90 μL of <i>p</i>NPP to the final concentration of 0.9 mg/mL. The mixture was incubated at 37 °C for 15 min and OD<sub>405</sub> was then measured.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Fluorescence Titration</h3><div class="NLM_p last">Purified full length WT SHP2 GST-fusion protein was diluted into 20 mM Tris-HCl, pH 7.5. Fluorescence spectra were recorded with a Luminescence Spectrometer LS50 (PerkinElmer, Boston, MA, USA). Titrations were performed by increasing the concentration of the compound while maintaining the SHP2 protein concentration at 3.0 μM. Contributions from background fluorescence of the inhibitor were accounted for by subtracting the fluorescence of the inhibitor alone from the protein–inhibitor solution. The excitation wavelength was 295 nm, and fluorescence was monitored from 360 to 500 nm. All reported fluorescence intensities were relative values and were not corrected for wavelength variations in detector response.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Thermal Shift Assay</h3><div class="NLM_p last">Thermal shift assays were performed as previously described.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> In brief, in a 20 μL final reaction system, purified His-tagged SHP2 protein (1 μg) in the buffer (50 mM Tris-HCl, pH 8.0, 500 mM NaCl, and 50 mM imidazole) was mixed with 10 μL of 5× Sypro Orange Protein Gel Stain (Life Technologies) (diluted in 100 mM HEPES, pH 7.5). Then, 0.2 μL of compound <b>1</b> dissolved in DMSO was added to final concentrations of 5, 10, and 60 μM. 1% (V/V) DMSO was used as the control. Samples were heated in a QuantStudio 3 Real-Time PCR System (ThermoFisher Scientific) from 22 to 95 °C in steps of 1 °C every 50 s. Melting curves were analyzed with Protein Thermal Shift Software Version 1.3 (ThermoFisher Scientific) to determine melting temperature (<i>T</i><sub>m</sub>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> MicroScale Thermophoresis (MST) Assay</h3><div class="NLM_p last">Purified His-tagged SHP2 protein (200 nM) in 100 μL of buffer (50 mM Tris-HCl, pH 8.0, 10 mM NaCl, and 0.005% Tween 20) was labeled with red-tris-NTA dye using a Monolith NT His-tag labeling kit (NanoTemper Technologies) following the protocol provided by the manufacturer. Compound <b>1</b> (600 μM) was diluted with PBST (PBS buffer containing 0.005% Tween 20) in 15 two-fold serial dilutions. Ten microliters of labeled protein was mixed with 10 μL of diluted <b>1</b> at various concentrations, and the mixtures were loaded to standard capillaries. Binding assays were run with a red filter on a Monolith NT.115 (NanoTemper Technologies). Automated MST measurement was performed with an MST power of 50%. The resulting dose–response curve was fitted to a one-site binding model to extract a <i>K</i><sub>d</sub> value.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Western Blot Analysis</h3><div class="NLM_p last">Ba/F<sub>3</sub> cells were starved overnight in serum-free and cytokine-free RPMI1640. Cells were then treated with <b>1</b> for 4 h before stimulation with IL-3 (2 ng/mL). Stimulated cells were harvested and lysed on ice with RIPA buffer containing 50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM NaF, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM PMSF, and protease inhibitor cocktail (Roche, Indianapolis, IN, USA). Equivalent amounts of protein (50 μg) were resolved on 10% SDS-PAGE and transferred to nitrocellulose membranes (Millipore, Bedford, MA, USA). Membranes were blocked with 2% BSA in TBS (20 mM Tris-HCl, pH 7.4 and 150 mM NaCl) for 1 h at room temperature and probed with primary antibodies overnight at 4 °C. Blots were washed with TBST and exposed to HRP conjugated goat-antimouse or goat-antirabbit secondary antibodies for 1 h at room temperature. Immunoreactive bands were detected by using ECL Plus Reagents (GE Healthcare, Piscataway, NJ, USA).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Colony-Forming Unit Assay</h3><div class="NLM_p last">Mouse bone marrow cells (2 × 10<sup>4</sup> cells/mL) or patient splenocytes or blood cells (5 × 10<sup>4</sup> cells/mL) were assayed for colony forming units (CFUs) in 0.9% methylcellulose IMDM containing 30% FBS, glutamine (10<sup>–4</sup> M), β-mercaptoethanol (3.3 × 10<sup>–5</sup> M), GM-CSF (1.0 ng/mL), and varying concentrations of <b>1</b> or the equivalent amount of DMSO. After 7 days (mouse bone marrow cells) or 14 days (patient cells) of culture at 37 °C in a humidified 5% CO<sub>2</sub> incubator, myeloid colonies (CFU-GM and CFU-M) were counted under an inverted microscope.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Statistical Analysis</h3><div class="NLM_p last">Data are presented as mean ± SD. Statistical significance was determined using unpaired two-tailed Student’s <i>t</i> test. <i>p</i> < 0.05 was considered statistically significant.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00513" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60744" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60744" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00513" class="ext-link">10.1021/acs.jmedchem.8b00513</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Top hits from the initial virtual database screening; PAINS results of the top 100 hits from the initial database screening and the ten derivatives of NSC681129; Proton NMR data of <b>1</b>; Proton NMR spectra data of <b>1</b>; NMR results of other derivatives synthesized; HPLC data of all derivatives synthesized (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Complex structures of <b>1</b> with SHP1 and SHP2 (PDB, PDB)</p></li><li><p class="inline">Molecular formula strings of <b>1</b> (CSV)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf">jm8b00513_si_001.pdf (809.42 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00513" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85780" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85780" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng-Kui Qu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood
Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30322, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicine, Division of Hematology and Oncology, Case Comprehensive
Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4256-8652" title="Orcid link">http://orcid.org/0000-0002-4256-8652</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#90f3f8f5fef7bdfbe5f9bee1e5d0f5fdffe2e9bef5f4e5"><span class="__cf_email__" data-cfemail="e2818a878c85cf89978bcc9397a2878f8d909bcc878697">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoqin Wu</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood
Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gang Xu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, Division of Hematology and Oncology, Case Comprehensive
Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaobo Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood
Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30322, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Medicine, Division of Hematology and Oncology, Case Comprehensive
Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Weiren Xu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, Division of Hematology and Oncology, Case Comprehensive
Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qianjin Li</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Division of Hematology/Oncology, Aflac Cancer and Blood
Disorders Center, Children’s Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Liu</span> - <span class="hlFld-Affiliation affiliation">Department
of Medicine, Division of Hematology and Oncology, Case Comprehensive
Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karen A. Kirby</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mignon L. Loh</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Division of Pediatric Hematology-Oncology, University of California, San Francisco, San Francisco, California 94122, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Li</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Anhui Medical University, Hefei 230032, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan G. Sarafianos</span> - <span class="hlFld-Affiliation affiliation">Department
of Pediatrics, Laboratory of Biochemical Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>These authors contributed equally to this work.</p><span class="author-information-subsection-header">Author Contributions</span><p>X.W., G.X., X.L., W.R.X., W.L., Q.L., and K.A.K. conducted the research and summarized the data. M.L.L., J.L., and S.G.S. provided critical reagents and advice on the work. C.K.Q. designed the experiments and provided technical training to the first three authors. X.W., G.X., X.L., W.R.X., and C.K.Q. wrote the manuscript with input from all authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Institutes of Health grant HD087760 and a Hyundai Hope on Wheels Scholar grant (to C.K.Q.).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">SHP-2</td><td class="NLM_def"><p class="first last">Src homology 2 domain-containing phosphatase 2</p></td></tr><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase</p></td></tr><tr><td class="NLM_term">SH2</td><td class="NLM_def"><p class="first last">Src homology 2</p></td></tr><tr><td class="NLM_term">pY</td><td class="NLM_def"><p class="first last">phosphotyrosine</p></td></tr><tr><td class="NLM_term"><i>p</i>NPP</td><td class="NLM_def"><p class="first last"><i>para</i>-nitrophenylphosphate</p></td></tr><tr><td class="NLM_term">NS</td><td class="NLM_def"><p class="first last">Noonan Syndrome</p></td></tr><tr><td class="NLM_term">JMML</td><td class="NLM_def"><p class="first last">Juvenile myelomonocytic leukemia</p></td></tr><tr><td class="NLM_term">WT</td><td class="NLM_def"><p class="first last">wildtype</p></td></tr><tr><td class="NLM_term">CFU</td><td class="NLM_def"><p class="first last">colony forming unit</p></td></tr><tr><td class="NLM_term">CADD</td><td class="NLM_def"><p class="first last">computer-aided drug design</p></td></tr><tr><td class="NLM_term">MST</td><td class="NLM_def"><p class="first last">MicroScale Thermophoresis</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41524" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41524" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, L.</span></span> <span> </span><span class="NLM_article-title">The ’Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/S0968-0004(03)00091-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2FS0968-0004%2803%2900091-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=12826400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-93&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%99Shp%E2%80%99ing+news%3A+SH2+domain-containing+tyrosine+phosphatases+in+cell+signaling&doi=10.1016%2FS0968-0004%2803%2900091-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span></div><div class="casAuthors">Neel, Benjamin G.; Gu, Haihua; Pao, Lily</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Src homol.-2 (SH2) domain-contg. phosphatases (Shps) are a small, highly conserved subfamily of protein tyrosine phosphatases, members of which are present in both vertebrates and invertebrates.  The mechanism of regulation of Shps by ligand binding is now well understood.  Much is also known about the normal signaling pathways regulated by each Shp and the consequences of Shp deficiency.  Recent studies have identified mutations in human Shp2 as the cause of the inherited disorder, Noonan syndrome.  Shp2 mutations might also contribute to the pathogenesis of some leukemias.  In addn., Shp2 might be a key virulence determinant for the important human pathogen, Helicobacter pylori.  Despite these efforts, however, the key targets of each Shp have remained elusive.  Identifying these substrates remains a major challenge for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zIEChntK0rVg90H21EOLACvtfcHk0lgyEKVYe80lBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D&md5=bce9fc3db0a41b29ba605251dc46c64f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2803%2900091-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252803%252900091-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2599Shp%25E2%2580%2599ing%2520news%253A%2520SH2%2520domain-containing%2520tyrosine%2520phosphatases%2520in%2520cell%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D93%26doi%3D10.1016%2FS0968-0004%2803%2900091-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: from genes, to function, to disease</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1038/nrm2039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fnrm2039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=17057753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=833-46&author=N.+K.+Tonks&title=Protein+tyrosine+phosphatases%3A+from+genes%2C+to+function%2C+to+disease&doi=10.1038%2Fnrm2039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: from genes, to function, to disease</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">833-846</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated manner with protein tyrosine kinases to control signalling pathways that underlie a broad spectrum of fundamental physiol. processes.  In this review, I describe recent breakthroughs in our understanding of the role of the PTPs in the regulation of signal transduction and the etiol. of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NdnwoKCC1bVg90H21EOLACvtfcHk0lgyEKVYe80lBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I&md5=20a078267093bb8415d9035a13b8ad17</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2039%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520from%2520genes%252C%2520to%2520function%252C%2520to%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D833%26epage%3D46%26doi%3D10.1038%2Fnrm2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, C. K.</span></span> <span> </span><span class="NLM_article-title">Protein tyrosine phosphatases in the JAK/STAT pathway</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4925</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.2741/3051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.2741%2F3051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=18508557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=4925-32&author=D.+Xuauthor=C.+K.+Qu&title=Protein+tyrosine+phosphatases+in+the+JAK%2FSTAT+pathway&doi=10.2741%2F3051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases in the JAK/STAT pathway</span></div><div class="casAuthors">Xu, Dan; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4925-4932</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in controlling cellular activities in response to extracellular cytokines.  Dysfunctions of the JAK/STAT pathway result in various hematopoietic and immune disorders.  The central events in regulating this pathway are tyrosine phosphorylation and dephosphorylation of the signaling components, which are carried out by protein tyrosine kinases and protein tyrosine phosphatases (PTP), resp.  Here, we review recent advances in the regulatory roles of PTPs, in particular, SHP2 phosphatase, in the JAK/STAT signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH1iYtqQyD_7Vg90H21EOLACvtfcHk0li5iBvqEffOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOjtrs%253D&md5=d3f84b6306220659ef34e4bf43cab87e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2741%2F3051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3051%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%2520in%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2008%26volume%3D13%26spage%3D4925%26epage%3D32%26doi%3D10.2741%2F3051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the tyrosine phosphatase SHP-2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-50&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+structure+of+the+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0li5iBvqEffOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520the%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D50%26doi%3D10.1016%2FS0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trub, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1038/379277a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2F379277a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=8538796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADyaK28Xmtl2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=277-80&author=M.+J.+Eckauthor=S.+Pluskeyauthor=T.+Trubauthor=S.+C.+Harrisonauthor=S.+E.+Shoelson&title=Spatial+constraints+on+the+recognition+of+phosphoproteins+by+the+tandem+SH2+domains+of+the+phosphatase+SH-PTP2&doi=10.1038%2F379277a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</span></div><div class="casAuthors">Eck, Michael J.; Pluskey, Scott; Trub, Thomas; Harrison, Stephen C.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6562</span>),
    <span class="NLM_cas:pages">277-80</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The domain organization of many signaling proteins facilitates a segregation of binding, catalytic and regulatory functions.  The mammalian SH2 domain protein tyrosine phosphatases (PTPs) contain tandem SH2 domains and a single carboxy-terminal catalytic domain.  SH-PTP1 (PTP1C, HCP) and SH-PTP2 (Syp, PTP2C, PTP1D) function downstream from tyrosine kinase-linked insulin, growth factor, cytokine and antigen receptors.  As well as directing subcellular localization by binding to receptors and their substrates, the two SH2 domains of these PTPs function together to regulate catalysis.  Here the authors report the structure of the tandem SH2 domains of SH-PTP2 in complex with monophosphopeptides.  A fixed relative orientation of the two domains, stabilized by a disulfide bond and a small hydrophobic patch within the interface, separates the peptide binding sites by ∼ 40 Å.  The defined orientation of the SH2 domains in the structure, and data showing that peptide orientation and spacing between binding sites is crit. for enzymic activation, suggest that spatial constraints are important in this multidomain protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojp1hm-r1vcbVg90H21EOLACvtfcHk0li5iBvqEffOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmtl2ntw%253D%253D&md5=c4d7380b9e9f320a09cbec59a93673b8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F379277a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379277a0%26sid%3Dliteratum%253Aachs%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DTrub%26aufirst%3DT.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DSpatial%2520constraints%2520on%2520the%2520recognition%2520of%2520phosphoproteins%2520by%2520the%2520tandem%2520SH2%2520domains%2520of%2520the%2520phosphatase%2520SH-PTP2%26jtitle%3DNature%26date%3D1996%26volume%3D379%26spage%3D277%26epage%3D80%26doi%3D10.1038%2F379277a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-54&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+mechanisms+for+SH2+domain+mediated+regulation+of+the+protein+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0li5iBvqEffOPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520mechanisms%2520for%2520SH2%2520domain%2520mediated%2520regulation%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D54%26doi%3D10.1016%2FS0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattikuti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieuw, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtiss, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotlib, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meshinchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Beau, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K. M.</span></span> <span> </span><span class="NLM_article-title">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1182/blood-2003-09-3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1182%2Fblood-2003-09-3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=14644997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=2325-31&author=M.+L.+Lohauthor=S.+Vattikutiauthor=S.+Schubbertauthor=M.+G.+Reynoldsauthor=E.+Carlsonauthor=K.+H.+Lieuwauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=D.+Stokoeauthor=J.+M.+Bonifasauthor=N.+P.+Curtissauthor=J.+Gotlibauthor=S.+Meshinchiauthor=M.+M.+Le+Beauauthor=P.+D.+Emanuelauthor=K.+M.+Shannon&title=Mutations+in+PTPN11+implicate+the+SHP-2+phosphatase+in+leukemogenesis&doi=10.1182%2Fblood-2003-09-3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span></div><div class="casAuthors">Loh, Mignon L.; Vattikuti, Shashaank; Schubbert, Suzanne; Reynolds, Melissa G.; Carlson, Elaine; Lieuw, Kenneth H.; Cheng, Jennifer W.; Lee, Connie M.; Stokoe, David; Bonifas, Jeannette M.; Curtiss, Nicole P.; Gotlib, Jason; Meshinchi, Soheil; Le Beau, Michelle M.; Emanuel, Peter D.; Shannon, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2325-2331</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The PTPN11 gene encodes SHP-2 (Src homol. 2 domain-contg. protein tyrosine Phosphatase), a non-receptor tyrosine protein tyrosine phosphatase (PTPase) that relays signals from activated growth factor receptors to p21Ras (Ras) and other signaling mols.  Mutations in PTPN11 cause Noonan syndrome (NS), a developmental disorder characterized by cardiac and skeletal defects.  NS is also assocd. with a spectrum of hematol. disorders, including juvenile myelomonocytic leukemia (JMML).  To test the hypothesis that PTPN11 mutations might contribute to myeloid leukemogenesis, we screened the entire coding region for mutations in 51 JMML specimens and in selected exons from 60 patients with other myeloid malignancies.  Missense mutations in PTPN11 were detected in 16 of 49 JMML specimens from patients without NS, but they were less common in other myeloid malignancies.  RAS, NF1, and PTPN11 mutations are largely mutually exclusive in JMML, which suggests that mutant SHP-2 proteins deregulate myeloid growth through Ras.  However, although Ba/F3 cells engineered to express leukemia-assocd. SHP-2 proteins cells showed enhanced growth factor-independent survival, biochem. anal. failed to demonstrate hyperactivation of the Ras effectors extracellular-regulated kinase (ERK) or Akt.  We conclude that SHP-2 is an important cellular PTPase that is mutated in myeloid malignancies.  Further investigation is required to clarify how these mutant proteins interact with Ras and other effectors to deregulate myeloid growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwm--W4OxYbVg90H21EOLACvtfcHk0lixxFCubvxCHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D&md5=6c64eb186b172aef05f71c5d3dedbc8e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-09-3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-09-3287%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DLieuw%26aufirst%3DK.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBonifas%26aufirst%3DJ.%2BM.%26aulast%3DCurtiss%26aufirst%3DN.%2BP.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DMutations%2520in%2520PTPN11%2520implicate%2520the%2520SHP-2%2520phosphatase%2520in%2520leukemogenesis%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D2325%26epage%3D31%26doi%3D10.1182%2Fblood-2003-09-3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazzaniga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordeddu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pession, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masera, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorcini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, A.</span></span> <span> </span><span class="NLM_article-title">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1182/blood-2003-11-3876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1182%2Fblood-2003-11-3876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=14982869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=307-13&author=M.+Tartagliaauthor=S.+Martinelliauthor=G.+Cazzanigaauthor=V.+Cordedduauthor=I.+Iavaroneauthor=M.+Spinelliauthor=C.+Palmiauthor=C.+Cartaauthor=A.+Pessionauthor=M.+Aricoauthor=G.+Maseraauthor=G.+Bassoauthor=M.+Sorciniauthor=B.+D.+Gelbauthor=A.+Biondi&title=Genetic+evidence+for+lineage-related+and+differentiation+stage-related+contribution+of+somatic+PTPN11+mutations+to+leukemogenesis+in+childhood+acute+leukemia&doi=10.1182%2Fblood-2003-11-3876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Martinelli, Simone; Cazzaniga, Giovanni; Cordeddu, Viviana; Iavarone, Ivano; Spinelli, Monica; Palmi, Chiara; Carta, Claudio; Pession, Andrea; Arico, Maurizio; Masera, Giuseppe; Basso, Giuseppe; Sorcini, Mariella; Gelb, Bruce D.; Biondi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-313</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">SHP-2 is a protein tyrosine phosphatase functioning as signal transducer downstream to growth factor and cytokine receptors.  SHP-2 is required during development, and germline mutations in PTPN11, the gene encoding SHP-2, cause Noonan syndrome.  SHP-2 plays a crucial role in hematopoietic cell development.  We recently demonstrated that somatic PTPN11 mutations are the most frequent lesion in juvenile myelomonocytic leukemia and are obsd. in a smaller percentage of children with other myeloid malignancies.  Here, we report that PTPN11 lesions occur in childhood acute lymphoblastic leukemia (ALL).  Mutations were obsd. in 23 of 317 B-cell precursor ALL cases, but not among 44 children with T-lineage ALL.  In the former, lesions prevalently occurred in TEL-AML1- cases with CD19+/CD10+/cyIgM- immunophenotype.  PTPN11, NRAS, and KRAS2 mutations were largely mutually exclusive and accounted for one third of common ALL cases.  We also show that, among 69 children with acute myeloid leukemia, PTPN11 mutations occurred in 4 of 12 cases with acute monocytic leukemia (FAB-M5).  Leukemia-assocd. PTPN11 mutations were missense and were predicted to result in SHP-2 gain-of-function.  Our findings provide evidence for a wider role of PTPN11 lesions in leukemogenesis, but also suggest a lineage-related and differentiation stage-related contribution of these lesions to clonal expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK8ifPYTWa1LVg90H21EOLACvtfcHk0lixxFCubvxCHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D&md5=d8a6592845c32adc35c9612bfa1d6a2f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-11-3876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-11-3876%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DCazzaniga%26aufirst%3DG.%26aulast%3DCordeddu%26aufirst%3DV.%26aulast%3DIavarone%26aufirst%3DI.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DPalmi%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DC.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DArico%26aufirst%3DM.%26aulast%3DMasera%26aufirst%3DG.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DSorcini%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DBiondi%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520lineage-related%2520and%2520differentiation%2520stage-related%2520contribution%2520of%2520somatic%2520PTPN11%2520mutations%2520to%2520leukemogenesis%2520in%2520childhood%2520acute%2520leukemia%26jtitle%3DBlood%26date%3D2004%26volume%3D104%26spage%3D307%26epage%3D13%26doi%3D10.1182%2Fblood-2003-11-3876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattikuti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerbing, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meshinchi, S.</span></span> <span> </span><span class="NLM_article-title">PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children’s Cancer Group</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1831</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1038/sj.leu.2403492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fsj.leu.2403492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15385933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVGitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1831-4&author=M.+L.+Lohauthor=M.+G.+Reynoldsauthor=S.+Vattikutiauthor=R.+B.+Gerbingauthor=T.+A.+Alonzoauthor=E.+Carlsonauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=B.+J.+Langeauthor=S.+Meshinchi&title=PTPN11+mutations+in+pediatric+patients+with+acute+myeloid+leukemia%3A+results+from+the+Children%E2%80%99s+Cancer+Group&doi=10.1038%2Fsj.leu.2403492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group</span></div><div class="casAuthors">Loh, M. L.; Reynolds, M. G.; Vattikuti, S.; Gerbing, R. B.; Alonzo, T. A.; Carlson, E.; Cheng, J. W.; Lee, C. M.; Lange, B. J.; Meshinchi, S.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1831-1834</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The PTPN11 gene encodes SHP-2, a nonreceptor protein tyrosine phosphatase that relays signals from activated growth factor receptors to p21ras (Ras) and other signaling mols.  Somatic PTPN11 mutations are common in patients with juvenile myelomonocytic leukemia (JMML) and have been reported in some other hematol. malignancies.  We analyzed specimens from 278 pediatric patients with acute myelogenous leukemia (AML) who were enrolled on Children's Cancer Group trials 2941 and 2961 for PTPN11 mutations.  Missense mutations of PTPN11 were detected in 11 (4%) of these samples.  None of these patients had mutations in NRAS; however, one patient had evidence of a FLT3 alteration.  Four of the patients with PTPN11 mutations (36%) were boys with French-American-British (FAB) morphol. M5 AML (P=0.012).  Patients with mutations also presented with elevated white blood cell counts.  There was no difference in clin. outcome for patients with and without PTPN11 mutations.  These characteristics identify a subset of pediatric AML with PTPN11 mutations that share clin. and biol. features with JMML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdJu1pJ0TC67Vg90H21EOLACvtfcHk0lgLsW484C_AHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVGitbw%253D&md5=5c55af87e820699e45ae71e494651910</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2403492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2403492%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DAlonzo%26aufirst%3DT.%2BA.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLange%26aufirst%3DB.%2BJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26atitle%3DPTPN11%2520mutations%2520in%2520pediatric%2520patients%2520with%2520acute%2520myeloid%2520leukemia%253A%2520results%2520from%2520the%2520Children%25E2%2580%2599s%2520Cancer%2520Group%26jtitle%3DLeukemia%26date%3D2004%26volume%3D18%26spage%3D1831%26epage%3D4%26doi%3D10.1038%2Fsj.leu.2403492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemeyer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahlen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1038/ng1156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-50&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+Hahlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+mutations+in+PTPN11+in+juvenile+myelomonocytic+leukemia%2C+myelodysplastic+syndromes+and+acute+myeloid+leukemia&doi=10.1038%2Fng1156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lgLsW484C_AHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DHahlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520mutations%2520in%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%252C%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D50%26doi%3D10.1038%2Fng1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehler, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Burgt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ion, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalidas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patton, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1038/ng772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-8&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+van+der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=M.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+PTPN11%2C+encoding+the+protein+tyrosine+phosphatase+SHP-2%2C+cause+Noonan+syndrome&doi=10.1038%2Fng772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lgLsW484C_AHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DM.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520PTPN11%252C%2520encoding%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%252C%2520cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D8%26doi%3D10.1038%2Fng772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentires-Alj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paez, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilhack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maris, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugarbaker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">8816</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-1923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1158%2F0008-5472.CAN-04-1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15604238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-20&author=M.+Bentires-Aljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbakerauthor=W.+G.+Richardsauthor=J.+Duauthor=L.+Girardauthor=J.+D.+Minnaauthor=M.+L.+Lohauthor=D.+E.+Fisherauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=M.+Meyersonauthor=W.+R.+Sellersauthor=B.+G.+Neel&title=Activating+mutations+of+the+noonan+syndrome-associated+SHP2%2FPTPN11+gene+in+human+solid+tumors+and+adult+acute+myelogenous+leukemia&doi=10.1158%2F0008-5472.CAN-04-1923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia</span></div><div class="casAuthors">Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S.; Keilhack, Heike; Halmos, Balazs; Naoki, Katsuhiko; Maris, John M.; Richardson, Andrea; Bardelli, Alberto; Sugarbaker, David J.; Richards, William G.; Du, Jinyan; Girard, Luc; Minna, John D.; Loh, Mignon L.; Fisher, David E.; Velculescu, Victor E.; Vogelstein, Bert; Meyerson, Matthew; Sellers, William R.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8816-8820</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The SH2 domain-contg. protein-tyrosine phosphatase PTPN11 (Shp2) is required for normal development and is an essential component of signaling pathways initiated by growth factors, cytokines, and extracellular matrix.  In many of these pathways, Shp2 acts upstream of Ras.  About 50% of patients with Noonan syndrome have germ-line PTPN11 gain of function mutations.  Assocns. between Noonan syndrome and an increased risk of some malignancies, notably leukemia and neuroblastoma, have been reported, and recent data indicate that somatic PTPN11 mutations occur in children with sporadic juvenile myelomonocytic leukemia, myelodysplasic syndrome, B-cell acute lymphoblastic leukemia, and acute myelogenous leukemia (AML).  Juvenile myelomonocytic leukemia patients without PTPN11 mutations have either homozygotic NF-1 deletion or activating RAS mutations.  Given the role of Shp2 in Ras activation and the frequent mutation of RAS in human tumors, these data raise the possibility that PTPN11 mutations play a broader role in cancer.  The authors asked whether PTPN11 mutations occur in other malignancies in which activating RAS mutations occur at low but significant frequency.  Sequencing of PTPN11 from 13 different human neoplasms including breast, lung, gastric, and neuroblastoma tumors and adult AML and acute lymphoblastic leukemia revealed 11 missense mutations.  Five are known mutations predicted to result in an activated form of Shp2, whereas six are new mutations.  Biochem. anal. confirmed that several of the new mutations result in increased Shp2 activity.  The data demonstrate that mutations in PTPN11 occur at low frequency in several human cancers, esp. neuroblastoma and AML, and suggest that Shp2 may be a novel target for antineoplastic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3taKvDtHXBLVg90H21EOLACvtfcHk0lg9SqLU2LoMfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK&md5=f6f9fb8c6e9d5260901a03081db259c7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DActivating%2520mutations%2520of%2520the%2520noonan%2520syndrome-associated%2520SHP2%252FPTPN11%2520gene%2520in%2520human%2520solid%2520tumors%2520and%2520adult%2520acute%2520myelogenous%2520leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D20%26doi%3D10.1158%2F0008-5472.CAN-04-1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keilhack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">30984</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1074/jbc.M504699200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1074%2Fjbc.M504699200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15987685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30984-93&author=H.+Keilhackauthor=F.+S.+Davidauthor=M.+McGregorauthor=L.+C.+Cantleyauthor=B.+G.+Neel&title=Diverse+biochemical+properties+of+Shp2+mutants.+Implications+for+disease+phenotypes&doi=10.1074%2Fjbc.M504699200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Biochemical Properties of Shp2 Mutants: implications for disease phenotypes</span></div><div class="casAuthors">Keilhack, Heike; David, Frank S.; McGregor, Malcolm; Cantley, Lewis C.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30984-30993</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mutations in the Src homol. 2 (SH2)-contg. protein-tyrosine phosphatase Shp2 (PTPN11) underlie half of the cases of the autosomal dominant genetic disorder Noonan syndrome, and somatic Shp2 mutations are found in several hematol. and solid malignancies.  Earlier studies of small nos. of mutants suggested that disease-assocd. mutations cause constitutive (SH2 binding-independent) activation and that cancer-assocd. mutants are more active than those assocd. with Noonan syndrome.  We have characterized a larger panel of Shp2 mutants and find that this "activity-centric" model cannot explain the behaviors of all pathogenic Shp2 mutations.  Instead, enzymic, structural, and math. modeling analyses show that these mutants can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate specificity to varying degrees.  Furthermore, there is no abs. correlation between the mutants' extents of basal activation and the diseases they induce.  We propose that activated mutants of Shp2 modulate signaling from specific stimuli to a subset of effectors and provide a theor. framework for understanding the complex relationship between Shp2 activation, intracellular signaling, and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJx5YZGoBn6bVg90H21EOLACvtfcHk0lg9SqLU2LoMfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D&md5=649d6897855861aa0e6aaaff4ed57125</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504699200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504699200%26sid%3Dliteratum%253Aachs%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DMcGregor%26aufirst%3DM.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DDiverse%2520biochemical%2520properties%2520of%2520Shp2%2520mutants.%2520Implications%2520for%2520disease%2520phenotypes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30984%26epage%3D93%26doi%3D10.1074%2Fjbc.M504699200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaitzidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutok, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">4414</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1182/blood-2008-10-182626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1182%2Fblood-2008-10-182626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=19179468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVGitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=4414-24&author=G.+Chanauthor=D.+Kalaitzidisauthor=T.+Usenkoauthor=J.+L.+Kutokauthor=W.+Yangauthor=M.+G.+Mohiauthor=B.+G.+Neel&title=Leukemogenic+Ptpn11+causes+fatal+myeloproliferative+disorder+via+cell-autonomous+effects+on+multiple+stages+of+hematopoiesis&doi=10.1182%2Fblood-2008-10-182626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Usenko, Tatiana; Kutok, Jeffery L.; Yang, Wentian; Mohi, M. Golam; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4414-4424</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">PTPN11, which encodes the tyrosine phosphatase SHP2, is mutated in approx. 35% of patients with juvenile myelomonocytic leukemia (JMML) and at a lower incidence in other neoplasms.  To model JMML pathogenesis, the authors generated knock-in mice that conditionally express the leukemia-assocd. mutant Ptpn11D61Y.  Expression of Ptpn11D61Y in all hematopoietic cells evokes a fatal myeloproliferative disorder (MPD), featuring leukocytosis, anemia, hepatosplenomegaly, and factor-independent colony formation by bone marrow (BM) and spleen cells.  The Lin-Sca1+cKit+ (LSK) compartment is expanded and "right-shifted," accompanied by increased stem cell factor (SCF)-evoked colony formation and Erk and Akt activation.  However, repopulating activity is decreased in diseased mice, and mice that do engraft with Ptpn11D61Y stem cells fail to develop MPD.  Ptpn11D61Y common myeloid progenitors (CMPs) and granulocyte-monocyte progenitors (GMPs) produce cytokine-independent colonies in a cell-autonomous manner and demonstrate elevated Erk and Stat5 activation in response to granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation.  Ptpn11D61Y megakaryocyte-erythrocyte progenitors (MEPs) yield increased nos. of erythrocyte burst-forming units (BFU-Es), but MEPs and erythrocyte-committed progenitors (EPs) produce fewer erythrocyte colony-forming units (CFU-Es), indicating defective erythroid differentiation.  These studies provide a mouse model for Ptpn11-evoked MPD and show that this disease results from cell-autonomous and distinct lineage-specific effects of mutant Ptpn11 on multiple stages of hematopoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cIq_57M9vrVg90H21EOLACvtfcHk0lg9SqLU2LoMfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVGitrg%253D&md5=e5363cc8f6acc1716ae263e5fb6c4585</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-10-182626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-10-182626%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DUsenko%26aufirst%3DT.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DLeukemogenic%2520Ptpn11%2520causes%2520fatal%2520myeloproliferative%2520disorder%2520via%2520cell-autonomous%2520effects%2520on%2520multiple%2520stages%2520of%2520hematopoiesis%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D4414%26epage%3D24%26doi%3D10.1182%2Fblood-2008-10-182626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, C. K.</span></span> <span> </span><span class="NLM_article-title">Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>208</i></span>,  <span class="NLM_fpage">1977</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1084/jem.20110450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1084%2Fjem.20110450" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2011&pages=1977-88&author=D.+Xuauthor=X.+Liuauthor=W.+M.+Yuauthor=H.+J.+Meyersonauthor=C.+Guoauthor=S.+L.+Gersonauthor=C.+K.+Qu&title=Non-lineage%2Fstage-restricted+effects+of+a+gain-of-function+mutation+in+tyrosine+phosphatase+Ptpn11+%28Shp2%29+on+malignant+transformation+of+hematopoietic+cells&doi=10.1084%2Fjem.20110450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20110450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20110450%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DMeyerson%26aufirst%3DH.%2BJ.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DGerson%26aufirst%3DS.%2BL.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DNon-lineage%252Fstage-restricted%2520effects%2520of%2520a%2520gain-of-function%2520mutation%2520in%2520tyrosine%2520phosphatase%2520Ptpn11%2520%2528Shp2%2529%2520on%2520malignant%2520transformation%2520of%2520hematopoietic%2520cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2011%26volume%3D208%26spage%3D1977%26epage%3D88%26doi%3D10.1084%2Fjem.20110450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Araki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismat, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutok, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1038/nm1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fnm1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15273746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=849-57&author=T.+Arakiauthor=M.+G.+Mohiauthor=F.+A.+Ismatauthor=R.+T.+Bronsonauthor=I.+R.+Williamsauthor=J.+L.+Kutokauthor=W.+Yangauthor=L.+I.+Paoauthor=D.+G.+Gillilandauthor=J.+A.+Epsteinauthor=B.+G.+Neel&title=Mouse+model+of+Noonan+syndrome+reveals+cell+type-+and+gene+dosage-dependent+effects+of+Ptpn11+mutation&doi=10.1038%2Fnm1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation</span></div><div class="casAuthors">Araki, Toshiyuki; Mohi, M. Golam; Ismat, Fraz A.; Bronson, Roderick T.; Williams, Ifor R.; Kutok, Jeffery L.; Yang, Wentian; Pao, Lily I.; Gilliland, D. Gary; Epstein, Jonathan A.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">849-857</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Noonan syndrome is a common human autosomal dominant birth defect, characterized by short stature, facial abnormalities, heart defects and possibly increased risk of leukemia.  Mutations of Ptpn11 (also known as Shp2), which encodes the protein-tyrosine phosphatase Shp2, occur in ∼50% of individuals with Noonan syndrome, but their mol., cellular and developmental effects, and the relationship between Noonan syndrome and leukemia, are unclear.  We generated mice expressing the Noonan syndrome-assocd. mutant D61G.  When homozygous, the D61G mutant is embryonic lethal, whereas heterozygotes have decreased viability.  Surviving Ptpn11D61G/+ embryos (∼50%) have short stature, craniofacial abnormalities similar to those in Noonan syndrome, and myeloproliferative disease.  Severely affected Ptpn11D61G/+ embryos (∼50%) have multiple cardiac defects similar to those in mice lacking the Ras-GAP protein neurofibromin.  Their endocardial cushions have increased Erk activation, but Erk hyperactivation is cell and pathway specific.  Our results clarify the relationship between Noonan syndrome and leukemia and show that a single Ptpn11 gain-of-function mutation evokes all major features of Noonan syndrome by acting on multiple developmental lineages in a gene dosage-dependent and pathway-selective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsmxo_WGTel7Vg90H21EOLACvtfcHk0lg9SInTJYg3YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWrt78%253D&md5=69aae2a9730455356988fa32e7652c00</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnm1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1084%26sid%3Dliteratum%253Aachs%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DIsmat%26aufirst%3DF.%2BA.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DWilliams%26aufirst%3DI.%2BR.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DPao%26aufirst%3DL.%2BI.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DEpstein%26aufirst%3DJ.%2BA.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DMouse%2520model%2520of%2520Noonan%2520syndrome%2520reveals%2520cell%2520type-%2520and%2520gene%2520dosage-dependent%2520effects%2520of%2520Ptpn11%2520mutation%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D849%26epage%3D57%26doi%3D10.1038%2Fnm1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel shp2 protein tyrosine phosphatase inhibitor</span>. <i>Molecular pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1124/mol.106.025536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1124%2Fmol.106.025536" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=562-70&author=L.+Chenauthor=S.+S.+Sungauthor=M.+L.+Yipauthor=H.+R.+Lawrenceauthor=Y.+Renauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Discovery+of+a+novel+shp2+protein+tyrosine+phosphatase+inhibitor&doi=10.1124%2Fmol.106.025536"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025536%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520shp2%2520protein%2520tyrosine%2520phosphatase%2520inhibitor%26jtitle%3DMolecular%2520pharmacology%26date%3D2006%26volume%3D70%26spage%3D562%26epage%3D70%26doi%3D10.1124%2Fmol.106.025536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geronikaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eleftheriou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A. K.</span></span> <span> </span><span class="NLM_article-title">2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5221</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/jm8004306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8004306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5221-8&author=A.+Geronikakiauthor=P.+Eleftheriouauthor=P.+Viciniauthor=I.+Alamauthor=A.+Dixitauthor=A.+K.+Saxena&title=2-Thiazolylimino%2Fheteroarylimino-5-arylidene-4-thiazolidinones+as+new+agents+with+SHP-2+inhibitory+action&doi=10.1021%2Fjm8004306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm8004306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8004306%26sid%3Dliteratum%253Aachs%26aulast%3DGeronikaki%26aufirst%3DA.%26aulast%3DEleftheriou%26aufirst%3DP.%26aulast%3DVicini%26aufirst%3DP.%26aulast%3DAlam%26aufirst%3DI.%26aulast%3DDixit%26aufirst%3DA.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26atitle%3D2-Thiazolylimino%252Fheteroarylimino-5-arylidene-4-thiazolidinones%2520as%2520new%2520agents%2520with%2520SHP-2%2520inhibitory%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5221%26epage%3D8%26doi%3D10.1021%2Fjm8004306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hellmuth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosskopf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosario, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span> <span> </span><span class="NLM_article-title">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">7275</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710468105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1073%2Fpnas.0710468105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=18480264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=7275-80&author=K.+Hellmuthauthor=S.+Grosskopfauthor=C.+T.+Lumauthor=M.+Wurteleauthor=N.+Roderauthor=J.+P.+von+Kriesauthor=M.+Rosarioauthor=J.+Rademannauthor=W.+Birchmeier&title=Specific+inhibitors+of+the+protein+tyrosine+phosphatase+Shp2+identified+by+high-throughput+docking&doi=10.1073%2Fpnas.0710468105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span></div><div class="casAuthors">Hellmuth, Klaus; Grosskopf, Stefanie; Lum, Ching Tung; Wuertele, Martin; Roeder, Nadine; von Kries, Jens Peter; Rosario, Marta; Rademann, Jorg; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7275-7280</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The protein tyrosine phosphatase Shp2 is a pos. regulator of growth factor signaling.  Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene.  We performed a high-throughput in silico screen for small-mol.-wt. compds. that bind the catalytic site of Shp2.  We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1 B.  PHPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis.  PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin.  Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-assocd. Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.  The PHPS compd. class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGponh1kw_h7jrVg90H21EOLACvtfcHk0lhiAx0JpJ1I-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D&md5=39c7dda94e32134c305e135e4c48b9d1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710468105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710468105%26sid%3Dliteratum%253Aachs%26aulast%3DHellmuth%26aufirst%3DK.%26aulast%3DGrosskopf%26aufirst%3DS.%26aulast%3DLum%26aufirst%3DC.%2BT.%26aulast%3DWurtele%26aufirst%3DM.%26aulast%3DRoder%26aufirst%3DN.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DSpecific%2520inhibitors%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520Shp2%2520identified%2520by%2520high-throughput%2520docking%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D7275%26epage%3D80%26doi%3D10.1073%2Fpnas.0710468105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pireddu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymanski, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4948</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1021/jm8002526</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8002526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4948-56&author=H.+R.+Lawrenceauthor=R.+Piredduauthor=L.+Chenauthor=Y.+Luoauthor=S.+S.+Sungauthor=A.+M.+Szymanskiauthor=M.+L.+Yipauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=J.+Wuauthor=N.+J.+Lawrence&title=Inhibitors+of+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28Shp2%29+based+on+oxindole+scaffolds&doi=10.1021%2Fjm8002526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds</span></div><div class="casAuthors">Lawrence, Harshani R.; Pireddu, Roberta; Chen, Liwei; Luo, Yunting; Sung, Shen-Shu; Szymanski, Ann Marie; Yip, M. L. Richard; Guida, Wayne C.; Sebti, Said M.; Wu, Jie; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4948-4956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of the NCI diversity set of compds. has led to the identification of NSC-117199, which inhibits the protein tyrosine phosphatase (PTP) Shp2 with an IC50 of 47 μM.  A focused library incorporating an isatin scaffold was designed and evaluated for inhibition of Shp2 and Shp1 PTP activities.  Several compds. were identified that selectively inhibit Shp2 over Shp1 and PTP1B with low to submicromolar activity.  A model for the binding of the active compds. is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRqLAauyGNBbVg90H21EOLACvtfcHk0lhiAx0JpJ1I-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D&md5=572227c5a8cfffb108388616bd36fdfe</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm8002526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002526%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DSzymanski%26aufirst%3DA.%2BM.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26atitle%3DInhibitors%2520of%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528Shp2%2529%2520based%2520on%2520oxindole%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4948%26epage%3D56%26doi%3D10.1021%2Fjm8002526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabinger, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2482</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1021/jm901645u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-93&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.+X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawanauthor=L.+Wangauthor=R.+J.+Chanauthor=Z.+Y.+Zhang&title=Salicylic+acid+based+small+molecule+inhibitor+for+the+oncogenic+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28SHP2%29&doi=10.1021%2Fjm901645u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)</span></div><div class="casAuthors">Zhang, Xian; He, Yantao; Liu, Sijiu; Yu, Zhihong; Jiang, Zhong-Xing; Yang, Zhenyun; Dong, Yuanshu; Nabinger, Sarah C.; Wu, Li; Gunawan, Andrea M.; Wang, Lina; Chan, Rebecca J.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2482-2493</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol.-2 domain contg. protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling.  Gain-of-function SHP2 mutations are assocd. with Noonan syndrome, various kinds of leukemias, and solid tumors.  Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy.  We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity.  Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compd. 9) with highly efficacious cellular activity.  Compd. 9 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation, providing supporting evidence that chem. inhibition of SHP2 may be therapeutically useful for anticancer and antileukemia treatment.  X-ray crystallog. anal. of the structure of SHP2 in complex with 9 reveals mol. determinants that can be exploited for the acquisition of more potent and selective SHP2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC82T5JpCRArVg90H21EOLACvtfcHk0lhiAx0JpJ1I-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D&md5=6f87897eda38ea485dc08e189f1b5ca8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DSalicylic%2520acid%2520based%2520small%2520molecule%2520inhibitor%2520for%2520the%2520oncogenic%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D93%26doi%3D10.1021%2Fjm901645u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, C. K.</span></span> <span> </span><span class="NLM_article-title">Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7212</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1021/jm400474r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400474r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7212-21&author=W.+Liuauthor=B.+Yuauthor=G.+Xuauthor=W.+R.+Xuauthor=M.+L.+Lohauthor=L.+D.+Tangauthor=C.+K.+Qu&title=Identification+of+cryptotanshinone+as+an+inhibitor+of+oncogenic+protein+tyrosine+phosphatase+SHP2+%28PTPN11%29&doi=10.1021%2Fjm400474r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)</span></div><div class="casAuthors">Liu, Wei; Yu, Bing; Xu, Gang; Xu, Wei-Ren; Loh, Mignon L.; Tang, Li-Da; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7212-7221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are assocd. with Noonan syndrome, childhood leukemias, and sporadic solid tumors.  Virtual screening combined with exptl. assays was performed to identify inhibitors of SHP2 from a database of natural products.  This effort led to the identification of cryptotanshinone as an inhibitor of SHP2.  Cryptotanshinone inhibited SHP2 with an IC50 of 22.50 μM.  Fluorescence titrn. expts. confirmed that it directly bound to SHP2.  Enzymic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor.  This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions.  Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in PTPN11 were found to be sensitive to this inhibitor.  Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed to treat PTPN11-assocd. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYelS47QYHLVg90H21EOLACvtfcHk0lgrm3_KXGXYmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN&md5=3bbbae68159ae4227bbf74d5573ca77a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm400474r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400474r%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%2BR.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DTang%26aufirst%3DL.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520cryptotanshinone%2520as%2520an%2520inhibitor%2520of%2520oncogenic%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520%2528PTPN11%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7212%26epage%3D21%26doi%3D10.1021%2Fjm400474r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. C.</span></span> <span> </span><span class="NLM_article-title">Targeting a cryptic allosteric site for selective inhibition of the oncogenic protein tyrosine phosphatase Shp2</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1021/bi5013595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi5013595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=497-504&author=C.+M.+Chioauthor=C.+S.+Limauthor=A.+C.+Bishop&title=Targeting+a+cryptic+allosteric+site+for+selective+inhibition+of+the+oncogenic+protein+tyrosine+phosphatase+Shp2&doi=10.1021%2Fbi5013595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting a Cryptic Allosteric Site for Selective Inhibition of the Oncogenic Protein Tyrosine Phosphatase Shp2</span></div><div class="casAuthors">Chio, Cynthia M.; Lim, Christopher S.; Bishop, Anthony C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">497-504</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs) have been the subject of considerable pharmaceutical-design efforts because of the ubiquitous connections between misregulation of PTP activity and human disease.  PTP-inhibitor discovery has been hampered, however, by the difficulty in identifying cell-permeable compds. that can selectively target PTP active sites, and no PTP inhibitors have progressed to the clinic.  The identification of allosteric sites on target PTPs therefore represents a potentially attractive soln. to the druggability problem of PTPs.  Here we report that the oncogenic PTP Shp2 contains an allosteric-inhibition site that renders the enzyme sensitive to potent and selective inhibition by cell-permeable biarsenical compds.  Because Shp2 contains no canonical tetracysteine biarsenical-binding motif, the enzyme's inhibitor-binding site is not readily predictable from its primary or three-dimensional structure.  Intriguingly, however, Shp2's PTP domain does contain a cysteine residue (C333) at a position that is removed from the active site and is occupied by proline in other classical PTPs.  We show that Shp2's unusual cysteine residue constitutes part of a Shp2-specific allosteric-inhibition site, and that Shp2's sensitivity to biarsenicals is dependent on the presence of the naturally occurring C333.  The determinative role of this residue in conferring inhibitor sensitivity is surprising because C333's side chain is inaccessible to solvent in Shp2 crystal structures.  The discovery of this cryptic Shp2 allosteric site may provide a means for targeting Shp2 activity with high specificity and suggests that buried-yet-targetable allosteric sites could be similarly uncovered in other protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWBChJ5ezZcbVg90H21EOLACvtfcHk0lgrm3_KXGXYmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrs7rK&md5=824fcbb6a26460197422c7008f35ca2b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi5013595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi5013595%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DC.%2BM.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DBishop%26aufirst%3DA.%2BC.%26atitle%3DTargeting%2520a%2520cryptic%2520allosteric%2520site%2520for%2520selective%2520inhibition%2520of%2520the%2520oncogenic%2520protein%2520tyrosine%2520phosphatase%2520Shp2%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26spage%3D497%26epage%3D504%26doi%3D10.1021%2Fbi5013595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonakos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slisz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span> <span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-52&author=Y.+N.+Chenauthor=M.+J.+LaMarcheauthor=H.+M.+Chanauthor=P.+Fekkesauthor=J.+Garcia-Fortanetauthor=M.+G.+Ackerauthor=B.+Antonakosauthor=C.+H.+Chenauthor=Z.+Chenauthor=V.+G.+Cookeauthor=J.+R.+Dobsonauthor=Z.+Dengauthor=F.+Feiauthor=B.+Firestoneauthor=M.+Fodorauthor=C.+Fridrichauthor=H.+Gaoauthor=D.+Grunenfelderauthor=H.+X.+Haoauthor=J.+Jacobauthor=S.+Hoauthor=K.+Hsiaoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=J.+Larrowauthor=L.+R.+La+Bonteauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=E.+Priceauthor=C.+Quinnauthor=S.+Shakyaauthor=M.+D.+Shultzauthor=J.+Sliszauthor=K.+Venkatesanauthor=P.+Wangauthor=M.+Warmuthauthor=S.+Williamsauthor=G.+Yangauthor=J.+Yuanauthor=J.+H.+Zhangauthor=P.+Zhuauthor=T.+Ramseyauthor=N.+J.+Keenauthor=W.+R.+Sellersauthor=T.+Stamsauthor=P.+D.+Fortin&title=Allosteric+inhibition+of+SHP2+phosphatase+inhibits+cancers+driven+by+receptor+tyrosine+kinases&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 μM), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lgrm3_KXGXYmA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BN.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DH.%2BM.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarcia-Fortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DAntonakos%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCooke%26aufirst%3DV.%2BG.%26aulast%3DDobson%26aufirst%3DJ.%2BR.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DF.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DH.%2BX.%26aulast%3DJacob%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DQuinn%26aufirst%3DC.%26aulast%3DShakya%26aufirst%3DS.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DVenkatesan%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%2520phosphatase%2520inhibits%2520cancers%2520driven%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D52%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia
Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Allosteric Inhibition of SHP2: Identification of a potent, selective, and orally efficacious phosphatase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7773</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00680</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00680" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7773-82&author=J.+Garcia%0AFortanetauthor=C.+H.+Chenauthor=Y.+N.+Chenauthor=Z.+Chenauthor=Z.+Dengauthor=B.+Firestoneauthor=P.+Fekkesauthor=M.+Fodorauthor=P.+D.+Fortinauthor=C.+Fridrichauthor=D.+Grunenfelderauthor=S.+Hoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=N.+Keenauthor=L.+R.+LaBonteauthor=J.+Larrowauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=F.+Lombardoauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=T.+Ramseyauthor=W.+R.+Sellersauthor=M.+D.+Shultzauthor=T.+Stamsauthor=C.+Towlerauthor=P.+Wangauthor=S.+L.+Williamsauthor=J.+H.+Zhangauthor=M.+J.+LaMarche&title=Allosteric+Inhibition+of+SHP2%3A+Identification+of+a+potent%2C+selective%2C+and+orally+efficacious+phosphatase+inhibitor&doi=10.1021%2Facs.jmedchem.6b00680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span></div><div class="casAuthors">Garcia Fortanet, Jorge; Chen, Christine Hiu-Tung; Chen, Ying-Nan P.; Chen, Zhouliang; Deng, Zhan; Firestone, Brant; Fekkes, Peter; Fodor, Michelle; Fortin, Pascal D.; Fridrich, Cary; Grunenfelder, Denise; Ho, Samuel; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Keen, Nick; LaBonte, Laura R.; Larrow, Jay; Lenoir, Francois; Liu, Gang; Liu, Shumei; Lombardo, Franco; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Ramsey, Timothy; Sellers, William R.; Shultz, Michael D.; Stams, Travis; Towler, Christopher; Wang, Ping; Williams, Sarah L.; Zhang, Ji-Hu; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7773-7782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway.  SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1).  Because it is an oncoprotein assocd. with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest.  Recently in our labs., a small mol. inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2.  A high throughput screen was performed to identify progressable chem. matter, and X-ray crystallog. revealed the location of binding in a previously undisclosed allosteric binding pocket.  Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein-ligand interactions were characterized.  These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (SHP099, 1), a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6RT7zfZnvfLVg90H21EOLACvtfcHk0ljQkfCkZ7cWNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP&md5=dfe43b5253e172576386f86797087f7b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%2BFortanet%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BN.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLaBonte%26aufirst%3DL.%2BR.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DAllosteric%2520Inhibition%2520of%2520SHP2%253A%2520Identification%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520phosphatase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7773%26epage%3D82%26doi%3D10.1021%2Facs.jmedchem.6b00680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-40&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0ljQkfCkZ7cWNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D40%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castleberry, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualtieri, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckerman, K. S.</span></span> <span> </span><span class="NLM_article-title">Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1704804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A280%3ADyaK3M7jslyiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1991&pages=925-9&author=P.+D.+Emanuelauthor=L.+J.+Batesauthor=R.+P.+Castleberryauthor=R.+J.+Gualtieriauthor=K.+S.+Zuckerman&title=Selective+hypersensitivity+to+granulocyte-macrophage+colony-stimulating+factor+by+juvenile+chronic+myeloid+leukemia+hematopoietic+progenitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</span></div><div class="casAuthors">Emanuel P D; Bates L J; Castleberry R P; Gualtieri R J; Zuckerman K S</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">925-9</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">Juvenile chronic myelogenous leukemia (JCML) is a good model for the study of myeloproliferation because JCML hematopoietic progenitor cells grow in vitro at very low cell densities without the addition of exogenous stimulus.  Previous studies have demonstrated that this proliferation is dependent on granulocyte-macrophage colony-stimulating factor (GM-CSF), and that removal of monocytes from the cell population before culture eliminates this "spontaneous" myeloproliferation, suggesting a paracrine role of monocyte stimulation.  However, subsequent studies have shown that increased GM-CSF production from the JCML monocytes is not a consistent finding and therefore not a plausible sole mechanism.  In examining hematopoietic growth factor dose-response curves, both JCML GM and erythroid nonadherent progenitor cell populations displayed a marked and selective hypersensitivity to GM-CSF.  Responses to interleukin-3 and G-CSF were identical to control dose-response curves.  This is the first demonstration of a myeloid leukemia in which hypersensitivity to a specific growth factor appears to be involved in the pathogenesis of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqJDPh116g5F1C8OJBvdfbfW6udTcc2eanH0hgsuXZN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7jslyiug%253D%253D&md5=380f655a2c503367555ebf1d922e3697</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DBates%26aufirst%3DL.%2BJ.%26aulast%3DCastleberry%26aufirst%3DR.%2BP.%26aulast%3DGualtieri%26aufirst%3DR.%2BJ.%26aulast%3DZuckerman%26aufirst%3DK.%2BS.%26atitle%3DSelective%2520hypersensitivity%2520to%2520granulocyte-macrophage%2520colony-stimulating%2520factor%2520by%2520juvenile%2520chronic%2520myeloid%2520leukemia%2520hematopoietic%2520progenitors%26jtitle%3DBlood%26date%3D1991%26volume%3D77%26spage%3D925%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Marcaigh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardak, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clapp, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K. M.</span></span> <span> </span><span class="NLM_article-title">Nf1 and Gmcsf interact in myeloid leukemogenesis</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(00)80415-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2FS1097-2765%2800%2980415-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=189-95&author=R.+A.+Birnbaumauthor=A.+O%E2%80%99Marcaighauthor=Z.+Wardakauthor=Y.+Y.+Zhangauthor=G.+Dranoffauthor=T.+Jacksauthor=D.+W.+Clappauthor=K.+M.+Shannon&title=Nf1+and+Gmcsf+interact+in+myeloid+leukemogenesis&doi=10.1016%2FS1097-2765%2800%2980415-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980415-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980415-3%26sid%3Dliteratum%253Aachs%26aulast%3DBirnbaum%26aufirst%3DR.%2BA.%26aulast%3DO%25E2%2580%2599Marcaigh%26aufirst%3DA.%26aulast%3DWardak%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%2BY.%26aulast%3DDranoff%26aufirst%3DG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DClapp%26aufirst%3DD.%2BW.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DNf1%2520and%2520Gmcsf%2520interact%2520in%2520myeloid%2520leukemogenesis%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D5%26spage%3D189%26epage%3D95%26doi%3D10.1016%2FS1097-2765%2800%2980415-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">12661</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.3390/ijms140612661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.3390%2Fijms140612661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=23774838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOmur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=12661-74&author=S.+X.+Sunauthor=X.+B.+Liauthor=W.+B.+Liuauthor=Y.+Maauthor=R.+L.+Wangauthor=X.+C.+Chengauthor=S.+Q.+Wangauthor=W.+Liu&title=Design%2C+synthesis%2C+biological+activity+and+molecular+dynamics+studies+of+specific+protein+tyrosine+phosphatase+1B+inhibitors+over+SHP-2&doi=10.3390%2Fijms140612661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2</span></div><div class="casAuthors">Sun, Su-Xia; Li, Xiao-Bo; Liu, Wen-Bo; Ma, Ying; Wang, Run-Ling; Cheng, Xian-Chao; Wang, Shu-Qing; Liu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">12661-12674, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Over expressing in PTPN1 (encoding Protein tyrosine phosphatase 1B, PTP1B), a protein tyrosine phosphatase (PTP) that plays an overall pos. role in insulin signaling, is linked to the pathogenesis of diabetes and obesity.  The relationship between PTP1B and human diseases exhibits PTP1B as the target to treat these diseases.  In this article, small wt. mols. of the imidazolidine series were screened from databases and optimized on silicon as the inhibitors of PTP1B based on the steric conformation and electronic configuration of thiazolidinedione (TZD) compds.  The top three candidates were tested using an in vitro biol. assay after synthesis.  Finally, we report a novel inhibitor, Compd. 13, that specifically inhibits PTP1B over the closely related phosphatase Src homol. 2 (SH2) domain-contg. phosphatase 2 (SHP-2) at 80 μM.  Its IC50 values are reported in this paper as well.  This compd. was further verified by computer anal. for its ability to combine the catalytic domains of PTP1B and SHP-2 by mol. dynamics (MD) simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVbZd73_ZSMbVg90H21EOLACvtfcHk0li0FAVTcT6c0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOmur%252FN&md5=b2ed9edbdebc76adac79d02c56e6afbd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3390%2Fijms140612661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140612661%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BX.%26aulast%3DLi%26aufirst%3DX.%2BB.%26aulast%3DLiu%26aufirst%3DW.%2BB.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DR.%2BL.%26aulast%3DCheng%26aufirst%3DX.%2BC.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520activity%2520and%2520molecular%2520dynamics%2520studies%2520of%2520specific%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitors%2520over%2520SHP-2%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D12661%26epage%3D74%26doi%3D10.3390%2Fijms140612661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, K. C.</span></span> <span> </span><span class="NLM_article-title">Low-frequency resonance and cooperativity of hemoglobin</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">3</span>, <span class="refDoi"> DOI: 10.1016/0968-0004(89)90026-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2F0968-0004%2889%2990026-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1989&pages=212-3&author=K.+C.+Chou&title=Low-frequency+resonance+and+cooperativity+of+hemoglobin&doi=10.1016%2F0968-0004%2889%2990026-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2F0968-0004%2889%2990026-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0968-0004%252889%252990026-1%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DK.%2BC.%26atitle%3DLow-frequency%2520resonance%2520and%2520cooperativity%2520of%2520hemoglobin%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D1989%26volume%3D14%26spage%3D212%26epage%3D3%26doi%3D10.1016%2F0968-0004%2889%2990026-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, K. C.</span></span> <span> </span><span class="NLM_article-title">The biological functions of low-frequency vibrations (phonons). 4. Resonance effects and allosteric transition</span>. <i>Biophys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/0301-4622(84)80005-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2F0301-4622%2884%2980005-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1984&pages=61-71&author=K.+C.+Chou&title=The+biological+functions+of+low-frequency+vibrations+%28phonons%29.+4.+Resonance+effects+and+allosteric+transition&doi=10.1016%2F0301-4622%2884%2980005-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0301-4622%2884%2980005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-4622%252884%252980005-8%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DK.%2BC.%26atitle%3DThe%2520biological%2520functions%2520of%2520low-frequency%2520vibrations%2520%2528phonons%2529.%25204.%2520Resonance%2520effects%2520and%2520allosteric%2520transition%26jtitle%3DBiophys.%2520Chem.%26date%3D1984%26volume%3D20%26spage%3D61%26epage%3D71%26doi%3D10.1016%2F0301-4622%2884%2980005-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, C. K.</span></span> <span> </span><span class="NLM_article-title">Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5995</span>– <span class="NLM_lpage">6004</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1206846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fsj.onc.1206846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=12955078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5995-6004&author=W.+M.+Yuauthor=T.+S.+Hawleyauthor=R.+G.+Hawleyauthor=C.+K.+Qu&title=Catalytic-dependent+and+-independent+roles+of+SHP-2+tyrosine+phosphatase+in+interleukin-3+signaling&doi=10.1038%2Fsj.onc.1206846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling</span></div><div class="casAuthors">Yu, Wen-Mei; Hawley, Teresa S.; Hawley, Robert G.; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">5995-6004</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 tyrosine phosphatase is highly expressed in hematopoietic cells, however, the function of SHP-2 in hematopoietic cell signaling is not well understood.  Here the authors focus on the role of SHP-2 phosphatase in the signal transduction of interleukin (IL)-3, a cytokine involved in hematopoietic cell survival, proliferation, and differentiation.  The authors established immortalized SHP-2-/- hematopoietic cell pools and showed that IL-3-induced proliferative response was diminished in SHP-2-/- cells.  Moreover, inhibition of the catalytic activity of SHP-2 in wild-type (WT) bone marrow hematopoietic progenitor cells and Ba/F3 cells by overexpression of catalytically inactive SHP-2 mutant suppressed their differentiative and proliferative responses to IL-3, demonstrating an important pos. role for SHP-2 in IL-3 signal transduction.  Further biochem. analyses revealed that IL-3-induced Jak/Stat, Erk, and PI3 kinase pathways in SHP-2-/- cells were impaired and reintroduction of WT SHP-2 into mutant cells partially restored IL-3 signaling.  Interestingly, in catalytically inactive SHP-2-overexpressing Ba/F3 cells, although IL-3-induced activation of Jak2 and Erk kinases was reduced and shortened, PI3 kinase activation remained unaltered.  Taken together, these results suggest that SHP-2 tyrosine phosphatase plays multiple roles in IL-3 signal transduction, functioning in both catalytic-dependent and -independent manners in the Jak/Stat, Erk, and PI3 kinase pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooEt8hYWxgTbVg90H21EOLACvtfcHk0lgCtSCGOjbKMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFansb8%253D&md5=5480c82a8f3a196648c50458f67287df</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206846%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DHawley%26aufirst%3DT.%2BS.%26aulast%3DHawley%26aufirst%3DR.%2BG.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DCatalytic-dependent%2520and%2520-independent%2520roles%2520of%2520SHP-2%2520tyrosine%2520phosphatase%2520in%2520interleukin-3%2520signaling%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D5995%26epage%3D6004%26doi%3D10.1038%2Fsj.onc.1206846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausdorff, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1128/MCB.16.3.1189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1128%2FMCB.16.3.1189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=8622663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADyaK28XhtFOlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=1189-202&author=A.+M.+Bennettauthor=S.+F.+Hausdorffauthor=A.+M.+O%E2%80%99Reillyauthor=R.+M.+Freemanauthor=B.+G.+Neel&title=Multiple+requirements+for+SHPTP2+in+epidermal+growth+factor-mediated+cell+cycle+progression&doi=10.1128%2FMCB.16.3.1189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression</span></div><div class="casAuthors">Bennett, Anton M.; Hausdorff, Sharon F.; O'Reilly, Alana M.; Freeman, Robert M., Jr.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1189-202</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Using transient overexpression and microinjection approaches, the authors examd. SHPTP2's function in growth factor signaling.  Overexpression of catalytically inactive SHPTP2 (PTP2CS) but not catalytically inactive SHPTP1, inhibited mitogen-activated protein (MAP) kinase activation and Elk-1 transactivation following epidermal growth factor (EGF) stimulation of 293 cells.  An SHPTP2 mutant with both C-terminal tyrosyl phosphorylation sites converted to phenylalanine (PTP26F) was also without effect; moreover, PTP2YF rescued PTP2CS-induced inhibition of EGF-induced Elk-1 transactivation.  PTP2CS did not inhibit transactivation by activated Ras, suggesting that SHPTP2 acts upstream of or parallel to Ras.  Neither PTP2CS nor PTP2YF inhibited platelet-derived growth factor (PDGF)-induced Elk-1 transactivation.  Thus, protein-tyrosine phosphate activity, but not tyrosyl phosphorylation of SHPTP2, is required for the immediate-early responses to EGF but not to PDGF.  To det. whether SHPTP2 is required later in the cell cycle, the authors assessed S-phase entry in NIH 3T3 cells microinjected with anti-SHPTP2 antibodies or with a glutathione S-transferase (GST) fusion protein encoding both SH2 domains (GST-SH2).  Microinjection of anti-SHPTP2 antibodies prior to stimulation inhibited EGF- but not PDGF- or serum-induced S-phase entry.  Anti-SHPTP2 antibodies or GST-SH2 fusion protein could inhibit EGF-induced S-phase entry for up to 8 h after EGF addn.  Although MAP kinase activation was detected shortly after EGF stimulation, no MAP kinase activation was detected around the restriction point.  Therefore, SHPTP2 is absolutely required for immediate-early and late events induced by some, but not all, growth factors, and the immediate-early and late signal transduction pathways regulated by SHPTP2 are distinguishable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeXoAZulZBWLVg90H21EOLACvtfcHk0lgCtSCGOjbKMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFOlsLo%253D&md5=4dd06df6d964ba990e8ed094afeec28e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.3.1189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.3.1189%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DA.%2BM.%26aulast%3DHausdorff%26aufirst%3DS.%2BF.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DA.%2BM.%26aulast%3DFreeman%26aufirst%3DR.%2BM.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DMultiple%2520requirements%2520for%2520SHPTP2%2520in%2520epidermal%2520growth%2520factor-mediated%2520cell%2520cycle%2520progression%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D1189%26epage%3D202%26doi%3D10.1128%2FMCB.16.3.1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-96&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lgCtSCGOjbKMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D96%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madhavi
Sastry, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-34&author=G.+M.+Madhavi%0ASastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0liOp7DiFYYksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D34%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, K. C.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e28111</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0028111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1371%2Fjournal.pone.0028111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=22140516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GgtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=X.+B.+Liauthor=S.+Q.+Wangauthor=W.+R.+Xuauthor=R.+L.+Wangauthor=K.+C.+Chou&title=Novel+inhibitor+design+for+hemagglutinin+against+H1N1+influenza+virus+by+core+hopping+method&doi=10.1371%2Fjournal.pone.0028111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method</span></div><div class="casAuthors">Li, Xiao-Bo; Wang, Shu-Qing; Xu, Wei-Ren; Wang, Run-Ling; Chou, Kuo-Chen</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e28111</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The worldwide spread of H1N1 avian influenza and the increasing reports about its resistance to the current drugs have made a high priority for developing new anti-influenza drugs.  Owing to its unique function in assisting viruses to bind the cellular surface, a key step for them to subsequently penetrate into the infected cell, hemagglutinin (HA) has become one of the main targets for drug design against influenza virus.  To develop potent HA inhibitors, the ZINC fragment database was searched for finding the optimal compd. with the core hopping technique.  As a result, the Neo6 compd. was obtained.  It has been shown through the subsequent mol. docking studies and mol. dynamic simulations that Neo6 not only assumes more favorable conformation at the binding pocket of HA but also has stronger binding interaction with its receptor.  Accordingly, Neo6 may become a promising candidate for developing new and more powerful drugs for treating influenza.  Or at the very least, the findings reported here may provide useful insights to stimulate new strategy in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo51HQOmljzpLVg90H21EOLACvtfcHk0liOp7DiFYYksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GgtbzP&md5=f26890062e6ed879b613ad7dec7ed244</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0028111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0028111%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BB.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DXu%26aufirst%3DW.%2BR.%26aulast%3DWang%26aufirst%3DR.%2BL.%26aulast%3DChou%26aufirst%3DK.%2BC.%26atitle%3DNovel%2520inhibitor%2520design%2520for%2520hemagglutinin%2520against%2520H1N1%2520influenza%2520virus%2520by%2520core%2520hopping%2520method%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0028111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Improving the prediction of absolute solvation free energies using the next generation OPLS force field</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2553</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/ct300203w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300203w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=2553-8&author=D.+Shivakumarauthor=E.+Harderauthor=W.+Dammauthor=R.+A.+Friesnerauthor=W.+Sherman&title=Improving+the+prediction+of+absolute+solvation+free+energies+using+the+next+generation+OPLS+force+field&doi=10.1021%2Fct300203w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field</span></div><div class="casAuthors">Shivakumar, Devleena; Harder, Edward; Damm, Wolfgang; Friesner, Richard A.; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2553-2558</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Explicit solvent mol. dynamics free energy perturbation simulations were performed to predict abs. solvation free energies of 239 diverse small mols.  We use OPLS2.0, the next generation OPLS force field, and compare the results with popular small mol. force fields-OPLS_2005, GAFF, and CHARMm-MSI.  OPLS2.0 produces the best correlation with exptl. data (R2 = 0.95, slope = 0.96) and the lowest av. unsigned errors (0.7 kcal/mol).  Important classes of compds. that performed suboptimally with OPLS_2005 show significant improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEngE5xV9Ev7Vg90H21EOLACvtfcHk0liOp7DiFYYksA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWjs7g%253D&md5=eceb7dab3a8d0c6ac586c620848412d1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fct300203w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300203w%26sid%3Dliteratum%253Aachs%26aulast%3DShivakumar%26aufirst%3DD.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DImproving%2520the%2520prediction%2520of%2520absolute%2520solvation%2520free%2520energies%2520using%2520the%2520next%2520generation%2520OPLS%2520force%2520field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D2553%26epage%3D8%26doi%3D10.1021%2Fct300203w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1021/ct900587b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct900587b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=1509-19&author=D.+Shivakumarauthor=J.+Williamsauthor=Y.+Wuauthor=W.+Dammauthor=J.+Shelleyauthor=W.+Sherman&title=Prediction+of+absolute+solvation+free+energies+using+molecular+dynamics+free+energy+perturbation+and+the+OPLS+force+field&doi=10.1021%2Fct900587b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field</span></div><div class="casAuthors">Shivakumar, Devleena; Williams, Joshua; Wu, Yujie; Damm, Wolfgang; Shelley, John; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1509-1519</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The accurate prediction of protein-ligand binding free energies is a primary objective in computer-aided drug design.  The solvation free energy of a small mol. provides a surrogate to the desolvation of the ligand in the thermodn. process of protein-ligand binding.  Here, we use explicit solvent mol. dynamics free energy perturbation to predict the abs. solvation free energies of a set of 239 small mols., spanning diverse chem. functional groups commonly found in drugs and drug-like mols.  We also compare the performance of abs. solvation free energies obtained using the OPLS_2005 force field with two other commonly used small mol. force fields - general AMBER force field (GAFF) with AM1-BCC charges and CHARMm-MSI with CHelpG charges.  Using the OPLS_2005 force field, we obtain high correlation with exptl. solvation free energies (R2 = 0.94) and low av. unsigned errors for a majority of the functional groups compared to AM1-BCC/GAFF or CHelpG/CHARMm-MSI.  However, OPLS_2005 has errors of over 1.3 kcal/mol for certain classes of polar compds.  We show that predictions on these compd. classes can be improved by using a semiempirical charge assignment method with an implicit bond charge correction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon_fkbSHqg3bVg90H21EOLACvtfcHk0lhnlU3QscHdyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslKhu7g%253D&md5=25d464fb9238e3235e881945c0b50a76</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fct900587b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct900587b%26sid%3Dliteratum%253Aachs%26aulast%3DShivakumar%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DShelley%26aufirst%3DJ.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DPrediction%2520of%2520absolute%2520solvation%2520free%2520energies%2520using%2520molecular%2520dynamics%2520free%2520energy%2520perturbation%2520and%2520the%2520OPLS%2520force%2520field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2010%26volume%3D6%26spage%3D1509%26epage%3D19%26doi%3D10.1021%2Fct900587b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oostenbrink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Vegt, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gunsteren, W. F.</span></span> <span> </span><span class="NLM_article-title">Validation of the 53A6 GROMOS force field</span>. <i>Eur. Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1007/s00249-004-0448-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1007%2Fs00249-004-0448-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15803330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2005&pages=273-84&author=C.+Oostenbrinkauthor=T.+A.+Soaresauthor=N.+F.+van+der+Vegtauthor=W.+F.+van+Gunsteren&title=Validation+of+the+53A6+GROMOS+force+field&doi=10.1007%2Fs00249-004-0448-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the 53A6 GROMOS force field</span></div><div class="casAuthors">Oostenbrink, Chris; Soares, Thereza A.; van der Vegt, Nico F. A.; van Gunsteren, Wilfred F.</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The quality of biomol. dynamics simulations relies critically on the force field that is used to describe the interactions between particles in the system.  Force fields, which are generally parameterized using exptl. data on small mols., can only prove themselves in realistic simulations of relevant biomol. systems.  In this work, we begin the validation of the new 53A6 GROMOS parameter set by examg. three test cases.  Simulations of the well-studied 129 residue protein hen egg-white lysozyme, of the DNA dodecamer d(CGCGAATTCGCG)2, and a proteinogenic β3-dodecapeptide were performed and analyzed.  It was found that the new parameter set performs as well as the previous parameter sets in terms of protein (45A3) and DNA (45A4) stability and that it is better at describing the folding-unfolding balance of the peptide.  The latter is a property that is directly assocd. with the free enthalpy of hydration, to which the 53A6 parameter set was parameterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9L1Tptp71r7Vg90H21EOLACvtfcHk0lhnlU3QscHdyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVajtb8%253D&md5=8a9b34e5dcac9d5d33489794c67ed513</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs00249-004-0448-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-004-0448-6%26sid%3Dliteratum%253Aachs%26aulast%3DOostenbrink%26aufirst%3DC.%26aulast%3DSoares%26aufirst%3DT.%2BA.%26aulast%3Dvan%2Bder%2BVegt%26aufirst%3DN.%2BF.%26aulast%3Dvan%2BGunsteren%26aufirst%3DW.%2BF.%26atitle%3DValidation%2520of%2520the%252053A6%2520GROMOS%2520force%2520field%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2005%26volume%3D34%26spage%3D273%26epage%3D84%26doi%3D10.1007%2Fs00249-004-0448-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuttelkopf, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aalten, D. M.</span></span> <span> </span><span class="NLM_article-title">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-63&author=A.+W.+Schuttelkopfauthor=D.+M.+van+Aalten&title=PRODRG%3A+a+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuttelkopf Alexander W; van Aalten Daan M F</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1355-63</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The small-molecule topology generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and molecular topologies suitable for X-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compounds from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the standard libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallographic R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdNRIcoht5aXy-c-E1v-fmfW6udTcc2ebFHuUHhgzOxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D&md5=1adce6cd2cacdace513a69efa33c4e93</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DPRODRG%253A%2520a%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D63%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pantoliano, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrella, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwasnoski, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobanov, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myslik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carver, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salemme, F. R.</span></span> <span> </span><span class="NLM_article-title">High-density miniaturized thermal shift assays as a general strategy for drug discovery</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1177/108705710100600609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1177%2F108705710100600609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=11788061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVCntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=429-40&author=M.+W.+Pantolianoauthor=E.+C.+Petrellaauthor=J.+D.+Kwasnoskiauthor=V.+S.+Lobanovauthor=J.+Myslikauthor=E.+Grafauthor=T.+Carverauthor=E.+Aselauthor=B.+A.+Springerauthor=P.+Laneauthor=F.+R.+Salemme&title=High-density+miniaturized+thermal+shift+assays+as+a+general+strategy+for+drug+discovery&doi=10.1177%2F108705710100600609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">High-density miniaturized thermal shift assays as a general strategy for drug discovery</span></div><div class="casAuthors">Pantoliano, Michael W.; Petrella, Eugene C.; Kwasnoski, Joseph D.; Lobanov, Victor S.; Myslik, James; Graf, Edward; Carver, Ted; Asel, Eric; Springer, Barry A.; Lane, Pamela; Salemme, F. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-440</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">More general and universally applicable drug discovery assay technologies are needed in order to keep pace with the recent advances in combinatorial chem. and genomics-based target generation.  Ligand-induced conformational stabilization of proteins is a well-understood phenomenon in which substrates, inhibitors, cofactors, and even other proteins provide enhanced stability to proteins on binding.  This phenomenon is based on the energetic coupling of the ligand-binding and protein-melting reactions.  In an attempt to harness these biophys. properties for drug discovery, fully automated instrumentation was designed and implemented to perform miniaturized fluorescence-based thermal shift assays in a microplate format for the high throughput screening of compd. libraries.  Validation of this process and instrumentation was achieved by investigating ligand binding to more than 100 protein targets.  The general applicability of the thermal shift screening strategy was found to be an important advantage because it circumvents the need to design and retool new assays with each new therapeutic target.  Moreover, the miniaturized thermal shift assay methodol. does not require any prior knowledge of a therapeutic target's function, making it ideally suited for the quant. high throughput drug screening and evaluation of targets derived from genomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp58y9R74HfiLVg90H21EOLACvtfcHk0liEh7E8ySBs-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVCntg%253D%253D&md5=deef07e6683f632cd078214ad88d9999</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1177%2F108705710100600609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705710100600609%26sid%3Dliteratum%253Aachs%26aulast%3DPantoliano%26aufirst%3DM.%2BW.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DKwasnoski%26aufirst%3DJ.%2BD.%26aulast%3DLobanov%26aufirst%3DV.%2BS.%26aulast%3DMyslik%26aufirst%3DJ.%26aulast%3DGraf%26aufirst%3DE.%26aulast%3DCarver%26aufirst%3DT.%26aulast%3DAsel%26aufirst%3DE.%26aulast%3DSpringer%26aufirst%3DB.%2BA.%26aulast%3DLane%26aufirst%3DP.%26aulast%3DSalemme%26aufirst%3DF.%2BR.%26atitle%3DHigh-density%2520miniaturized%2520thermal%2520shift%2520assays%2520as%2520a%2520general%2520strategy%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2001%26volume%3D6%26spage%3D429%26epage%3D40%26doi%3D10.1177%2F108705710100600609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aulabaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellestad, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2004.04.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2Fj.ab.2004.04.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15301960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=153-9&author=M.+C.+Loauthor=A.+Aulabaughauthor=G.+Jinauthor=R.+Cowlingauthor=J.+Bardauthor=M.+Malamasauthor=G.+Ellestad&title=Evaluation+of+fluorescence-based+thermal+shift+assays+for+hit+identification+in+drug+discovery&doi=10.1016%2Fj.ab.2004.04.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery</span></div><div class="casAuthors">Lo, Mei-Chu; Aulabaugh, Ann; Jin, Guixian; Cowling, Rebecca; Bard, Jonathan; Malamas, Michael; Ellestad, George</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The fluorescence-based thermal shift assay is a general method for identification of inhibitors of target proteins from compd. libraries.  Using an environmentally sensitive fluorescent dye to monitor protein thermal unfolding, the ligand-binding affinity can be assessed from the shift of the unfolding temp. (ΔTm) obtained in the presence of ligands relative to that obtained in the absence of ligands.  In this article, we report that the thermal shift assay can be conducted in an inexpensive, com. available device for temp. control and fluorescence detection.  The binding affinities obtained from thermal shift assays are compared with the binding affinities measured by isothermal titrn. calorimetry and with the IC50 values from enzymic assays.  The potential pitfalls in the data anal. of thermal shift assays are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qMM9vchBGrVg90H21EOLACvtfcHk0liEh7E8ySBs-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVKhu7g%253D&md5=bc10d980128340c79d7d2abc9a56463b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DM.%2BC.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DMalamas%26aufirst%3DM.%26aulast%3DEllestad%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520fluorescence-based%2520thermal%2520shift%2520assays%2520for%2520hit%2520identification%2520in%2520drug%2520discovery%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26spage%3D153%26epage%3D9%26doi%3D10.1016%2Fj.ab.2004.04.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argintaru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00980</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00980" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=647-656&author=M.+Fodorauthor=E.+Priceauthor=P.+Wangauthor=H.+Luauthor=A.+Argintaruauthor=Z.+Chenauthor=M.+Glickauthor=H.+X.+Haoauthor=M.+Katoauthor=R.+Koenigauthor=J.+R.+LaRochelleauthor=G.+Liuauthor=E.+McNeillauthor=D.+Majumdarauthor=G.+A.+Nishiguchiauthor=L.+B.+Perezauthor=G.+Parisauthor=C.+M.+Quinnauthor=T.+Ramseyauthor=M.+Sendzikauthor=M.+D.+Shultzauthor=S.+L.+Williamsauthor=T.+Stamsauthor=S.+C.+Blacklowauthor=M.+G.+Ackerauthor=M.+J.+LaMarche&title=Dual+Allosteric+Inhibition+of+SHP2+Phosphatase&doi=10.1021%2Facschembio.7b00980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Dual allosteric inhibition of SHP2 phosphatase</span></div><div class="casAuthors">Fodor, Michelle; Price, Edmund; Wang, Ping; Lu, Hengyu; Argintaru, Andreea; Chen, Zhouliang; Glick, Meir; Hao, Huai-Xiang; Kato, Mitsunori; Koenig, Robert; La Rochelle, Jonathan R.; Liu, Gang; McNeill, Eric; Majumdar, Dyuti; Nishiguchi, Gisele A.; Perez, Lawrence B.; Paris, Gregory; Quinn, Christopher M.; Ramsey, Timothy; Sendzik, Martin; Shultz, Michael David; Williams, Sarah L.; Stams, Travis; Blacklow, Stephen C.; Acker, Michael G.; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">647-656</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a cytoplasmic protein tyrosine phosphatase encoded by the PTPN11 gene and is involved in cell proliferation, differentiation, and survival.  Recently, we reported an allosteric mechanism of inhibition that stabilizes the auto-inhibited conformation of SHP2.  SHP099 (1) was identified and characterized as a moderately potent, orally bioavailable, allosteric small mol. inhibitor, which binds to a tunnel-like pocket formed by the confluence of three domains of SHP2.  In this report, we describe further screening strategies that enabled the identification of a second, distinct small mol. allosteric site.  SHP244 (2) was identified as a weak inhibitor of SHP2 with modest thermal stabilization of the enzyme.  X-ray crystallog. revealed that 2 binds and stabilizes the inactive, closed conformation of SHP2, at a distinct, previously unexplored binding site-a cleft formed at the interface of the N-terminal SH2 and PTP domains.  Derivatization of 2 using structure-based design resulted in an increase in SHP2 thermal stabilization, biochem. inhibition, and subsequent MAPK pathway modulation.  Downregulation of DUSP6 mRNA, a downstream MAPK pathway marker, was obsd. in KYSE-520 cancer cells.  Remarkably, simultaneous occupation of both allosteric sites by 1 and 2 was possible, as characterized by cooperative biochem. inhibition expts. and X-ray crystallog.  Combining an allosteric site 1 inhibitor with an allosteric site 2 inhibitor led to enhanced pharmacol. pathway inhibition in cells.  This work illustrates a rare example of dual allosteric targeted protein inhibition, demonstrates screening methodol. and tactics to identify allosteric inhibitors, and enables further interrogation of SHP2 in cancer and related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdw7pTS6sOLVg90H21EOLACvtfcHk0liEh7E8ySBs-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D&md5=8e4de4c353b9fc196c81e1cb51e367df</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DArgintaru%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGlick%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DH.%2BX.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DR.%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMcNeill%26aufirst%3DE.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26aulast%3DParis%26aufirst%3DG.%26aulast%3DQuinn%26aufirst%3DC.%2BM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DDual%2520Allosteric%2520Inhibition%2520of%2520SHP2%2520Phosphatase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D647%26epage%3D656%26doi%3D10.1021%2Facschembio.7b00980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 21 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yelena Mostinski, Guus J. J. E. Heynen, Maria Pascual López-Alberca, Jerome Paul, Sandra Miksche, Silke Radetzki, David Schaller, Elena Shanina, Carola Seyffarth, Yuliya Kolomeets, Nandor Ziebart, Judith de Schryver, Sylvia Oestreich, Martin Neuenschwander, Yvette Roske, Udo Heinemann, Christoph Rademacher, Andrea Volkamer, Jens Peter von Kries, Walter Birchmeier, <span class="NLM_string-name hlFld-ContribAuthor">Marc Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14780-14804. <a href="https://doi.org/10.1021/acs.jmedchem.0c01265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BPyrazolones%252Bto%252BAzaindoles%25253A%252BEvolution%252Bof%252BActive-Site%252BSHP2%252BInhibitors%252BBased%252Bon%252BScaffold%252BHopping%252Band%252BBioisosteric%252BReplacement%26aulast%3DMostinski%26aufirst%3DYelena%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D19112020%26volume%3D63%26issue%3D23%26spage%3D14780%26epage%3D14804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinrui Yuan, Hong Bu, Jinpei Zhou, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Huibin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11368-11396. <a href="https://doi.org/10.1021/acs.jmedchem.0c00249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bof%252BSHP2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BCurrent%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D10062020%26date%3D27052020%26volume%3D63%26issue%3D20%26spage%3D11368%26epage%3D11396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Guo</span>, <span class="hlFld-ContribAuthor ">Yaping  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (22)
                                     , 5504-5523. <a href="https://doi.org/10.1002/slct.202100186" title="DOI URL">https://doi.org/10.1002/slct.202100186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100186%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCross%252Bthe%252BUndruggable%252BBarrier%25252C%252Bthe%252BDevelopment%252Bof%252BSHP2%252BInhibitors%25253A%252BFrom%252BCatalytic%252BSite%252BInhibitors%252Bto%252BAllosteric%252BInhibitors%26aulast%3DGuo%26aufirst%3DYu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D22%26spage%3D5504%26epage%3D5523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengzhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Canrong  Wu</span>, <span class="hlFld-ContribAuthor ">Kaiyin  Yang</span>, <span class="hlFld-ContribAuthor ">Qiqi  Wang</span>, <span class="hlFld-ContribAuthor ">Yirong  Zhou</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel PROTACs for degradation of SHP2 protein. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104788. <a href="https://doi.org/10.1016/j.bioorg.2021.104788" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104788%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252BPROTACs%252Bfor%252Bdegradation%252Bof%252BSHP2%252Bprotein%26aulast%3DZheng%26aufirst%3DMengzhu%26date%3D2021%26volume%3D110%26spage%3D104788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangan  Mitra</span>, <span class="hlFld-ContribAuthor ">Senthil R.  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Small‐Molecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 777-787. <a href="https://doi.org/10.1002/cmdc.202000706" title="DOI URL">https://doi.org/10.1002/cmdc.202000706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000706%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSmall%2525E2%252580%252590Molecule%252BInhibitors%252Bof%252BShp2%252BPhosphatase%252Bas%252BPotential%252BChemotherapeutic%252BAgents%252Bfor%252BGlioblastoma%25253A%252BA%252BMinireview%26aulast%3DMitra%26aufirst%3DRangan%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D777%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yihui  Song</span>, <span class="hlFld-ContribAuthor ">Min  Zhao</span>, <span class="hlFld-ContribAuthor ">Yahong  Wu</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A multifunctional cross-validation high-throughput screening protocol enabling the discovery of new SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 750-762. <a href="https://doi.org/10.1016/j.apsb.2020.10.021" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.10.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.10.021%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DA%252Bmultifunctional%252Bcross-validation%252Bhigh-throughput%252Bscreening%252Bprotocol%252Benabling%252Bthe%252Bdiscovery%252Bof%252Bnew%252BSHP2%252Binhibitors%26aulast%3DSong%26aufirst%3DYihui%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D750%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yong  Feng</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Zhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing-Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Lu</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 WT and SHP2F285S by molecular dynamics study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2021,</strong> <em>103 </em>, 107807. <a href="https://doi.org/10.1016/j.jmgm.2020.107807" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DExploring%252Bthe%252Bmechanism%252Bof%252Bthe%252Bpotent%252Ballosteric%252Binhibitor%252Bcompound2%252Bon%252BSHP2%252BWT%252Band%252BSHP2F285S%252Bby%252Bmolecular%252Bdynamics%252Bstudy%26aulast%3DZhou%26aufirst%3DLiang%26date%3D2021%26volume%3D103%26spage%3D107807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities – A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 721-773. <a href="https://doi.org/10.1111/cbdd.13807" title="DOI URL">https://doi.org/10.1111/cbdd.13807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DEmerging%252Bchemical%252Bscaffolds%252Bwith%252Bpotential%252BSHP2%252Bphosphatase%252Binhibitory%252Bcapabilities%252B%2525E2%252580%252593%252BA%252Bcomprehensive%252Breview%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D721%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmine  Fedele</span>, <span class="hlFld-ContribAuthor ">Shuai  Li</span>, <span class="hlFld-ContribAuthor ">Kai Wen  Teng</span>, <span class="hlFld-ContribAuthor ">Connor J.R.  Foster</span>, <span class="hlFld-ContribAuthor ">David  Peng</span>, <span class="hlFld-ContribAuthor ">Hao  Ran</span>, <span class="hlFld-ContribAuthor ">Paolo  Mita</span>, <span class="hlFld-ContribAuthor ">Mitchell J.  Geer</span>, <span class="hlFld-ContribAuthor ">Takamitsu  Hattori</span>, <span class="hlFld-ContribAuthor ">Akiko  Koide</span>, <span class="hlFld-ContribAuthor ">Yubao  Wang</span>, <span class="hlFld-ContribAuthor ">Kwan Ho  Tang</span>, <span class="hlFld-ContribAuthor ">Joshua  Leinwand</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Brian  Diskin</span>, <span class="hlFld-ContribAuthor ">Jiehui  Deng</span>, <span class="hlFld-ContribAuthor ">Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Igor  Dolgalev</span>, <span class="hlFld-ContribAuthor ">Ugur  Ozerdem</span>, <span class="hlFld-ContribAuthor ">George  Miller</span>, <span class="hlFld-ContribAuthor ">Shohei  Koide</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">Benjamin G.  Neel</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Medicine</span><span> <strong>2021,</strong> <em>218 </em>
                                    (1)
                                     <a href="https://doi.org/10.1084/jem.20201414" title="DOI URL">https://doi.org/10.1084/jem.20201414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1084/jem.20201414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1084%2Fjem.20201414%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Medicine%26atitle%3DSHP2%252Binhibition%252Bdiminishes%252BKRASG12C%252Bcycling%252Band%252Bpromotes%252Btumor%252Bmicroenvironment%252Bremodeling%26aulast%3DFedele%26aufirst%3DCarmine%26date%3D2021%26date%3D2020%26volume%3D218%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhendong  Song</span>, <span class="hlFld-ContribAuthor ">Meijing  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Xue-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ziyang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 13-29. <a href="https://doi.org/10.1016/j.apsb.2020.07.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Bin%252Btumor-targeted%252Btherapies%26aulast%3DSong%26aufirst%3DZhendong%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D13%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">祥东  孟</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of Aminobenzoic Acid Derivatives against SHP2. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>09 </em>
                                    (02)
                                     , 87-93. <a href="https://doi.org/10.12677/HJMCe.2021.92011" title="DOI URL">https://doi.org/10.12677/HJMCe.2021.92011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2021.92011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2021.92011%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiological%252BEvaluation%252Bof%252BAminobenzoic%252BAcid%252BDerivatives%252Bagainst%252BSHP2%26aulast%3D%25E5%25AD%259F%26aufirst%3D%25E7%25A5%25A5%25E4%25B8%259C%26date%3D2021%26volume%3D09%26issue%3D02%26spage%3D87%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Hao-Xin  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Lu</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold-based selective SHP2 inhibitors design using core hopping, molecular docking, biological evaluation and molecular simulation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>105 </em>, 104391. <a href="https://doi.org/10.1016/j.bioorg.2020.104391" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104391</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104391%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DScaffold-based%252Bselective%252BSHP2%252Binhibitors%252Bdesign%252Busing%252Bcore%252Bhopping%25252C%252Bmolecular%252Bdocking%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bsimulation%26aulast%3DLi%26aufirst%3DWei-Ya%26date%3D2020%26volume%3D105%26spage%3D104391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Yao-Nan  Jia</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112657. <a href="https://doi.org/10.1016/j.ejmech.2020.112657" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112657%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Band%252BPROTAC%252Bdegraders%26aulast%3DTang%26aufirst%3DKai%26date%3D2020%26volume%3D204%26spage%3D112657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Bing  Yang</span>, <span class="hlFld-ContribAuthor ">Rui-Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>100 </em>, 103875. <a href="https://doi.org/10.1016/j.bioorg.2020.103875" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103875%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyridine%252Bderivatives%252Bas%252Bselective%252BSHP2%252Binhibitors%26aulast%3DLiu%26aufirst%3DWen-Shan%26date%3D2020%26volume%3D100%26spage%3D103875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lanlan  Li</span>, <span class="hlFld-ContribAuthor ">Xiaoling  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Du</span>, <span class="hlFld-ContribAuthor ">Meiju  Zhang</span>, <span class="hlFld-ContribAuthor ">Yubin  Feng</span>, <span class="hlFld-ContribAuthor ">Xuewen  Qian</span>, <span class="hlFld-ContribAuthor ">Shufang  Li</span>, <span class="hlFld-ContribAuthor ">Tianxi  Du</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Peng</span>, <span class="hlFld-ContribAuthor ">Feihu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">ATPR induces acute promyelocytic leukemia cells differentiation and growth arrest by blockade of SHP2/Rho/ROCK1 pathway. </span><span class="cited-content_cbyCitation_journal-name">Toxicology and Applied Pharmacology</span><span> <strong>2020,</strong> <em>399 </em>, 115053. <a href="https://doi.org/10.1016/j.taap.2020.115053" title="DOI URL">https://doi.org/10.1016/j.taap.2020.115053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.taap.2020.115053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.taap.2020.115053%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%2520and%2520Applied%2520Pharmacology%26atitle%3DATPR%252Binduces%252Bacute%252Bpromyelocytic%252Bleukemia%252Bcells%252Bdifferentiation%252Band%252Bgrowth%252Barrest%252Bby%252Bblockade%252Bof%252BSHP2%25252FRho%25252FROCK1%252Bpathway%26aulast%3DLi%26aufirst%3DLanlan%26date%3D2020%26volume%3D399%26spage%3D115053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendran  Satheeshkumar</span>, <span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Ya  Gao</span>, <span class="hlFld-ContribAuthor ">Li-Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Ting-Jun  Hou</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yun-Long  Zhu</span>, <span class="hlFld-ContribAuthor ">Yu-Bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Wen-Long  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (11)
                                     , 127170. <a href="https://doi.org/10.1016/j.bmcl.2020.127170" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127170%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bheterocyclic%252Bbis-aryl%252Bamides%252Bas%252Bnovel%252BSrc%252Bhomology%252B2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DSatheeshkumar%26aufirst%3DRajendran%26date%3D2020%26volume%3D30%26issue%3D11%26spage%3D127170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dadong  Shen</span>, <span class="hlFld-ContribAuthor ">Wenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guofeng  Wu</span>, <span class="hlFld-ContribAuthor ">Runpu  Shen</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112117. <a href="https://doi.org/10.1016/j.ejmech.2020.112117" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112117%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bpotential%252Bof%252Btargeting%252BSHP2%252Bin%252Bhuman%252Bdevelopmental%252Bdisorders%252Band%252Bcancers%26aulast%3DShen%26aufirst%3DDadong%26date%3D2020%26volume%3D190%26spage%3D112117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Liu</span>, <span class="hlFld-ContribAuthor ">Jiao  Qu</span>, <span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a promising strategy for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>152 </em>, 104595. <a href="https://doi.org/10.1016/j.phrs.2019.104595" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104595%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Bpromising%252Bstrategy%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DLiu%26aufirst%3DQianqian%26date%3D2020%26volume%3D152%26spage%3D104595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">勃  冯</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of Benzo[c]heterocyclic Compounds against SHP2. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>08 </em>
                                    (03)
                                     , 79-83. <a href="https://doi.org/10.12677/HJMCe.2020.83009" title="DOI URL">https://doi.org/10.12677/HJMCe.2020.83009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2020.83009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2020.83009%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiological%252BEvaluation%252Bof%252BBenzo%25255Bc%25255Dheterocyclic%252BCompounds%252Bagainst%252BSHP2%26aulast%3D%25E5%2586%25AF%26aufirst%3D%25E5%258B%2583%26date%3D2020%26volume%3D08%26issue%3D03%26spage%3D79%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lixia  Lin</span>, <span class="hlFld-ContribAuthor ">Liping  Lu</span>, <span class="hlFld-ContribAuthor ">Ran  Du</span>, <span class="hlFld-ContribAuthor ">Caixia  Yuan</span>, <span class="hlFld-ContribAuthor ">Miaoli  Zhu</span>, <span class="hlFld-ContribAuthor ">Xueqi  Fu</span>, <span class="hlFld-ContribAuthor ">Shu  Xing</span>. </span><span class="cited-content_cbyCitation_article-title">A Ce(
              iii
              ) complex potently inhibits the activity and expression of tyrosine phosphatase SHP-2. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2019,</strong> <em>48 </em>
                                    (47)
                                     , 17673-17682. <a href="https://doi.org/10.1039/C9DT03200B" title="DOI URL">https://doi.org/10.1039/C9DT03200B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9DT03200B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9DT03200B%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DA%252BCe%252528%252Biii%252B%252529%252Bcomplex%252Bpotently%252Binhibits%252Bthe%252Bactivity%252Band%252Bexpression%252Bof%252Btyrosine%252Bphosphatase%252BSHP-2%26aulast%3DLin%26aufirst%3DLixia%26date%3D2019%26date%3D2019%26volume%3D48%26issue%3D47%26spage%3D17673%26epage%3D17682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panagiotis  Parsonidis</span>, <span class="hlFld-ContribAuthor ">Mahammad  Shaik</span>, <span class="hlFld-ContribAuthor ">Athanasia Panagiota  Serafeim</span>, <span class="hlFld-ContribAuthor ">Ioanna  Vlachou</span>, <span class="hlFld-ContribAuthor ">Vasiliki  Daikopoulou</span>, <span class="hlFld-ContribAuthor ">Ioannis  Papasotiriou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Activity of Pyrazine Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4389. <a href="https://doi.org/10.3390/molecules24234389" title="DOI URL">https://doi.org/10.3390/molecules24234389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234389%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BActivity%252Bof%252BPyrazine%252BCompounds%26aulast%3DParsonidis%26aufirst%3DPanagiotis%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Identification of a drug docking site in SHP2 that has unique features in both amino acid composition and structure. (A) SiteMap was used to explore potential binding sites in the SHP2 receptor for computational docking studies. Five possible binding sites were identified. The characters of potential binding sites were assessed by calculating various properties, such as size, volume, amino acid exposure, enclosure, contact, hydrophobicity, hydrophilicity, and donor/acceptor ratio. Site 1 in SHP2 was chosen for subsequent CADD <i>in silico</i> database screening. (B) Comparison between Site 1 in SHP2 and a corresponding site in SHP1. Different amino acid sequences between SHP2 and SHP1 are shown as green cartoons, and key residues are shown as green carbon sticks.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Identification of <b>1</b> as a novel inhibitor of SHP2. (A) Chemical structure of <b>1</b>. (B) Phosphatase assays were carried out using full length SHP2 or SHP1 as the enzyme and a phospho-peptide as the substrate in the presence of various concentrations of <b>1</b>, as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. For IC<sub>50</sub> determinations, six concentrations of <b>1</b> were tested. Results shown are the mean ± SD of three independent experiments. (C) Phosphatase activities of full length WT SHP2, full length SHP2 E76K, and the SHP2 PTP domain were assessed in the presence of <b>1</b> at various concentrations as above. IC<sub>50</sub> values were then determined. Experiments were repeated independently three times, similar results were obtained in each experiment. Results shown are the mean ± SD of triplicates from one experiment. (D) Phosphatase activities of full length WT SHP2, full length SHP2 E76K, and the SHP2 PTP domain were determined in the presence of <b>1</b> (10 μM) using a phospho-peptide or <i>p</i>NPP as the substrate, as detailed in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Experiments were repeated independently three times, similar results were obtained in each experiment. Results shown are the mean ± SD of triplicates from one experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Compound <b>1</b> directly binds to the SHP2 protein and functions as an inhibitor. (A) Enzymatic kinetic analyses in the presence or absence of <b>1</b> were performed using full length WT SHP2 (0.1 μg) as the enzyme. Compound <b>1</b> concentrations used in this experiment were 0, 10, and 20 μM. Lineweaver–Burk plot was generated to show <b>1</b>-mediated SHP2 inhibition. Experiments were repeated independently three times. Results shown are the mean ± SD of three independent experiments. (B) Fluorescence titration of SHP2 was performed by increasing the concentrations of <b>1</b> while maintaining the WT SHP2 protein concentration at 3.0 μM. The fluorescence intensity is plotted against the log concentration in mol/L (Log[M]). Experiments were repeated independently three times, similar results were obtained in each experiment. Data shown are the mean ± SD of triplicates from one representative experiment. (C) Thermal shift assays were performed as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Representative dose response melting curves of His-tagged SHP2 in the presence of <b>1</b> are shown. <i>T</i><sub>m</sub> data shown are the mean ± SD of three independent experiments. (D) MST binding affinity assays were performed as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. One representative dose–response curve of <b>1</b> binding to His-tagged SHP2 is shown. Fnorm, normalized fluorescence. Experiments were repeated independently three times. Reported <i>K</i><sub>d</sub> is the mean ± SD of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>1</b> inhibits IL-3-induced signaling and cell proliferation. (A) Ba/F<sub>3</sub> cells were cultured in IL-3 (1.0 ng/mL) containing medium supplemented with <b>1</b> at the indicated concentrations or DMSO. Cell numbers were determined 48 h later using a One Solution Cell Proliferation Assay kit. Experiments were performed three times with similar results obtained in each. Data shown are the mean ± SD of triplicates from one representative experiment. (B) Ba/F<sub>3</sub> cells were deprived of IL-3 overnight. Cells were treated with <b>1</b> (20 μM) for 4 h and then stimulated with IL-3 (2.0 ng/mL) for the indicated times. (C) Ba/F<sub>3</sub> cells were deprived of IL-3 overnight. Cells were treated with <b>1</b> at the indicated concentrations for 4 h and then stimulated with IL-3 (2.0 ng/mL) for 10 min. Whole cell lysates were prepared. Levels of p-Erk, p-Akt, p-Jak2, and p-Stat5 were determined by immunoblotting analyses. Blots were striped and reprobed with anti-Erk, anti-Akt, anti-Jak2, and anti-Stat5 antibodies to check for protein loading. Experiments were repeated independently three times. Representative results from one experiment are shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Effects of <b>1</b> are diminished in SHP2 knockout cells while cells harboring hyperactivated SHP2 are more sensitive to <b>1</b>. (A) <i>Ptpn11</i> conditional knockout (<i>Ptpn11</i><sup><i>fl/fl</i></sup>/Ade-Cre<sup>+</sup>) mouse embryonic fibroblasts (MEFs) and WT (<i>Ptpn11</i><sup><i>+/+</i></sup>/Ade-Cre<sup>+</sup>) control cells were infected with adeno-Cre viruses and then treated with <b>1</b> at 6 μM or DMSO. Cell growth rates were determined at 24, 48, and 72 h using a One Solution Cell Proliferation Assay kit. SHP2 levels in knockout and control cells were analyzed by immunoblotting analyses with anti-SHP2 antibody. Blots were striped and reprobed with anti-β-actin antibody to monitor protein loading. Experiments were performed three times. Similar results were obtained in each. Data shown are the mean ± SD of triplicates from one representative experiment. (B) <i>Ptpn11</i><sup><i>E76K/+</i></sup> and <i>Ptpn11</i><sup><i>+/+</i></sup> control MEFs were treated with <b>1</b> (6 μM). Cell numbers were determined using a One Solution Cell Proliferation Assay kit. Experiments were performed three times. Similar results were obtained in each. Data shown are the mean ± SD of triplicates from one representative experiment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Lung cancer cells harboring hyperactivated SHP2 are more sensitive to <b>1</b> than lung cancer cells expressing WT SHP2. (A) Human lung cancer cell line H661 carrying the <i>PTPN11</i><sup><i>N58S/+</i></sup> mutation and H596 with WT <i>PTPN11</i> were treated with <b>1</b> at the indicated concentrations for 48 h. DMSO-treated cells were included as negative controls. Cell numbers were determined using a One Solution Cell Proliferation Assay kit. Experiments were repeated three times, similar results were obtained in each experiment. Data are presented as the mean ± SD of triplicates from one representative experiment. (B) H661 cells were treated with <b>1</b> at 0, 10, and 20 μM. Apoptotic cells were quantified 24 h later by FACS using an Annexin V staining kit. Cell cycle changes were determined by propidium iodide staining followed by FACS analyses. Experiments were performed three times. Apoptosis data presented are the mean ± SD of three experiments. Cell cycle profiles are representatives of three independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/medium/jm-2018-00513g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Mouse and JMML patient leukemic cells are more sensitive to <b>1</b> than normal control cells. (A) Bone marrow cells harvested from <i>Ptpn11</i><sup><i>E76K/+</i></sup><i>/Mx1-Cre</i><sup><i>+</i></sup> and <i>Ptpn11</i><sup><i>+/+</i></sup><i>/Mx1-Cre</i><sup><i>+</i></sup> mice were plated in methylcellulose medium containing GM-CSF (1.0 ng/mL) and <b>1</b> at the indicated concentrations or DMSO. Hematopoietic colonies that were generated were enumerated 7 days later and normalized against the number of colonies derived from WT control cells treated with DMSO. Data are presented as the mean ± SD of three independent experiments. (B) Splenocytes/marrow cells/blood cells from JMML patients with the <i>PTPN11</i><sup><i>E76K/+</i></sup> mutation and apheresis samples from healthy donors were plated in methylcellulose medium containing GM-CSF (1.0 ng/mL) and <b>1</b> at the indicated concentrations or control DMSO. Leukemic colonies that were produced were enumerated 14 days later and normalized against the number of colonies derived from the cells treated with DMSO. Three patient samples and three apheresis samples were tested in three independent experiments. Similar results were obtained in each. Data are presented as the mean ± SD of triplicates from one patient sample.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b00513/20190211/images/large/jm-2018-00513g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00513&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i40">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80357" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80357" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, L.</span></span> <span> </span><span class="NLM_article-title">The ’Shp’ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">284</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1016/S0968-0004(03)00091-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2FS0968-0004%2803%2900091-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=12826400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-93&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%99Shp%E2%80%99ing+news%3A+SH2+domain-containing+tyrosine+phosphatases+in+cell+signaling&doi=10.1016%2FS0968-0004%2803%2900091-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span></div><div class="casAuthors">Neel, Benjamin G.; Gu, Haihua; Pao, Lily</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Src homol.-2 (SH2) domain-contg. phosphatases (Shps) are a small, highly conserved subfamily of protein tyrosine phosphatases, members of which are present in both vertebrates and invertebrates.  The mechanism of regulation of Shps by ligand binding is now well understood.  Much is also known about the normal signaling pathways regulated by each Shp and the consequences of Shp deficiency.  Recent studies have identified mutations in human Shp2 as the cause of the inherited disorder, Noonan syndrome.  Shp2 mutations might also contribute to the pathogenesis of some leukemias.  In addn., Shp2 might be a key virulence determinant for the important human pathogen, Helicobacter pylori.  Despite these efforts, however, the key targets of each Shp have remained elusive.  Identifying these substrates remains a major challenge for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zIEChntK0rVg90H21EOLACvtfcHk0liQP5T7eDoWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D&md5=bce9fc3db0a41b29ba605251dc46c64f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2803%2900091-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252803%252900091-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2599Shp%25E2%2580%2599ing%2520news%253A%2520SH2%2520domain-containing%2520tyrosine%2520phosphatases%2520in%2520cell%2520signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D93%26doi%3D10.1016%2FS0968-0004%2803%2900091-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonks, N. K.</span></span> <span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: from genes, to function, to disease</span>. <i>Nat. Rev. Mol. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">833</span>– <span class="NLM_lpage">46</span>, <span class="refDoi"> DOI: 10.1038/nrm2039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fnrm2039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=17057753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=833-46&author=N.+K.+Tonks&title=Protein+tyrosine+phosphatases%3A+from+genes%2C+to+function%2C+to+disease&doi=10.1038%2Fnrm2039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: from genes, to function, to disease</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">833-846</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated manner with protein tyrosine kinases to control signalling pathways that underlie a broad spectrum of fundamental physiol. processes.  In this review, I describe recent breakthroughs in our understanding of the role of the PTPs in the regulation of signal transduction and the etiol. of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NdnwoKCC1bVg90H21EOLACvtfcHk0liQP5T7eDoWrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I&md5=20a078267093bb8415d9035a13b8ad17</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm2039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2039%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520from%2520genes%252C%2520to%2520function%252C%2520to%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D833%26epage%3D46%26doi%3D10.1038%2Fnrm2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, C. K.</span></span> <span> </span><span class="NLM_article-title">Protein tyrosine phosphatases in the JAK/STAT pathway</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4925</span>– <span class="NLM_lpage">32</span>, <span class="refDoi"> DOI: 10.2741/3051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.2741%2F3051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=18508557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=4925-32&author=D.+Xuauthor=C.+K.+Qu&title=Protein+tyrosine+phosphatases+in+the+JAK%2FSTAT+pathway&doi=10.2741%2F3051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases in the JAK/STAT pathway</span></div><div class="casAuthors">Xu, Dan; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">4925-4932</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway is crucial in controlling cellular activities in response to extracellular cytokines.  Dysfunctions of the JAK/STAT pathway result in various hematopoietic and immune disorders.  The central events in regulating this pathway are tyrosine phosphorylation and dephosphorylation of the signaling components, which are carried out by protein tyrosine kinases and protein tyrosine phosphatases (PTP), resp.  Here, we review recent advances in the regulatory roles of PTPs, in particular, SHP2 phosphatase, in the JAK/STAT signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqH1iYtqQyD_7Vg90H21EOLACvtfcHk0lindRNSDMTFTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOjtrs%253D&md5=d3f84b6306220659ef34e4bf43cab87e</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.2741%2F3051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F3051%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%2520in%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2008%26volume%3D13%26spage%3D4925%26epage%3D32%26doi%3D10.2741%2F3051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hof, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhe-Paganon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of the tyrosine phosphatase SHP-2</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">441</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/S0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-50&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+structure+of+the+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0lindRNSDMTFTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520the%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D50%26doi%3D10.1016%2FS0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eck, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pluskey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trub, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoelson, S. E.</span></span> <span> </span><span class="NLM_article-title">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1038/379277a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2F379277a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=8538796" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADyaK28Xmtl2ntw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=1996&pages=277-80&author=M.+J.+Eckauthor=S.+Pluskeyauthor=T.+Trubauthor=S.+C.+Harrisonauthor=S.+E.+Shoelson&title=Spatial+constraints+on+the+recognition+of+phosphoproteins+by+the+tandem+SH2+domains+of+the+phosphatase+SH-PTP2&doi=10.1038%2F379277a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2</span></div><div class="casAuthors">Eck, Michael J.; Pluskey, Scott; Trub, Thomas; Harrison, Stephen C.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">6562</span>),
    <span class="NLM_cas:pages">277-80</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Macmillan Magazines</span>)
        </div><div class="casAbstract">The domain organization of many signaling proteins facilitates a segregation of binding, catalytic and regulatory functions.  The mammalian SH2 domain protein tyrosine phosphatases (PTPs) contain tandem SH2 domains and a single carboxy-terminal catalytic domain.  SH-PTP1 (PTP1C, HCP) and SH-PTP2 (Syp, PTP2C, PTP1D) function downstream from tyrosine kinase-linked insulin, growth factor, cytokine and antigen receptors.  As well as directing subcellular localization by binding to receptors and their substrates, the two SH2 domains of these PTPs function together to regulate catalysis.  Here the authors report the structure of the tandem SH2 domains of SH-PTP2 in complex with monophosphopeptides.  A fixed relative orientation of the two domains, stabilized by a disulfide bond and a small hydrophobic patch within the interface, separates the peptide binding sites by ∼ 40 Å.  The defined orientation of the SH2 domains in the structure, and data showing that peptide orientation and spacing between binding sites is crit. for enzymic activation, suggest that spatial constraints are important in this multidomain protein-protein interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojp1hm-r1vcbVg90H21EOLACvtfcHk0lindRNSDMTFTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xmtl2ntw%253D%253D&md5=c4d7380b9e9f320a09cbec59a93673b8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2F379277a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F379277a0%26sid%3Dliteratum%253Aachs%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DTrub%26aufirst%3DT.%26aulast%3DHarrison%26aufirst%3DS.%2BC.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DSpatial%2520constraints%2520on%2520the%2520recognition%2520of%2520phosphoproteins%2520by%2520the%2520tandem%2520SH2%2520domains%2520of%2520the%2520phosphatase%2520SH-PTP2%26jtitle%3DNature%26date%3D1996%26volume%3D379%26spage%3D277%26epage%3D80%26doi%3D10.1038%2F379277a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-54&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+mechanisms+for+SH2+domain+mediated+regulation+of+the+protein+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0lindRNSDMTFTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520mechanisms%2520for%2520SH2%2520domain%2520mediated%2520regulation%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D54%26doi%3D10.1016%2FS0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattikuti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubbert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieuw, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokoe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonifas, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtiss, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gotlib, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meshinchi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Beau, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K. M.</span></span> <span> </span><span class="NLM_article-title">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">2325</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1182/blood-2003-09-3287</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1182%2Fblood-2003-09-3287" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=14644997" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2004&pages=2325-31&author=M.+L.+Lohauthor=S.+Vattikutiauthor=S.+Schubbertauthor=M.+G.+Reynoldsauthor=E.+Carlsonauthor=K.+H.+Lieuwauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=D.+Stokoeauthor=J.+M.+Bonifasauthor=N.+P.+Curtissauthor=J.+Gotlibauthor=S.+Meshinchiauthor=M.+M.+Le+Beauauthor=P.+D.+Emanuelauthor=K.+M.+Shannon&title=Mutations+in+PTPN11+implicate+the+SHP-2+phosphatase+in+leukemogenesis&doi=10.1182%2Fblood-2003-09-3287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis</span></div><div class="casAuthors">Loh, Mignon L.; Vattikuti, Shashaank; Schubbert, Suzanne; Reynolds, Melissa G.; Carlson, Elaine; Lieuw, Kenneth H.; Cheng, Jennifer W.; Lee, Connie M.; Stokoe, David; Bonifas, Jeannette M.; Curtiss, Nicole P.; Gotlib, Jason; Meshinchi, Soheil; Le Beau, Michelle M.; Emanuel, Peter D.; Shannon, Kevin M.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2325-2331</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">The PTPN11 gene encodes SHP-2 (Src homol. 2 domain-contg. protein tyrosine Phosphatase), a non-receptor tyrosine protein tyrosine phosphatase (PTPase) that relays signals from activated growth factor receptors to p21Ras (Ras) and other signaling mols.  Mutations in PTPN11 cause Noonan syndrome (NS), a developmental disorder characterized by cardiac and skeletal defects.  NS is also assocd. with a spectrum of hematol. disorders, including juvenile myelomonocytic leukemia (JMML).  To test the hypothesis that PTPN11 mutations might contribute to myeloid leukemogenesis, we screened the entire coding region for mutations in 51 JMML specimens and in selected exons from 60 patients with other myeloid malignancies.  Missense mutations in PTPN11 were detected in 16 of 49 JMML specimens from patients without NS, but they were less common in other myeloid malignancies.  RAS, NF1, and PTPN11 mutations are largely mutually exclusive in JMML, which suggests that mutant SHP-2 proteins deregulate myeloid growth through Ras.  However, although Ba/F3 cells engineered to express leukemia-assocd. SHP-2 proteins cells showed enhanced growth factor-independent survival, biochem. anal. failed to demonstrate hyperactivation of the Ras effectors extracellular-regulated kinase (ERK) or Akt.  We conclude that SHP-2 is an important cellular PTPase that is mutated in myeloid malignancies.  Further investigation is required to clarify how these mutant proteins interact with Ras and other effectors to deregulate myeloid growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiwm--W4OxYbVg90H21EOLACvtfcHk0liGCXDk7UQL4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlCjsrc%253D&md5=6c64eb186b172aef05f71c5d3dedbc8e</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-09-3287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-09-3287%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DSchubbert%26aufirst%3DS.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DLieuw%26aufirst%3DK.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DStokoe%26aufirst%3DD.%26aulast%3DBonifas%26aufirst%3DJ.%2BM.%26aulast%3DCurtiss%26aufirst%3DN.%2BP.%26aulast%3DGotlib%26aufirst%3DJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26aulast%3DLe%2BBeau%26aufirst%3DM.%2BM.%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DMutations%2520in%2520PTPN11%2520implicate%2520the%2520SHP-2%2520phosphatase%2520in%2520leukemogenesis%26jtitle%3DBlood%26date%3D2004%26volume%3D103%26spage%3D2325%26epage%3D31%26doi%3D10.1182%2Fblood-2003-09-3287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinelli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cazzaniga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordeddu, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iavarone, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palmi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pession, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arico, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masera, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basso, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorcini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biondi, A.</span></span> <span> </span><span class="NLM_article-title">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">307</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1182/blood-2003-11-3876</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1182%2Fblood-2003-11-3876" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=14982869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2004&pages=307-13&author=M.+Tartagliaauthor=S.+Martinelliauthor=G.+Cazzanigaauthor=V.+Cordedduauthor=I.+Iavaroneauthor=M.+Spinelliauthor=C.+Palmiauthor=C.+Cartaauthor=A.+Pessionauthor=M.+Aricoauthor=G.+Maseraauthor=G.+Bassoauthor=M.+Sorciniauthor=B.+D.+Gelbauthor=A.+Biondi&title=Genetic+evidence+for+lineage-related+and+differentiation+stage-related+contribution+of+somatic+PTPN11+mutations+to+leukemogenesis+in+childhood+acute+leukemia&doi=10.1182%2Fblood-2003-11-3876"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic evidence for lineage-related and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Martinelli, Simone; Cazzaniga, Giovanni; Cordeddu, Viviana; Iavarone, Ivano; Spinelli, Monica; Palmi, Chiara; Carta, Claudio; Pession, Andrea; Arico, Maurizio; Masera, Giuseppe; Basso, Giuseppe; Sorcini, Mariella; Gelb, Bruce D.; Biondi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">307-313</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">SHP-2 is a protein tyrosine phosphatase functioning as signal transducer downstream to growth factor and cytokine receptors.  SHP-2 is required during development, and germline mutations in PTPN11, the gene encoding SHP-2, cause Noonan syndrome.  SHP-2 plays a crucial role in hematopoietic cell development.  We recently demonstrated that somatic PTPN11 mutations are the most frequent lesion in juvenile myelomonocytic leukemia and are obsd. in a smaller percentage of children with other myeloid malignancies.  Here, we report that PTPN11 lesions occur in childhood acute lymphoblastic leukemia (ALL).  Mutations were obsd. in 23 of 317 B-cell precursor ALL cases, but not among 44 children with T-lineage ALL.  In the former, lesions prevalently occurred in TEL-AML1- cases with CD19+/CD10+/cyIgM- immunophenotype.  PTPN11, NRAS, and KRAS2 mutations were largely mutually exclusive and accounted for one third of common ALL cases.  We also show that, among 69 children with acute myeloid leukemia, PTPN11 mutations occurred in 4 of 12 cases with acute monocytic leukemia (FAB-M5).  Leukemia-assocd. PTPN11 mutations were missense and were predicted to result in SHP-2 gain-of-function.  Our findings provide evidence for a wider role of PTPN11 lesions in leukemogenesis, but also suggest a lineage-related and differentiation stage-related contribution of these lesions to clonal expansion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqK8ifPYTWa1LVg90H21EOLACvtfcHk0liGCXDk7UQL4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFSnsbw%253D&md5=d8a6592845c32adc35c9612bfa1d6a2f</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1182%2Fblood-2003-11-3876&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2003-11-3876%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMartinelli%26aufirst%3DS.%26aulast%3DCazzaniga%26aufirst%3DG.%26aulast%3DCordeddu%26aufirst%3DV.%26aulast%3DIavarone%26aufirst%3DI.%26aulast%3DSpinelli%26aufirst%3DM.%26aulast%3DPalmi%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DC.%26aulast%3DPession%26aufirst%3DA.%26aulast%3DArico%26aufirst%3DM.%26aulast%3DMasera%26aufirst%3DG.%26aulast%3DBasso%26aufirst%3DG.%26aulast%3DSorcini%26aufirst%3DM.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26aulast%3DBiondi%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520lineage-related%2520and%2520differentiation%2520stage-related%2520contribution%2520of%2520somatic%2520PTPN11%2520mutations%2520to%2520leukemogenesis%2520in%2520childhood%2520acute%2520leukemia%26jtitle%3DBlood%26date%3D2004%26volume%3D104%26spage%3D307%26epage%3D13%26doi%3D10.1182%2Fblood-2003-11-3876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vattikuti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerbing, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonzo, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lange, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meshinchi, S.</span></span> <span> </span><span class="NLM_article-title">PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children’s Cancer Group</span>. <i>Leukemia</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1831</span>– <span class="NLM_lpage">4</span>, <span class="refDoi"> DOI: 10.1038/sj.leu.2403492</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fsj.leu.2403492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15385933" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovVGitbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=1831-4&author=M.+L.+Lohauthor=M.+G.+Reynoldsauthor=S.+Vattikutiauthor=R.+B.+Gerbingauthor=T.+A.+Alonzoauthor=E.+Carlsonauthor=J.+W.+Chengauthor=C.+M.+Leeauthor=B.+J.+Langeauthor=S.+Meshinchi&title=PTPN11+mutations+in+pediatric+patients+with+acute+myeloid+leukemia%3A+results+from+the+Children%E2%80%99s+Cancer+Group&doi=10.1038%2Fsj.leu.2403492"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group</span></div><div class="casAuthors">Loh, M. L.; Reynolds, M. G.; Vattikuti, S.; Gerbing, R. B.; Alonzo, T. A.; Carlson, E.; Cheng, J. W.; Lee, C. M.; Lange, B. J.; Meshinchi, S.</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1831-1834</span>CODEN:
                <span class="NLM_cas:coden">LEUKED</span>;
        ISSN:<span class="NLM_cas:issn">0887-6924</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The PTPN11 gene encodes SHP-2, a nonreceptor protein tyrosine phosphatase that relays signals from activated growth factor receptors to p21ras (Ras) and other signaling mols.  Somatic PTPN11 mutations are common in patients with juvenile myelomonocytic leukemia (JMML) and have been reported in some other hematol. malignancies.  We analyzed specimens from 278 pediatric patients with acute myelogenous leukemia (AML) who were enrolled on Children's Cancer Group trials 2941 and 2961 for PTPN11 mutations.  Missense mutations of PTPN11 were detected in 11 (4%) of these samples.  None of these patients had mutations in NRAS; however, one patient had evidence of a FLT3 alteration.  Four of the patients with PTPN11 mutations (36%) were boys with French-American-British (FAB) morphol. M5 AML (P=0.012).  Patients with mutations also presented with elevated white blood cell counts.  There was no difference in clin. outcome for patients with and without PTPN11 mutations.  These characteristics identify a subset of pediatric AML with PTPN11 mutations that share clin. and biol. features with JMML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdJu1pJ0TC67Vg90H21EOLACvtfcHk0lhdBG7JEdvaBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovVGitbw%253D&md5=5c55af87e820699e45ae71e494651910</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fsj.leu.2403492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.leu.2403492%26sid%3Dliteratum%253Aachs%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DVattikuti%26aufirst%3DS.%26aulast%3DGerbing%26aufirst%3DR.%2BB.%26aulast%3DAlonzo%26aufirst%3DT.%2BA.%26aulast%3DCarlson%26aufirst%3DE.%26aulast%3DCheng%26aufirst%3DJ.%2BW.%26aulast%3DLee%26aufirst%3DC.%2BM.%26aulast%3DLange%26aufirst%3DB.%2BJ.%26aulast%3DMeshinchi%26aufirst%3DS.%26atitle%3DPTPN11%2520mutations%2520in%2520pediatric%2520patients%2520with%2520acute%2520myeloid%2520leukemia%253A%2520results%2520from%2520the%2520Children%25E2%2580%2599s%2520Cancer%2520Group%26jtitle%3DLeukemia%26date%3D2004%26volume%3D18%26spage%3D1831%26epage%3D4%26doi%3D10.1038%2Fsj.leu.2403492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niemeyer, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buechner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahlen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Licht, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1038/ng1156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-50&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+Hahlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+mutations+in+PTPN11+in+juvenile+myelomonocytic+leukemia%2C+myelodysplastic+syndromes+and+acute+myeloid+leukemia&doi=10.1038%2Fng1156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lhdBG7JEdvaBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DHahlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520mutations%2520in%2520PTPN11%2520in%2520juvenile%2520myelomonocytic%2520leukemia%252C%2520myelodysplastic%2520syndromes%2520and%2520acute%2520myeloid%2520leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D50%26doi%3D10.1038%2Fng1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tartaglia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehler, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zampino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunner, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kremer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Burgt, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crosby, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ion, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeffery, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalidas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patton, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucherlapati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelb, B. D.</span></span> <span> </span><span class="NLM_article-title">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span>. <i>Nat. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1038/ng772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-8&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+van+der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=M.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+PTPN11%2C+encoding+the+protein+tyrosine+phosphatase+SHP-2%2C+cause+Noonan+syndrome&doi=10.1038%2Fng772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lhdBG7JEdvaBA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DM.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520PTPN11%252C%2520encoding%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%252C%2520cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D8%26doi%3D10.1038%2Fng772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentires-Alj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paez, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keilhack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naoki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maris, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bardelli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sugarbaker, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richards, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velculescu, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">8816</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-1923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1158%2F0008-5472.CAN-04-1923" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15604238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-20&author=M.+Bentires-Aljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbakerauthor=W.+G.+Richardsauthor=J.+Duauthor=L.+Girardauthor=J.+D.+Minnaauthor=M.+L.+Lohauthor=D.+E.+Fisherauthor=V.+E.+Velculescuauthor=B.+Vogelsteinauthor=M.+Meyersonauthor=W.+R.+Sellersauthor=B.+G.+Neel&title=Activating+mutations+of+the+noonan+syndrome-associated+SHP2%2FPTPN11+gene+in+human+solid+tumors+and+adult+acute+myelogenous+leukemia&doi=10.1158%2F0008-5472.CAN-04-1923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia</span></div><div class="casAuthors">Bentires-Alj, Mohamed; Paez, J. Guillermo; David, Frank S.; Keilhack, Heike; Halmos, Balazs; Naoki, Katsuhiko; Maris, John M.; Richardson, Andrea; Bardelli, Alberto; Sugarbaker, David J.; Richards, William G.; Du, Jinyan; Girard, Luc; Minna, John D.; Loh, Mignon L.; Fisher, David E.; Velculescu, Victor E.; Vogelstein, Bert; Meyerson, Matthew; Sellers, William R.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8816-8820</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The SH2 domain-contg. protein-tyrosine phosphatase PTPN11 (Shp2) is required for normal development and is an essential component of signaling pathways initiated by growth factors, cytokines, and extracellular matrix.  In many of these pathways, Shp2 acts upstream of Ras.  About 50% of patients with Noonan syndrome have germ-line PTPN11 gain of function mutations.  Assocns. between Noonan syndrome and an increased risk of some malignancies, notably leukemia and neuroblastoma, have been reported, and recent data indicate that somatic PTPN11 mutations occur in children with sporadic juvenile myelomonocytic leukemia, myelodysplasic syndrome, B-cell acute lymphoblastic leukemia, and acute myelogenous leukemia (AML).  Juvenile myelomonocytic leukemia patients without PTPN11 mutations have either homozygotic NF-1 deletion or activating RAS mutations.  Given the role of Shp2 in Ras activation and the frequent mutation of RAS in human tumors, these data raise the possibility that PTPN11 mutations play a broader role in cancer.  The authors asked whether PTPN11 mutations occur in other malignancies in which activating RAS mutations occur at low but significant frequency.  Sequencing of PTPN11 from 13 different human neoplasms including breast, lung, gastric, and neuroblastoma tumors and adult AML and acute lymphoblastic leukemia revealed 11 missense mutations.  Five are known mutations predicted to result in an activated form of Shp2, whereas six are new mutations.  Biochem. anal. confirmed that several of the new mutations result in increased Shp2 activity.  The data demonstrate that mutations in PTPN11 occur at low frequency in several human cancers, esp. neuroblastoma and AML, and suggest that Shp2 may be a novel target for antineoplastic therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3taKvDtHXBLVg90H21EOLACvtfcHk0ljicxUn5eTCqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOms7fK&md5=f6f9fb8c6e9d5260901a03081db259c7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentires-Alj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DFisher%26aufirst%3DD.%2BE.%26aulast%3DVelculescu%26aufirst%3DV.%2BE.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DActivating%2520mutations%2520of%2520the%2520noonan%2520syndrome-associated%2520SHP2%252FPTPN11%2520gene%2520in%2520human%2520solid%2520tumors%2520and%2520adult%2520acute%2520myelogenous%2520leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D20%26doi%3D10.1158%2F0008-5472.CAN-04-1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keilhack, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGregor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>280</i></span>,  <span class="NLM_fpage">30984</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1074/jbc.M504699200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1074%2Fjbc.M504699200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15987685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30984-93&author=H.+Keilhackauthor=F.+S.+Davidauthor=M.+McGregorauthor=L.+C.+Cantleyauthor=B.+G.+Neel&title=Diverse+biochemical+properties+of+Shp2+mutants.+Implications+for+disease+phenotypes&doi=10.1074%2Fjbc.M504699200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Biochemical Properties of Shp2 Mutants: implications for disease phenotypes</span></div><div class="casAuthors">Keilhack, Heike; David, Frank S.; McGregor, Malcolm; Cantley, Lewis C.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30984-30993</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mutations in the Src homol. 2 (SH2)-contg. protein-tyrosine phosphatase Shp2 (PTPN11) underlie half of the cases of the autosomal dominant genetic disorder Noonan syndrome, and somatic Shp2 mutations are found in several hematol. and solid malignancies.  Earlier studies of small nos. of mutants suggested that disease-assocd. mutations cause constitutive (SH2 binding-independent) activation and that cancer-assocd. mutants are more active than those assocd. with Noonan syndrome.  We have characterized a larger panel of Shp2 mutants and find that this "activity-centric" model cannot explain the behaviors of all pathogenic Shp2 mutations.  Instead, enzymic, structural, and math. modeling analyses show that these mutants can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate specificity to varying degrees.  Furthermore, there is no abs. correlation between the mutants' extents of basal activation and the diseases they induce.  We propose that activated mutants of Shp2 modulate signaling from specific stimuli to a subset of effectors and provide a theor. framework for understanding the complex relationship between Shp2 activation, intracellular signaling, and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJx5YZGoBn6bVg90H21EOLACvtfcHk0ljicxUn5eTCqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D&md5=649d6897855861aa0e6aaaff4ed57125</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504699200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504699200%26sid%3Dliteratum%253Aachs%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DMcGregor%26aufirst%3DM.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DDiverse%2520biochemical%2520properties%2520of%2520Shp2%2520mutants.%2520Implications%2520for%2520disease%2520phenotypes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30984%26epage%3D93%26doi%3D10.1074%2Fjbc.M504699200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaitzidis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutok, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">4414</span>– <span class="NLM_lpage">24</span>, <span class="refDoi"> DOI: 10.1182/blood-2008-10-182626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1182%2Fblood-2008-10-182626" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=19179468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlvVGitrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2009&pages=4414-24&author=G.+Chanauthor=D.+Kalaitzidisauthor=T.+Usenkoauthor=J.+L.+Kutokauthor=W.+Yangauthor=M.+G.+Mohiauthor=B.+G.+Neel&title=Leukemogenic+Ptpn11+causes+fatal+myeloproliferative+disorder+via+cell-autonomous+effects+on+multiple+stages+of+hematopoiesis&doi=10.1182%2Fblood-2008-10-182626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Usenko, Tatiana; Kutok, Jeffery L.; Yang, Wentian; Mohi, M. Golam; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4414-4424</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">PTPN11, which encodes the tyrosine phosphatase SHP2, is mutated in approx. 35% of patients with juvenile myelomonocytic leukemia (JMML) and at a lower incidence in other neoplasms.  To model JMML pathogenesis, the authors generated knock-in mice that conditionally express the leukemia-assocd. mutant Ptpn11D61Y.  Expression of Ptpn11D61Y in all hematopoietic cells evokes a fatal myeloproliferative disorder (MPD), featuring leukocytosis, anemia, hepatosplenomegaly, and factor-independent colony formation by bone marrow (BM) and spleen cells.  The Lin-Sca1+cKit+ (LSK) compartment is expanded and "right-shifted," accompanied by increased stem cell factor (SCF)-evoked colony formation and Erk and Akt activation.  However, repopulating activity is decreased in diseased mice, and mice that do engraft with Ptpn11D61Y stem cells fail to develop MPD.  Ptpn11D61Y common myeloid progenitors (CMPs) and granulocyte-monocyte progenitors (GMPs) produce cytokine-independent colonies in a cell-autonomous manner and demonstrate elevated Erk and Stat5 activation in response to granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation.  Ptpn11D61Y megakaryocyte-erythrocyte progenitors (MEPs) yield increased nos. of erythrocyte burst-forming units (BFU-Es), but MEPs and erythrocyte-committed progenitors (EPs) produce fewer erythrocyte colony-forming units (CFU-Es), indicating defective erythroid differentiation.  These studies provide a mouse model for Ptpn11-evoked MPD and show that this disease results from cell-autonomous and distinct lineage-specific effects of mutant Ptpn11 on multiple stages of hematopoiesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3cIq_57M9vrVg90H21EOLACvtfcHk0lg0kJ4Kd9IKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlvVGitrg%253D&md5=e5363cc8f6acc1716ae263e5fb6c4585</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1182%2Fblood-2008-10-182626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2008-10-182626%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DUsenko%26aufirst%3DT.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DLeukemogenic%2520Ptpn11%2520causes%2520fatal%2520myeloproliferative%2520disorder%2520via%2520cell-autonomous%2520effects%2520on%2520multiple%2520stages%2520of%2520hematopoiesis%26jtitle%3DBlood%26date%3D2009%26volume%3D113%26spage%3D4414%26epage%3D24%26doi%3D10.1182%2Fblood-2008-10-182626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, C. K.</span></span> <span> </span><span class="NLM_article-title">Non-lineage/stage-restricted effects of a gain-of-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>208</i></span>,  <span class="NLM_fpage">1977</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1084/jem.20110450</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1084%2Fjem.20110450" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2011&pages=1977-88&author=D.+Xuauthor=X.+Liuauthor=W.+M.+Yuauthor=H.+J.+Meyersonauthor=C.+Guoauthor=S.+L.+Gersonauthor=C.+K.+Qu&title=Non-lineage%2Fstage-restricted+effects+of+a+gain-of-function+mutation+in+tyrosine+phosphatase+Ptpn11+%28Shp2%29+on+malignant+transformation+of+hematopoietic+cells&doi=10.1084%2Fjem.20110450"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1084%2Fjem.20110450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20110450%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DMeyerson%26aufirst%3DH.%2BJ.%26aulast%3DGuo%26aufirst%3DC.%26aulast%3DGerson%26aufirst%3DS.%2BL.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DNon-lineage%252Fstage-restricted%2520effects%2520of%2520a%2520gain-of-function%2520mutation%2520in%2520tyrosine%2520phosphatase%2520Ptpn11%2520%2528Shp2%2529%2520on%2520malignant%2520transformation%2520of%2520hematopoietic%2520cells%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2011%26volume%3D208%26spage%3D1977%26epage%3D88%26doi%3D10.1084%2Fjem.20110450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Araki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohi, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ismat, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronson, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kutok, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, L. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilliland, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">849</span>– <span class="NLM_lpage">57</span>, <span class="refDoi"> DOI: 10.1038/nm1084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fnm1084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15273746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFWrt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=849-57&author=T.+Arakiauthor=M.+G.+Mohiauthor=F.+A.+Ismatauthor=R.+T.+Bronsonauthor=I.+R.+Williamsauthor=J.+L.+Kutokauthor=W.+Yangauthor=L.+I.+Paoauthor=D.+G.+Gillilandauthor=J.+A.+Epsteinauthor=B.+G.+Neel&title=Mouse+model+of+Noonan+syndrome+reveals+cell+type-+and+gene+dosage-dependent+effects+of+Ptpn11+mutation&doi=10.1038%2Fnm1084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation</span></div><div class="casAuthors">Araki, Toshiyuki; Mohi, M. Golam; Ismat, Fraz A.; Bronson, Roderick T.; Williams, Ifor R.; Kutok, Jeffery L.; Yang, Wentian; Pao, Lily I.; Gilliland, D. Gary; Epstein, Jonathan A.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">849-857</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Noonan syndrome is a common human autosomal dominant birth defect, characterized by short stature, facial abnormalities, heart defects and possibly increased risk of leukemia.  Mutations of Ptpn11 (also known as Shp2), which encodes the protein-tyrosine phosphatase Shp2, occur in ∼50% of individuals with Noonan syndrome, but their mol., cellular and developmental effects, and the relationship between Noonan syndrome and leukemia, are unclear.  We generated mice expressing the Noonan syndrome-assocd. mutant D61G.  When homozygous, the D61G mutant is embryonic lethal, whereas heterozygotes have decreased viability.  Surviving Ptpn11D61G/+ embryos (∼50%) have short stature, craniofacial abnormalities similar to those in Noonan syndrome, and myeloproliferative disease.  Severely affected Ptpn11D61G/+ embryos (∼50%) have multiple cardiac defects similar to those in mice lacking the Ras-GAP protein neurofibromin.  Their endocardial cushions have increased Erk activation, but Erk hyperactivation is cell and pathway specific.  Our results clarify the relationship between Noonan syndrome and leukemia and show that a single Ptpn11 gain-of-function mutation evokes all major features of Noonan syndrome by acting on multiple developmental lineages in a gene dosage-dependent and pathway-selective manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsmxo_WGTel7Vg90H21EOLACvtfcHk0lg0kJ4Kd9IKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFWrt78%253D&md5=69aae2a9730455356988fa32e7652c00</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnm1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1084%26sid%3Dliteratum%253Aachs%26aulast%3DAraki%26aufirst%3DT.%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DIsmat%26aufirst%3DF.%2BA.%26aulast%3DBronson%26aufirst%3DR.%2BT.%26aulast%3DWilliams%26aufirst%3DI.%2BR.%26aulast%3DKutok%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DPao%26aufirst%3DL.%2BI.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26aulast%3DEpstein%26aufirst%3DJ.%2BA.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DMouse%2520model%2520of%2520Noonan%2520syndrome%2520reveals%2520cell%2520type-%2520and%2520gene%2520dosage-dependent%2520effects%2520of%2520Ptpn11%2520mutation%26jtitle%3DNat.%2520Med.%26date%3D2004%26volume%3D10%26spage%3D849%26epage%3D57%26doi%3D10.1038%2Fnm1084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel shp2 protein tyrosine phosphatase inhibitor</span>. <i>Molecular pharmacology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">562</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1124/mol.106.025536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1124%2Fmol.106.025536" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=562-70&author=L.+Chenauthor=S.+S.+Sungauthor=M.+L.+Yipauthor=H.+R.+Lawrenceauthor=Y.+Renauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Discovery+of+a+novel+shp2+protein+tyrosine+phosphatase+inhibitor&doi=10.1124%2Fmol.106.025536"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025536%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520shp2%2520protein%2520tyrosine%2520phosphatase%2520inhibitor%26jtitle%3DMolecular%2520pharmacology%26date%3D2006%26volume%3D70%26spage%3D562%26epage%3D70%26doi%3D10.1124%2Fmol.106.025536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geronikaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eleftheriou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dixit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A. K.</span></span> <span> </span><span class="NLM_article-title">2-Thiazolylimino/heteroarylimino-5-arylidene-4-thiazolidinones as new agents with SHP-2 inhibitory action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">5221</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/jm8004306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8004306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5221-8&author=A.+Geronikakiauthor=P.+Eleftheriouauthor=P.+Viciniauthor=I.+Alamauthor=A.+Dixitauthor=A.+K.+Saxena&title=2-Thiazolylimino%2Fheteroarylimino-5-arylidene-4-thiazolidinones+as+new+agents+with+SHP-2+inhibitory+action&doi=10.1021%2Fjm8004306"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm8004306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8004306%26sid%3Dliteratum%253Aachs%26aulast%3DGeronikaki%26aufirst%3DA.%26aulast%3DEleftheriou%26aufirst%3DP.%26aulast%3DVicini%26aufirst%3DP.%26aulast%3DAlam%26aufirst%3DI.%26aulast%3DDixit%26aufirst%3DA.%26aulast%3DSaxena%26aufirst%3DA.%2BK.%26atitle%3D2-Thiazolylimino%252Fheteroarylimino-5-arylidene-4-thiazolidinones%2520as%2520new%2520agents%2520with%2520SHP-2%2520inhibitory%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5221%26epage%3D8%26doi%3D10.1021%2Fjm8004306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hellmuth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosskopf, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lum, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurtele, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roder, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Kries, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosario, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rademann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birchmeier, W.</span></span> <span> </span><span class="NLM_article-title">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">7275</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710468105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1073%2Fpnas.0710468105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=18480264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=7275-80&author=K.+Hellmuthauthor=S.+Grosskopfauthor=C.+T.+Lumauthor=M.+Wurteleauthor=N.+Roderauthor=J.+P.+von+Kriesauthor=M.+Rosarioauthor=J.+Rademannauthor=W.+Birchmeier&title=Specific+inhibitors+of+the+protein+tyrosine+phosphatase+Shp2+identified+by+high-throughput+docking&doi=10.1073%2Fpnas.0710468105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span></div><div class="casAuthors">Hellmuth, Klaus; Grosskopf, Stefanie; Lum, Ching Tung; Wuertele, Martin; Roeder, Nadine; von Kries, Jens Peter; Rosario, Marta; Rademann, Jorg; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7275-7280</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The protein tyrosine phosphatase Shp2 is a pos. regulator of growth factor signaling.  Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene.  We performed a high-throughput in silico screen for small-mol.-wt. compds. that bind the catalytic site of Shp2.  We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1 B.  PHPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis.  PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin.  Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-assocd. Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.  The PHPS compd. class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGponh1kw_h7jrVg90H21EOLACvtfcHk0lgmdhA0taLuDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D&md5=39c7dda94e32134c305e135e4c48b9d1</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710468105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710468105%26sid%3Dliteratum%253Aachs%26aulast%3DHellmuth%26aufirst%3DK.%26aulast%3DGrosskopf%26aufirst%3DS.%26aulast%3DLum%26aufirst%3DC.%2BT.%26aulast%3DWurtele%26aufirst%3DM.%26aulast%3DRoder%26aufirst%3DN.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DSpecific%2520inhibitors%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520Shp2%2520identified%2520by%2520high-throughput%2520docking%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D7275%26epage%3D80%26doi%3D10.1073%2Fpnas.0710468105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pireddu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szymanski, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guida, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebti, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lawrence, N. J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">4948</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1021/jm8002526</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8002526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4948-56&author=H.+R.+Lawrenceauthor=R.+Piredduauthor=L.+Chenauthor=Y.+Luoauthor=S.+S.+Sungauthor=A.+M.+Szymanskiauthor=M.+L.+Yipauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=J.+Wuauthor=N.+J.+Lawrence&title=Inhibitors+of+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28Shp2%29+based+on+oxindole+scaffolds&doi=10.1021%2Fjm8002526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds</span></div><div class="casAuthors">Lawrence, Harshani R.; Pireddu, Roberta; Chen, Liwei; Luo, Yunting; Sung, Shen-Shu; Szymanski, Ann Marie; Yip, M. L. Richard; Guida, Wayne C.; Sebti, Said M.; Wu, Jie; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4948-4956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of the NCI diversity set of compds. has led to the identification of NSC-117199, which inhibits the protein tyrosine phosphatase (PTP) Shp2 with an IC50 of 47 μM.  A focused library incorporating an isatin scaffold was designed and evaluated for inhibition of Shp2 and Shp1 PTP activities.  Several compds. were identified that selectively inhibit Shp2 over Shp1 and PTP1B with low to submicromolar activity.  A model for the binding of the active compds. is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRqLAauyGNBbVg90H21EOLACvtfcHk0lgmdhA0taLuDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D&md5=572227c5a8cfffb108388616bd36fdfe</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm8002526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002526%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DSzymanski%26aufirst%3DA.%2BM.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26atitle%3DInhibitors%2520of%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528Shp2%2529%2520based%2520on%2520oxindole%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4948%26epage%3D56%26doi%3D10.1021%2Fjm8002526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabinger, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunawan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span> <span> </span><span class="NLM_article-title">Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2482</span>– <span class="NLM_lpage">93</span>, <span class="refDoi"> DOI: 10.1021/jm901645u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-93&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.+X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawanauthor=L.+Wangauthor=R.+J.+Chanauthor=Z.+Y.+Zhang&title=Salicylic+acid+based+small+molecule+inhibitor+for+the+oncogenic+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28SHP2%29&doi=10.1021%2Fjm901645u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)</span></div><div class="casAuthors">Zhang, Xian; He, Yantao; Liu, Sijiu; Yu, Zhihong; Jiang, Zhong-Xing; Yang, Zhenyun; Dong, Yuanshu; Nabinger, Sarah C.; Wu, Li; Gunawan, Andrea M.; Wang, Lina; Chan, Rebecca J.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2482-2493</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol.-2 domain contg. protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling.  Gain-of-function SHP2 mutations are assocd. with Noonan syndrome, various kinds of leukemias, and solid tumors.  Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy.  We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity.  Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compd. 9) with highly efficacious cellular activity.  Compd. 9 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation, providing supporting evidence that chem. inhibition of SHP2 may be therapeutically useful for anticancer and antileukemia treatment.  X-ray crystallog. anal. of the structure of SHP2 in complex with 9 reveals mol. determinants that can be exploited for the acquisition of more potent and selective SHP2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC82T5JpCRArVg90H21EOLACvtfcHk0lja_SM6Up2Ilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D&md5=6f87897eda38ea485dc08e189f1b5ca8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DSalicylic%2520acid%2520based%2520small%2520molecule%2520inhibitor%2520for%2520the%2520oncogenic%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D93%26doi%3D10.1021%2Fjm901645u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loh, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, C. K.</span></span> <span> </span><span class="NLM_article-title">Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">7212</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1021/jm400474r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400474r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7212-21&author=W.+Liuauthor=B.+Yuauthor=G.+Xuauthor=W.+R.+Xuauthor=M.+L.+Lohauthor=L.+D.+Tangauthor=C.+K.+Qu&title=Identification+of+cryptotanshinone+as+an+inhibitor+of+oncogenic+protein+tyrosine+phosphatase+SHP2+%28PTPN11%29&doi=10.1021%2Fjm400474r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)</span></div><div class="casAuthors">Liu, Wei; Yu, Bing; Xu, Gang; Xu, Wei-Ren; Loh, Mignon L.; Tang, Li-Da; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7212-7221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are assocd. with Noonan syndrome, childhood leukemias, and sporadic solid tumors.  Virtual screening combined with exptl. assays was performed to identify inhibitors of SHP2 from a database of natural products.  This effort led to the identification of cryptotanshinone as an inhibitor of SHP2.  Cryptotanshinone inhibited SHP2 with an IC50 of 22.50 μM.  Fluorescence titrn. expts. confirmed that it directly bound to SHP2.  Enzymic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor.  This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions.  Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in PTPN11 were found to be sensitive to this inhibitor.  Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed to treat PTPN11-assocd. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYelS47QYHLVg90H21EOLACvtfcHk0lja_SM6Up2Ilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN&md5=3bbbae68159ae4227bbf74d5573ca77a</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm400474r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400474r%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%2BR.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DTang%26aufirst%3DL.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520cryptotanshinone%2520as%2520an%2520inhibitor%2520of%2520oncogenic%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520%2528PTPN11%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7212%26epage%3D21%26doi%3D10.1021%2Fjm400474r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chio, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, A. C.</span></span> <span> </span><span class="NLM_article-title">Targeting a cryptic allosteric site for selective inhibition of the oncogenic protein tyrosine phosphatase Shp2</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1021/bi5013595</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi5013595" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=497-504&author=C.+M.+Chioauthor=C.+S.+Limauthor=A.+C.+Bishop&title=Targeting+a+cryptic+allosteric+site+for+selective+inhibition+of+the+oncogenic+protein+tyrosine+phosphatase+Shp2&doi=10.1021%2Fbi5013595"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting a Cryptic Allosteric Site for Selective Inhibition of the Oncogenic Protein Tyrosine Phosphatase Shp2</span></div><div class="casAuthors">Chio, Cynthia M.; Lim, Christopher S.; Bishop, Anthony C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">497-504</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs) have been the subject of considerable pharmaceutical-design efforts because of the ubiquitous connections between misregulation of PTP activity and human disease.  PTP-inhibitor discovery has been hampered, however, by the difficulty in identifying cell-permeable compds. that can selectively target PTP active sites, and no PTP inhibitors have progressed to the clinic.  The identification of allosteric sites on target PTPs therefore represents a potentially attractive soln. to the druggability problem of PTPs.  Here we report that the oncogenic PTP Shp2 contains an allosteric-inhibition site that renders the enzyme sensitive to potent and selective inhibition by cell-permeable biarsenical compds.  Because Shp2 contains no canonical tetracysteine biarsenical-binding motif, the enzyme's inhibitor-binding site is not readily predictable from its primary or three-dimensional structure.  Intriguingly, however, Shp2's PTP domain does contain a cysteine residue (C333) at a position that is removed from the active site and is occupied by proline in other classical PTPs.  We show that Shp2's unusual cysteine residue constitutes part of a Shp2-specific allosteric-inhibition site, and that Shp2's sensitivity to biarsenicals is dependent on the presence of the naturally occurring C333.  The determinative role of this residue in conferring inhibitor sensitivity is surprising because C333's side chain is inaccessible to solvent in Shp2 crystal structures.  The discovery of this cryptic Shp2 allosteric site may provide a means for targeting Shp2 activity with high specificity and suggests that buried-yet-targetable allosteric sites could be similarly uncovered in other protein families.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWBChJ5ezZcbVg90H21EOLACvtfcHk0lja_SM6Up2Ilw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrs7rK&md5=824fcbb6a26460197422c7008f35ca2b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fbi5013595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi5013595%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DC.%2BM.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DBishop%26aufirst%3DA.%2BC.%26atitle%3DTargeting%2520a%2520cryptic%2520allosteric%2520site%2520for%2520selective%2520inhibition%2520of%2520the%2520oncogenic%2520protein%2520tyrosine%2520phosphatase%2520Shp2%26jtitle%3DBiochemistry%26date%3D2015%26volume%3D54%26spage%3D497%26epage%3D504%26doi%3D10.1021%2Fbi5013595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonakos, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fei, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacob, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La Bonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slisz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatesan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warmuth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span> <span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>535</i></span>,  <span class="NLM_fpage">148</span>– <span class="NLM_lpage">52</span>, <span class="refDoi"> DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-52&author=Y.+N.+Chenauthor=M.+J.+LaMarcheauthor=H.+M.+Chanauthor=P.+Fekkesauthor=J.+Garcia-Fortanetauthor=M.+G.+Ackerauthor=B.+Antonakosauthor=C.+H.+Chenauthor=Z.+Chenauthor=V.+G.+Cookeauthor=J.+R.+Dobsonauthor=Z.+Dengauthor=F.+Feiauthor=B.+Firestoneauthor=M.+Fodorauthor=C.+Fridrichauthor=H.+Gaoauthor=D.+Grunenfelderauthor=H.+X.+Haoauthor=J.+Jacobauthor=S.+Hoauthor=K.+Hsiaoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=J.+Larrowauthor=L.+R.+La+Bonteauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=E.+Priceauthor=C.+Quinnauthor=S.+Shakyaauthor=M.+D.+Shultzauthor=J.+Sliszauthor=K.+Venkatesanauthor=P.+Wangauthor=M.+Warmuthauthor=S.+Williamsauthor=G.+Yangauthor=J.+Yuanauthor=J.+H.+Zhangauthor=P.+Zhuauthor=T.+Ramseyauthor=N.+J.+Keenauthor=W.+R.+Sellersauthor=T.+Stamsauthor=P.+D.+Fortin&title=Allosteric+inhibition+of+SHP2+phosphatase+inhibits+cancers+driven+by+receptor+tyrosine+kinases&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 μM), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lhQy2J0mR5BHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BN.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DH.%2BM.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarcia-Fortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DAntonakos%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCooke%26aufirst%3DV.%2BG.%26aulast%3DDobson%26aufirst%3DJ.%2BR.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DF.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHao%26aufirst%3DH.%2BX.%26aulast%3DJacob%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLa%2BBonte%26aufirst%3DL.%2BR.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DQuinn%26aufirst%3DC.%26aulast%3DShakya%26aufirst%3DS.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DVenkatesan%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DKeen%26aufirst%3DN.%2BJ.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%2520phosphatase%2520inhibits%2520cancers%2520driven%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D52%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia
Fortanet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Firestone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fekkes, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fortin, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fridrich, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunenfelder, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaBonte, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larrow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenoir, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lombardo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palermo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Towler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Allosteric Inhibition of SHP2: Identification of a potent, selective, and orally efficacious phosphatase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7773</span>– <span class="NLM_lpage">82</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00680</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00680" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7773-82&author=J.+Garcia%0AFortanetauthor=C.+H.+Chenauthor=Y.+N.+Chenauthor=Z.+Chenauthor=Z.+Dengauthor=B.+Firestoneauthor=P.+Fekkesauthor=M.+Fodorauthor=P.+D.+Fortinauthor=C.+Fridrichauthor=D.+Grunenfelderauthor=S.+Hoauthor=Z.+B.+Kangauthor=R.+Karkiauthor=M.+Katoauthor=N.+Keenauthor=L.+R.+LaBonteauthor=J.+Larrowauthor=F.+Lenoirauthor=G.+Liuauthor=S.+Liuauthor=F.+Lombardoauthor=D.+Majumdarauthor=M.+J.+Meyerauthor=M.+Palermoauthor=L.+Perezauthor=M.+Puauthor=T.+Ramseyauthor=W.+R.+Sellersauthor=M.+D.+Shultzauthor=T.+Stamsauthor=C.+Towlerauthor=P.+Wangauthor=S.+L.+Williamsauthor=J.+H.+Zhangauthor=M.+J.+LaMarche&title=Allosteric+Inhibition+of+SHP2%3A+Identification+of+a+potent%2C+selective%2C+and+orally+efficacious+phosphatase+inhibitor&doi=10.1021%2Facs.jmedchem.6b00680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span></div><div class="casAuthors">Garcia Fortanet, Jorge; Chen, Christine Hiu-Tung; Chen, Ying-Nan P.; Chen, Zhouliang; Deng, Zhan; Firestone, Brant; Fekkes, Peter; Fodor, Michelle; Fortin, Pascal D.; Fridrich, Cary; Grunenfelder, Denise; Ho, Samuel; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Keen, Nick; LaBonte, Laura R.; Larrow, Jay; Lenoir, Francois; Liu, Gang; Liu, Shumei; Lombardo, Franco; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Ramsey, Timothy; Sellers, William R.; Shultz, Michael D.; Stams, Travis; Towler, Christopher; Wang, Ping; Williams, Sarah L.; Zhang, Ji-Hu; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7773-7782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway.  SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1).  Because it is an oncoprotein assocd. with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest.  Recently in our labs., a small mol. inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2.  A high throughput screen was performed to identify progressable chem. matter, and X-ray crystallog. revealed the location of binding in a previously undisclosed allosteric binding pocket.  Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein-ligand interactions were characterized.  These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (SHP099, 1), a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6RT7zfZnvfLVg90H21EOLACvtfcHk0li2yAwUH0R0Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP&md5=dfe43b5253e172576386f86797087f7b</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%2BFortanet%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BN.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFridrich%26aufirst%3DC.%26aulast%3DGrunenfelder%26aufirst%3DD.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DKang%26aufirst%3DZ.%2BB.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLaBonte%26aufirst%3DL.%2BR.%26aulast%3DLarrow%26aufirst%3DJ.%26aulast%3DLenoir%26aufirst%3DF.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DM.%2BJ.%26aulast%3DPalermo%26aufirst%3DM.%26aulast%3DPerez%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DTowler%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DZhang%26aufirst%3DJ.%2BH.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DAllosteric%2520Inhibition%2520of%2520SHP2%253A%2520Identification%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520phosphatase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7773%26epage%3D82%26doi%3D10.1021%2Facs.jmedchem.6b00680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-40&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0li2yAwUH0R0Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D40%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emanuel, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castleberry, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gualtieri, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuckerman, K. S.</span></span> <span> </span><span class="NLM_article-title">Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">925</span>– <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1704804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A280%3ADyaK3M7jslyiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1991&pages=925-9&author=P.+D.+Emanuelauthor=L.+J.+Batesauthor=R.+P.+Castleberryauthor=R.+J.+Gualtieriauthor=K.+S.+Zuckerman&title=Selective+hypersensitivity+to+granulocyte-macrophage+colony-stimulating+factor+by+juvenile+chronic+myeloid+leukemia+hematopoietic+progenitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors</span></div><div class="casAuthors">Emanuel P D; Bates L J; Castleberry R P; Gualtieri R J; Zuckerman K S</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">925-9</span>
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    </div><div class="casAbstract">Juvenile chronic myelogenous leukemia (JCML) is a good model for the study of myeloproliferation because JCML hematopoietic progenitor cells grow in vitro at very low cell densities without the addition of exogenous stimulus.  Previous studies have demonstrated that this proliferation is dependent on granulocyte-macrophage colony-stimulating factor (GM-CSF), and that removal of monocytes from the cell population before culture eliminates this "spontaneous" myeloproliferation, suggesting a paracrine role of monocyte stimulation.  However, subsequent studies have shown that increased GM-CSF production from the JCML monocytes is not a consistent finding and therefore not a plausible sole mechanism.  In examining hematopoietic growth factor dose-response curves, both JCML GM and erythroid nonadherent progenitor cell populations displayed a marked and selective hypersensitivity to GM-CSF.  Responses to interleukin-3 and G-CSF were identical to control dose-response curves.  This is the first demonstration of a myeloid leukemia in which hypersensitivity to a specific growth factor appears to be involved in the pathogenesis of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSqJDPh116g5F1C8OJBvdfbfW6udTcc2eaBIUQd80VX_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M7jslyiug%253D%253D&md5=380f655a2c503367555ebf1d922e3697</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmanuel%26aufirst%3DP.%2BD.%26aulast%3DBates%26aufirst%3DL.%2BJ.%26aulast%3DCastleberry%26aufirst%3DR.%2BP.%26aulast%3DGualtieri%26aufirst%3DR.%2BJ.%26aulast%3DZuckerman%26aufirst%3DK.%2BS.%26atitle%3DSelective%2520hypersensitivity%2520to%2520granulocyte-macrophage%2520colony-stimulating%2520factor%2520by%2520juvenile%2520chronic%2520myeloid%2520leukemia%2520hematopoietic%2520progenitors%26jtitle%3DBlood%26date%3D1991%26volume%3D77%26spage%3D925%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Birnbaum, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Marcaigh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardak, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dranoff, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacks, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clapp, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, K. M.</span></span> <span> </span><span class="NLM_article-title">Nf1 and Gmcsf interact in myeloid leukemogenesis</span>. <i>Mol. Cell</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1016/S1097-2765(00)80415-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2FS1097-2765%2800%2980415-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=189-95&author=R.+A.+Birnbaumauthor=A.+O%E2%80%99Marcaighauthor=Z.+Wardakauthor=Y.+Y.+Zhangauthor=G.+Dranoffauthor=T.+Jacksauthor=D.+W.+Clappauthor=K.+M.+Shannon&title=Nf1+and+Gmcsf+interact+in+myeloid+leukemogenesis&doi=10.1016%2FS1097-2765%2800%2980415-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2800%2980415-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252800%252980415-3%26sid%3Dliteratum%253Aachs%26aulast%3DBirnbaum%26aufirst%3DR.%2BA.%26aulast%3DO%25E2%2580%2599Marcaigh%26aufirst%3DA.%26aulast%3DWardak%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%2BY.%26aulast%3DDranoff%26aufirst%3DG.%26aulast%3DJacks%26aufirst%3DT.%26aulast%3DClapp%26aufirst%3DD.%2BW.%26aulast%3DShannon%26aufirst%3DK.%2BM.%26atitle%3DNf1%2520and%2520Gmcsf%2520interact%2520in%2520myeloid%2520leukemogenesis%26jtitle%3DMol.%2520Cell%26date%3D2000%26volume%3D5%26spage%3D189%26epage%3D95%26doi%3D10.1016%2FS1097-2765%2800%2980415-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">12661</span>– <span class="NLM_lpage">74</span>, <span class="refDoi"> DOI: 10.3390/ijms140612661</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.3390%2Fijms140612661" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=23774838" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFOmur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=12661-74&author=S.+X.+Sunauthor=X.+B.+Liauthor=W.+B.+Liuauthor=Y.+Maauthor=R.+L.+Wangauthor=X.+C.+Chengauthor=S.+Q.+Wangauthor=W.+Liu&title=Design%2C+synthesis%2C+biological+activity+and+molecular+dynamics+studies+of+specific+protein+tyrosine+phosphatase+1B+inhibitors+over+SHP-2&doi=10.3390%2Fijms140612661"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, biological activity and molecular dynamics studies of specific protein tyrosine phosphatase 1B inhibitors over SHP-2</span></div><div class="casAuthors">Sun, Su-Xia; Li, Xiao-Bo; Liu, Wen-Bo; Ma, Ying; Wang, Run-Ling; Cheng, Xian-Chao; Wang, Shu-Qing; Liu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">12661-12674, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Over expressing in PTPN1 (encoding Protein tyrosine phosphatase 1B, PTP1B), a protein tyrosine phosphatase (PTP) that plays an overall pos. role in insulin signaling, is linked to the pathogenesis of diabetes and obesity.  The relationship between PTP1B and human diseases exhibits PTP1B as the target to treat these diseases.  In this article, small wt. mols. of the imidazolidine series were screened from databases and optimized on silicon as the inhibitors of PTP1B based on the steric conformation and electronic configuration of thiazolidinedione (TZD) compds.  The top three candidates were tested using an in vitro biol. assay after synthesis.  Finally, we report a novel inhibitor, Compd. 13, that specifically inhibits PTP1B over the closely related phosphatase Src homol. 2 (SH2) domain-contg. phosphatase 2 (SHP-2) at 80 μM.  Its IC50 values are reported in this paper as well.  This compd. was further verified by computer anal. for its ability to combine the catalytic domains of PTP1B and SHP-2 by mol. dynamics (MD) simulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVbZd73_ZSMbVg90H21EOLACvtfcHk0lgoF19EM0jiww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFOmur%252FN&md5=b2ed9edbdebc76adac79d02c56e6afbd</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.3390%2Fijms140612661&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms140612661%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DS.%2BX.%26aulast%3DLi%26aufirst%3DX.%2BB.%26aulast%3DLiu%26aufirst%3DW.%2BB.%26aulast%3DMa%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DR.%2BL.%26aulast%3DCheng%26aufirst%3DX.%2BC.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DLiu%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%252C%2520biological%2520activity%2520and%2520molecular%2520dynamics%2520studies%2520of%2520specific%2520protein%2520tyrosine%2520phosphatase%25201B%2520inhibitors%2520over%2520SHP-2%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2013%26volume%3D14%26spage%3D12661%26epage%3D74%26doi%3D10.3390%2Fijms140612661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, K. C.</span></span> <span> </span><span class="NLM_article-title">Low-frequency resonance and cooperativity of hemoglobin</span>. <i>Trends Biochem. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">3</span>, <span class="refDoi"> DOI: 10.1016/0968-0004(89)90026-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2F0968-0004%2889%2990026-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1989&pages=212-3&author=K.+C.+Chou&title=Low-frequency+resonance+and+cooperativity+of+hemoglobin&doi=10.1016%2F0968-0004%2889%2990026-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2F0968-0004%2889%2990026-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0968-0004%252889%252990026-1%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DK.%2BC.%26atitle%3DLow-frequency%2520resonance%2520and%2520cooperativity%2520of%2520hemoglobin%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D1989%26volume%3D14%26spage%3D212%26epage%3D3%26doi%3D10.1016%2F0968-0004%2889%2990026-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chou, K. C.</span></span> <span> </span><span class="NLM_article-title">The biological functions of low-frequency vibrations (phonons). 4. Resonance effects and allosteric transition</span>. <i>Biophys. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/0301-4622(84)80005-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2F0301-4622%2884%2980005-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1984&pages=61-71&author=K.+C.+Chou&title=The+biological+functions+of+low-frequency+vibrations+%28phonons%29.+4.+Resonance+effects+and+allosteric+transition&doi=10.1016%2F0301-4622%2884%2980005-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2F0301-4622%2884%2980005-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-4622%252884%252980005-8%26sid%3Dliteratum%253Aachs%26aulast%3DChou%26aufirst%3DK.%2BC.%26atitle%3DThe%2520biological%2520functions%2520of%2520low-frequency%2520vibrations%2520%2528phonons%2529.%25204.%2520Resonance%2520effects%2520and%2520allosteric%2520transition%26jtitle%3DBiophys.%2520Chem.%26date%3D1984%26volume%3D20%26spage%3D61%26epage%3D71%26doi%3D10.1016%2F0301-4622%2884%2980005-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hawley, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, C. K.</span></span> <span> </span><span class="NLM_article-title">Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling</span>. <i>Oncogene</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">5995</span>– <span class="NLM_lpage">6004</span>, <span class="refDoi"> DOI: 10.1038/sj.onc.1206846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1038%2Fsj.onc.1206846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=12955078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFansb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=5995-6004&author=W.+M.+Yuauthor=T.+S.+Hawleyauthor=R.+G.+Hawleyauthor=C.+K.+Qu&title=Catalytic-dependent+and+-independent+roles+of+SHP-2+tyrosine+phosphatase+in+interleukin-3+signaling&doi=10.1038%2Fsj.onc.1206846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic-dependent and -independent roles of SHP-2 tyrosine phosphatase in interleukin-3 signaling</span></div><div class="casAuthors">Yu, Wen-Mei; Hawley, Teresa S.; Hawley, Robert G.; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">5995-6004</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 tyrosine phosphatase is highly expressed in hematopoietic cells, however, the function of SHP-2 in hematopoietic cell signaling is not well understood.  Here the authors focus on the role of SHP-2 phosphatase in the signal transduction of interleukin (IL)-3, a cytokine involved in hematopoietic cell survival, proliferation, and differentiation.  The authors established immortalized SHP-2-/- hematopoietic cell pools and showed that IL-3-induced proliferative response was diminished in SHP-2-/- cells.  Moreover, inhibition of the catalytic activity of SHP-2 in wild-type (WT) bone marrow hematopoietic progenitor cells and Ba/F3 cells by overexpression of catalytically inactive SHP-2 mutant suppressed their differentiative and proliferative responses to IL-3, demonstrating an important pos. role for SHP-2 in IL-3 signal transduction.  Further biochem. analyses revealed that IL-3-induced Jak/Stat, Erk, and PI3 kinase pathways in SHP-2-/- cells were impaired and reintroduction of WT SHP-2 into mutant cells partially restored IL-3 signaling.  Interestingly, in catalytically inactive SHP-2-overexpressing Ba/F3 cells, although IL-3-induced activation of Jak2 and Erk kinases was reduced and shortened, PI3 kinase activation remained unaltered.  Taken together, these results suggest that SHP-2 tyrosine phosphatase plays multiple roles in IL-3 signal transduction, functioning in both catalytic-dependent and -independent manners in the Jak/Stat, Erk, and PI3 kinase pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooEt8hYWxgTbVg90H21EOLACvtfcHk0lgb0-ruN7wQUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFansb8%253D&md5=5480c82a8f3a196648c50458f67287df</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1206846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1206846%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DW.%2BM.%26aulast%3DHawley%26aufirst%3DT.%2BS.%26aulast%3DHawley%26aufirst%3DR.%2BG.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DCatalytic-dependent%2520and%2520-independent%2520roles%2520of%2520SHP-2%2520tyrosine%2520phosphatase%2520in%2520interleukin-3%2520signaling%26jtitle%3DOncogene%26date%3D2003%26volume%3D22%26spage%3D5995%26epage%3D6004%26doi%3D10.1038%2Fsj.onc.1206846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hausdorff, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Reilly, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neel, B. G.</span></span> <span> </span><span class="NLM_article-title">Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">1189</span>– <span class="NLM_lpage">202</span>, <span class="refDoi"> DOI: 10.1128/MCB.16.3.1189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1128%2FMCB.16.3.1189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=8622663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADyaK28XhtFOlsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1996&pages=1189-202&author=A.+M.+Bennettauthor=S.+F.+Hausdorffauthor=A.+M.+O%E2%80%99Reillyauthor=R.+M.+Freemanauthor=B.+G.+Neel&title=Multiple+requirements+for+SHPTP2+in+epidermal+growth+factor-mediated+cell+cycle+progression&doi=10.1128%2FMCB.16.3.1189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple requirements for SHPTP2 in epidermal growth factor-mediated cell cycle progression</span></div><div class="casAuthors">Bennett, Anton M.; Hausdorff, Sharon F.; O'Reilly, Alana M.; Freeman, Robert M., Jr.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1189-202</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Using transient overexpression and microinjection approaches, the authors examd. SHPTP2's function in growth factor signaling.  Overexpression of catalytically inactive SHPTP2 (PTP2CS) but not catalytically inactive SHPTP1, inhibited mitogen-activated protein (MAP) kinase activation and Elk-1 transactivation following epidermal growth factor (EGF) stimulation of 293 cells.  An SHPTP2 mutant with both C-terminal tyrosyl phosphorylation sites converted to phenylalanine (PTP26F) was also without effect; moreover, PTP2YF rescued PTP2CS-induced inhibition of EGF-induced Elk-1 transactivation.  PTP2CS did not inhibit transactivation by activated Ras, suggesting that SHPTP2 acts upstream of or parallel to Ras.  Neither PTP2CS nor PTP2YF inhibited platelet-derived growth factor (PDGF)-induced Elk-1 transactivation.  Thus, protein-tyrosine phosphate activity, but not tyrosyl phosphorylation of SHPTP2, is required for the immediate-early responses to EGF but not to PDGF.  To det. whether SHPTP2 is required later in the cell cycle, the authors assessed S-phase entry in NIH 3T3 cells microinjected with anti-SHPTP2 antibodies or with a glutathione S-transferase (GST) fusion protein encoding both SH2 domains (GST-SH2).  Microinjection of anti-SHPTP2 antibodies prior to stimulation inhibited EGF- but not PDGF- or serum-induced S-phase entry.  Anti-SHPTP2 antibodies or GST-SH2 fusion protein could inhibit EGF-induced S-phase entry for up to 8 h after EGF addn.  Although MAP kinase activation was detected shortly after EGF stimulation, no MAP kinase activation was detected around the restriction point.  Therefore, SHPTP2 is absolutely required for immediate-early and late events induced by some, but not all, growth factors, and the immediate-early and late signal transduction pathways regulated by SHPTP2 are distinguishable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeXoAZulZBWLVg90H21EOLACvtfcHk0lgb0-ruN7wQUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XhtFOlsLo%253D&md5=4dd06df6d964ba990e8ed094afeec28e</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FMCB.16.3.1189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.16.3.1189%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DA.%2BM.%26aulast%3DHausdorff%26aufirst%3DS.%2BF.%26aulast%3DO%25E2%2580%2599Reilly%26aufirst%3DA.%2BM.%26aulast%3DFreeman%26aufirst%3DR.%2BM.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DMultiple%2520requirements%2520for%2520SHPTP2%2520in%2520epidermal%2520growth%2520factor-mediated%2520cell%2520cycle%2520progression%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1996%26volume%3D16%26spage%3D1189%26epage%3D202%26doi%3D10.1128%2FMCB.16.3.1189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Repasky, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenwood, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halgren, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanschagrin, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mainz, D. T.</span></span> <span> </span><span class="NLM_article-title">Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6177</span>– <span class="NLM_lpage">96</span>, <span class="refDoi"> DOI: 10.1021/jm051256o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051256o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6177-96&author=R.+A.+Friesnerauthor=R.+B.+Murphyauthor=M.+P.+Repaskyauthor=L.+L.+Fryeauthor=J.+R.+Greenwoodauthor=T.+A.+Halgrenauthor=P.+C.+Sanschagrinauthor=D.+T.+Mainz&title=Extra+precision+glide%3A+docking+and+scoring+incorporating+a+model+of+hydrophobic+enclosure+for+protein-ligand+complexes&doi=10.1021%2Fjm051256o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Extra Precision Glide: Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein-Ligand Complexes</span></div><div class="casAuthors">Friesner, Richard A.; Murphy, Robert B.; Repasky, Matthew P.; Frye, Leah L.; Greenwood, Jeremy R.; Halgren, Thomas A.; Sanschagrin, Paul C.; Mainz, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6177-6196</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel scoring function to est. protein-ligand binding affinities has been developed and implemented as the Glide 4.0 XP scoring function and docking protocol.  In addn. to unique water desolvation energy terms, protein-ligand structural motifs leading to enhanced binding affinity are included:(1) hydrophobic enclosure where groups of lipophilic ligand atoms are enclosed on opposite faces by lipophilic protein atoms, (2) neutral-neutral single or correlated hydrogen bonds in a hydrophobically enclosed environment, and (3) five categories of charged-charged hydrogen bonds.  The XP scoring function and docking protocol have been developed to reproduce exptl. binding affinities for a set of 198 complexes (RMSDs of 2.26 and 1.73 kcal/mol over all and well-docked ligands, resp.) and to yield quality enrichments for a set of fifteen screens of pharmaceutical importance.  Enrichment results demonstrate the importance of the novel XP mol. recognition and water scoring in sepg. active and inactive ligands and avoiding false positives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZiwN12vaY7Vg90H21EOLACvtfcHk0lgb0-ruN7wQUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpvVGmurg%253D&md5=ea428c82ead0d8c27f8c1a7b694a1edf</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm051256o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051256o%26sid%3Dliteratum%253Aachs%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DMurphy%26aufirst%3DR.%2BB.%26aulast%3DRepasky%26aufirst%3DM.%2BP.%26aulast%3DFrye%26aufirst%3DL.%2BL.%26aulast%3DGreenwood%26aufirst%3DJ.%2BR.%26aulast%3DHalgren%26aufirst%3DT.%2BA.%26aulast%3DSanschagrin%26aufirst%3DP.%2BC.%26aulast%3DMainz%26aufirst%3DD.%2BT.%26atitle%3DExtra%2520precision%2520glide%253A%2520docking%2520and%2520scoring%2520incorporating%2520a%2520model%2520of%2520hydrophobic%2520enclosure%2520for%2520protein-ligand%2520complexes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6177%26epage%3D96%26doi%3D10.1021%2Fjm051256o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madhavi
Sastry, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adzhigirey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annabhimoju, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">221</span>– <span class="NLM_lpage">34</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9644-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1007%2Fs10822-013-9644-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=23579614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=221-34&author=G.+M.+Madhavi%0ASastryauthor=M.+Adzhigireyauthor=T.+Dayauthor=R.+Annabhimojuauthor=W.+Sherman&title=Protein+and+ligand+preparation%3A+parameters%2C+protocols%2C+and+influence+on+virtual+screening+enrichments&doi=10.1007%2Fs10822-013-9644-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments</span></div><div class="casAuthors">Madhavi Sastry, G.; Adzhigirey, Matvey; Day, Tyler; Annabhimoju, Ramakrishna; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-234</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Structure-based virtual screening plays an important role in drug discovery and complements other screening approaches.  In general, protein crystal structures are prepd. prior to docking in order to add hydrogen atoms, optimize hydrogen bonds, remove at. clashes, and perform other operations that are not part of the x-ray crystal structure refinement process.  In addn., ligands must be prepd. to create 3-dimensional geometries, assign proper bond orders, and generate accessible tautomer and ionization states prior to virtual screening.  While the prerequisite for proper system prepn. is generally accepted in the field, an extensive study of the prepn. steps and their effect on virtual screening enrichments has not been performed.  In this work, we systematically explore each of the steps involved in prepg. a system for virtual screening.  We first explore a large no. of parameters using the Glide validation set of 36 crystal structures and 1,000 decoys.  We then apply a subset of protocols to the DUD database.  We show that database enrichment is improved with proper prepn. and that neglecting certain steps of the prepn. process produces a systematic degrdn. in enrichments, which can be large for some targets.  We provide examples illustrating the structural changes introduced by the prepn. that impact database enrichment.  While the work presented here was performed with the Protein Prepn. Wizard and Glide, the insights and guidance are expected to be generalizable to structure-based virtual screening with other docking methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruqN5nIOJtR7Vg90H21EOLACvtfcHk0lijkiJvl34d4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslalu7c%253D&md5=259a6d547ef3e1310e091fb50fe8de16</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9644-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9644-8%26sid%3Dliteratum%253Aachs%26aulast%3DMadhavi%2BSastry%26aufirst%3DG.%2BM.%26aulast%3DAdzhigirey%26aufirst%3DM.%26aulast%3DDay%26aufirst%3DT.%26aulast%3DAnnabhimoju%26aufirst%3DR.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DProtein%2520and%2520ligand%2520preparation%253A%2520parameters%252C%2520protocols%252C%2520and%2520influence%2520on%2520virtual%2520screening%2520enrichments%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D221%26epage%3D34%26doi%3D10.1007%2Fs10822-013-9644-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, K. C.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e28111</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0028111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1371%2Fjournal.pone.0028111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=22140516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1GgtbzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=X.+B.+Liauthor=S.+Q.+Wangauthor=W.+R.+Xuauthor=R.+L.+Wangauthor=K.+C.+Chou&title=Novel+inhibitor+design+for+hemagglutinin+against+H1N1+influenza+virus+by+core+hopping+method&doi=10.1371%2Fjournal.pone.0028111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitor design for hemagglutinin against H1N1 influenza virus by core hopping method</span></div><div class="casAuthors">Li, Xiao-Bo; Wang, Shu-Qing; Xu, Wei-Ren; Wang, Run-Ling; Chou, Kuo-Chen</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e28111</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The worldwide spread of H1N1 avian influenza and the increasing reports about its resistance to the current drugs have made a high priority for developing new anti-influenza drugs.  Owing to its unique function in assisting viruses to bind the cellular surface, a key step for them to subsequently penetrate into the infected cell, hemagglutinin (HA) has become one of the main targets for drug design against influenza virus.  To develop potent HA inhibitors, the ZINC fragment database was searched for finding the optimal compd. with the core hopping technique.  As a result, the Neo6 compd. was obtained.  It has been shown through the subsequent mol. docking studies and mol. dynamic simulations that Neo6 not only assumes more favorable conformation at the binding pocket of HA but also has stronger binding interaction with its receptor.  Accordingly, Neo6 may become a promising candidate for developing new and more powerful drugs for treating influenza.  Or at the very least, the findings reported here may provide useful insights to stimulate new strategy in this area.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo51HQOmljzpLVg90H21EOLACvtfcHk0lijkiJvl34d4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1GgtbzP&md5=f26890062e6ed879b613ad7dec7ed244</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0028111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0028111%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BB.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DXu%26aufirst%3DW.%2BR.%26aulast%3DWang%26aufirst%3DR.%2BL.%26aulast%3DChou%26aufirst%3DK.%2BC.%26atitle%3DNovel%2520inhibitor%2520design%2520for%2520hemagglutinin%2520against%2520H1N1%2520influenza%2520virus%2520by%2520core%2520hopping%2520method%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0028111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friesner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Improving the prediction of absolute solvation free energies using the next generation OPLS force field</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2553</span>– <span class="NLM_lpage">8</span>, <span class="refDoi"> DOI: 10.1021/ct300203w</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct300203w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFWjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=2553-8&author=D.+Shivakumarauthor=E.+Harderauthor=W.+Dammauthor=R.+A.+Friesnerauthor=W.+Sherman&title=Improving+the+prediction+of+absolute+solvation+free+energies+using+the+next+generation+OPLS+force+field&doi=10.1021%2Fct300203w"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field</span></div><div class="casAuthors">Shivakumar, Devleena; Harder, Edward; Damm, Wolfgang; Friesner, Richard A.; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2553-2558</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Explicit solvent mol. dynamics free energy perturbation simulations were performed to predict abs. solvation free energies of 239 diverse small mols.  We use OPLS2.0, the next generation OPLS force field, and compare the results with popular small mol. force fields-OPLS_2005, GAFF, and CHARMm-MSI.  OPLS2.0 produces the best correlation with exptl. data (R2 = 0.95, slope = 0.96) and the lowest av. unsigned errors (0.7 kcal/mol).  Important classes of compds. that performed suboptimally with OPLS_2005 show significant improvements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEngE5xV9Ev7Vg90H21EOLACvtfcHk0liyI0RBH-c7UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFWjs7g%253D&md5=eceb7dab3a8d0c6ac586c620848412d1</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fct300203w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct300203w%26sid%3Dliteratum%253Aachs%26aulast%3DShivakumar%26aufirst%3DD.%26aulast%3DHarder%26aufirst%3DE.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DFriesner%26aufirst%3DR.%2BA.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DImproving%2520the%2520prediction%2520of%2520absolute%2520solvation%2520free%2520energies%2520using%2520the%2520next%2520generation%2520OPLS%2520force%2520field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2012%26volume%3D8%26spage%3D2553%26epage%3D8%26doi%3D10.1021%2Fct300203w" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shivakumar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damm, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shelley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, W.</span></span> <span> </span><span class="NLM_article-title">Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field</span>. <i>J. Chem. Theory Comput.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1509</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1021/ct900587b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ct900587b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkslKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=1509-19&author=D.+Shivakumarauthor=J.+Williamsauthor=Y.+Wuauthor=W.+Dammauthor=J.+Shelleyauthor=W.+Sherman&title=Prediction+of+absolute+solvation+free+energies+using+molecular+dynamics+free+energy+perturbation+and+the+OPLS+force+field&doi=10.1021%2Fct900587b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field</span></div><div class="casAuthors">Shivakumar, Devleena; Williams, Joshua; Wu, Yujie; Damm, Wolfgang; Shelley, John; Sherman, Woody</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Theory and Computation</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1509-1519</span>CODEN:
                <span class="NLM_cas:coden">JCTCCE</span>;
        ISSN:<span class="NLM_cas:issn">1549-9618</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The accurate prediction of protein-ligand binding free energies is a primary objective in computer-aided drug design.  The solvation free energy of a small mol. provides a surrogate to the desolvation of the ligand in the thermodn. process of protein-ligand binding.  Here, we use explicit solvent mol. dynamics free energy perturbation to predict the abs. solvation free energies of a set of 239 small mols., spanning diverse chem. functional groups commonly found in drugs and drug-like mols.  We also compare the performance of abs. solvation free energies obtained using the OPLS_2005 force field with two other commonly used small mol. force fields - general AMBER force field (GAFF) with AM1-BCC charges and CHARMm-MSI with CHelpG charges.  Using the OPLS_2005 force field, we obtain high correlation with exptl. solvation free energies (R2 = 0.94) and low av. unsigned errors for a majority of the functional groups compared to AM1-BCC/GAFF or CHelpG/CHARMm-MSI.  However, OPLS_2005 has errors of over 1.3 kcal/mol for certain classes of polar compds.  We show that predictions on these compd. classes can be improved by using a semiempirical charge assignment method with an implicit bond charge correction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon_fkbSHqg3bVg90H21EOLACvtfcHk0liyI0RBH-c7UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkslKhu7g%253D&md5=25d464fb9238e3235e881945c0b50a76</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fct900587b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fct900587b%26sid%3Dliteratum%253Aachs%26aulast%3DShivakumar%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DDamm%26aufirst%3DW.%26aulast%3DShelley%26aufirst%3DJ.%26aulast%3DSherman%26aufirst%3DW.%26atitle%3DPrediction%2520of%2520absolute%2520solvation%2520free%2520energies%2520using%2520molecular%2520dynamics%2520free%2520energy%2520perturbation%2520and%2520the%2520OPLS%2520force%2520field%26jtitle%3DJ.%2520Chem.%2520Theory%2520Comput.%26date%3D2010%26volume%3D6%26spage%3D1509%26epage%3D19%26doi%3D10.1021%2Fct900587b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oostenbrink, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soares, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Vegt, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Gunsteren, W. F.</span></span> <span> </span><span class="NLM_article-title">Validation of the 53A6 GROMOS force field</span>. <i>Eur. Biophys. J.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">273</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1007/s00249-004-0448-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1007%2Fs00249-004-0448-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15803330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2MXksVajtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2005&pages=273-84&author=C.+Oostenbrinkauthor=T.+A.+Soaresauthor=N.+F.+van+der+Vegtauthor=W.+F.+van+Gunsteren&title=Validation+of+the+53A6+GROMOS+force+field&doi=10.1007%2Fs00249-004-0448-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Validation of the 53A6 GROMOS force field</span></div><div class="casAuthors">Oostenbrink, Chris; Soares, Thereza A.; van der Vegt, Nico F. A.; van Gunsteren, Wilfred F.</div><div class="citationInfo"><span class="NLM_cas:title">European Biophysics Journal</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">273-284</span>CODEN:
                <span class="NLM_cas:coden">EBJOE8</span>;
        ISSN:<span class="NLM_cas:issn">0175-7571</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">The quality of biomol. dynamics simulations relies critically on the force field that is used to describe the interactions between particles in the system.  Force fields, which are generally parameterized using exptl. data on small mols., can only prove themselves in realistic simulations of relevant biomol. systems.  In this work, we begin the validation of the new 53A6 GROMOS parameter set by examg. three test cases.  Simulations of the well-studied 129 residue protein hen egg-white lysozyme, of the DNA dodecamer d(CGCGAATTCGCG)2, and a proteinogenic β3-dodecapeptide were performed and analyzed.  It was found that the new parameter set performs as well as the previous parameter sets in terms of protein (45A3) and DNA (45A4) stability and that it is better at describing the folding-unfolding balance of the peptide.  The latter is a property that is directly assocd. with the free enthalpy of hydration, to which the 53A6 parameter set was parameterized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9L1Tptp71r7Vg90H21EOLACvtfcHk0ljyvQarYDcjVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXksVajtb8%253D&md5=8a9b34e5dcac9d5d33489794c67ed513</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs00249-004-0448-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00249-004-0448-6%26sid%3Dliteratum%253Aachs%26aulast%3DOostenbrink%26aufirst%3DC.%26aulast%3DSoares%26aufirst%3DT.%2BA.%26aulast%3Dvan%2Bder%2BVegt%26aufirst%3DN.%2BF.%26aulast%3Dvan%2BGunsteren%26aufirst%3DW.%2BF.%26atitle%3DValidation%2520of%2520the%252053A6%2520GROMOS%2520force%2520field%26jtitle%3DEur.%2520Biophys.%2520J.%26date%3D2005%26volume%3D34%26spage%3D273%26epage%3D84%26doi%3D10.1007%2Fs00249-004-0448-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuttelkopf, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aalten, D. M.</span></span> <span> </span><span class="NLM_article-title">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-63&author=A.+W.+Schuttelkopfauthor=D.+M.+van+Aalten&title=PRODRG%3A+a+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuttelkopf Alexander W; van Aalten Daan M F</div><div class="citationInfo"><span class="NLM_cas:title">Acta crystallographica. Section D, Biological crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Pt 8</span>),
    <span class="NLM_cas:pages">1355-63</span>
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    </div><div class="casAbstract">The small-molecule topology generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and molecular topologies suitable for X-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compounds from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the standard libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallographic R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdNRIcoht5aXy-c-E1v-fmfW6udTcc2eYuHe3El9yDBbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czmslGmtA%253D%253D&md5=1adce6cd2cacdace513a69efa33c4e93</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSchuttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%26atitle%3DPRODRG%253A%2520a%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D63%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pantoliano, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrella, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwasnoski, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lobanov, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myslik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carver, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springer, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salemme, F. R.</span></span> <span> </span><span class="NLM_article-title">High-density miniaturized thermal shift assays as a general strategy for drug discovery</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1177/108705710100600609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1177%2F108705710100600609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=11788061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVCntg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2001&pages=429-40&author=M.+W.+Pantolianoauthor=E.+C.+Petrellaauthor=J.+D.+Kwasnoskiauthor=V.+S.+Lobanovauthor=J.+Myslikauthor=E.+Grafauthor=T.+Carverauthor=E.+Aselauthor=B.+A.+Springerauthor=P.+Laneauthor=F.+R.+Salemme&title=High-density+miniaturized+thermal+shift+assays+as+a+general+strategy+for+drug+discovery&doi=10.1177%2F108705710100600609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">High-density miniaturized thermal shift assays as a general strategy for drug discovery</span></div><div class="casAuthors">Pantoliano, Michael W.; Petrella, Eugene C.; Kwasnoski, Joseph D.; Lobanov, Victor S.; Myslik, James; Graf, Edward; Carver, Ted; Asel, Eric; Springer, Barry A.; Lane, Pamela; Salemme, F. R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">429-440</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">More general and universally applicable drug discovery assay technologies are needed in order to keep pace with the recent advances in combinatorial chem. and genomics-based target generation.  Ligand-induced conformational stabilization of proteins is a well-understood phenomenon in which substrates, inhibitors, cofactors, and even other proteins provide enhanced stability to proteins on binding.  This phenomenon is based on the energetic coupling of the ligand-binding and protein-melting reactions.  In an attempt to harness these biophys. properties for drug discovery, fully automated instrumentation was designed and implemented to perform miniaturized fluorescence-based thermal shift assays in a microplate format for the high throughput screening of compd. libraries.  Validation of this process and instrumentation was achieved by investigating ligand binding to more than 100 protein targets.  The general applicability of the thermal shift screening strategy was found to be an important advantage because it circumvents the need to design and retool new assays with each new therapeutic target.  Moreover, the miniaturized thermal shift assay methodol. does not require any prior knowledge of a therapeutic target's function, making it ideally suited for the quant. high throughput drug screening and evaluation of targets derived from genomics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp58y9R74HfiLVg90H21EOLACvtfcHk0lhy9wZpI65ebQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVCntg%253D%253D&md5=deef07e6683f632cd078214ad88d9999</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1177%2F108705710100600609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F108705710100600609%26sid%3Dliteratum%253Aachs%26aulast%3DPantoliano%26aufirst%3DM.%2BW.%26aulast%3DPetrella%26aufirst%3DE.%2BC.%26aulast%3DKwasnoski%26aufirst%3DJ.%2BD.%26aulast%3DLobanov%26aufirst%3DV.%2BS.%26aulast%3DMyslik%26aufirst%3DJ.%26aulast%3DGraf%26aufirst%3DE.%26aulast%3DCarver%26aufirst%3DT.%26aulast%3DAsel%26aufirst%3DE.%26aulast%3DSpringer%26aufirst%3DB.%2BA.%26aulast%3DLane%26aufirst%3DP.%26aulast%3DSalemme%26aufirst%3DF.%2BR.%26atitle%3DHigh-density%2520miniaturized%2520thermal%2520shift%2520assays%2520as%2520a%2520general%2520strategy%2520for%2520drug%2520discovery%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2001%26volume%3D6%26spage%3D429%26epage%3D40%26doi%3D10.1177%2F108705710100600609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aulabaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowling, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malamas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellestad, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>332</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2004.04.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=10.1016%2Fj.ab.2004.04.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=15301960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsVKhu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=332&publication_year=2004&pages=153-9&author=M.+C.+Loauthor=A.+Aulabaughauthor=G.+Jinauthor=R.+Cowlingauthor=J.+Bardauthor=M.+Malamasauthor=G.+Ellestad&title=Evaluation+of+fluorescence-based+thermal+shift+assays+for+hit+identification+in+drug+discovery&doi=10.1016%2Fj.ab.2004.04.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery</span></div><div class="casAuthors">Lo, Mei-Chu; Aulabaugh, Ann; Jin, Guixian; Cowling, Rebecca; Bard, Jonathan; Malamas, Michael; Ellestad, George</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">332</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-159</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The fluorescence-based thermal shift assay is a general method for identification of inhibitors of target proteins from compd. libraries.  Using an environmentally sensitive fluorescent dye to monitor protein thermal unfolding, the ligand-binding affinity can be assessed from the shift of the unfolding temp. (ΔTm) obtained in the presence of ligands relative to that obtained in the absence of ligands.  In this article, we report that the thermal shift assay can be conducted in an inexpensive, com. available device for temp. control and fluorescence detection.  The binding affinities obtained from thermal shift assays are compared with the binding affinities measured by isothermal titrn. calorimetry and with the IC50 values from enzymic assays.  The potential pitfalls in the data anal. of thermal shift assays are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qMM9vchBGrVg90H21EOLACvtfcHk0lhy9wZpI65ebQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsVKhu7g%253D&md5=bc10d980128340c79d7d2abc9a56463b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2004.04.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2004.04.031%26sid%3Dliteratum%253Aachs%26aulast%3DLo%26aufirst%3DM.%2BC.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DMalamas%26aufirst%3DM.%26aulast%3DEllestad%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520fluorescence-based%2520thermal%2520shift%2520assays%2520for%2520hit%2520identification%2520in%2520drug%2520discovery%26jtitle%3DAnal.%2520Biochem.%26date%3D2004%26volume%3D332%26spage%3D153%26epage%3D9%26doi%3D10.1016%2Fj.ab.2004.04.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fodor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Argintaru, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glick, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaRochelle, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiguchi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sendzik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shultz, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stams, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blacklow, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acker, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMarche, M. J.</span></span> <span> </span><span class="NLM_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1021/acschembio.7b00980</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.7b00980" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=647-656&author=M.+Fodorauthor=E.+Priceauthor=P.+Wangauthor=H.+Luauthor=A.+Argintaruauthor=Z.+Chenauthor=M.+Glickauthor=H.+X.+Haoauthor=M.+Katoauthor=R.+Koenigauthor=J.+R.+LaRochelleauthor=G.+Liuauthor=E.+McNeillauthor=D.+Majumdarauthor=G.+A.+Nishiguchiauthor=L.+B.+Perezauthor=G.+Parisauthor=C.+M.+Quinnauthor=T.+Ramseyauthor=M.+Sendzikauthor=M.+D.+Shultzauthor=S.+L.+Williamsauthor=T.+Stamsauthor=S.+C.+Blacklowauthor=M.+G.+Ackerauthor=M.+J.+LaMarche&title=Dual+Allosteric+Inhibition+of+SHP2+Phosphatase&doi=10.1021%2Facschembio.7b00980"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Dual allosteric inhibition of SHP2 phosphatase</span></div><div class="casAuthors">Fodor, Michelle; Price, Edmund; Wang, Ping; Lu, Hengyu; Argintaru, Andreea; Chen, Zhouliang; Glick, Meir; Hao, Huai-Xiang; Kato, Mitsunori; Koenig, Robert; La Rochelle, Jonathan R.; Liu, Gang; McNeill, Eric; Majumdar, Dyuti; Nishiguchi, Gisele A.; Perez, Lawrence B.; Paris, Gregory; Quinn, Christopher M.; Ramsey, Timothy; Sendzik, Martin; Shultz, Michael David; Williams, Sarah L.; Stams, Travis; Blacklow, Stephen C.; Acker, Michael G.; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">647-656</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a cytoplasmic protein tyrosine phosphatase encoded by the PTPN11 gene and is involved in cell proliferation, differentiation, and survival.  Recently, we reported an allosteric mechanism of inhibition that stabilizes the auto-inhibited conformation of SHP2.  SHP099 (1) was identified and characterized as a moderately potent, orally bioavailable, allosteric small mol. inhibitor, which binds to a tunnel-like pocket formed by the confluence of three domains of SHP2.  In this report, we describe further screening strategies that enabled the identification of a second, distinct small mol. allosteric site.  SHP244 (2) was identified as a weak inhibitor of SHP2 with modest thermal stabilization of the enzyme.  X-ray crystallog. revealed that 2 binds and stabilizes the inactive, closed conformation of SHP2, at a distinct, previously unexplored binding site-a cleft formed at the interface of the N-terminal SH2 and PTP domains.  Derivatization of 2 using structure-based design resulted in an increase in SHP2 thermal stabilization, biochem. inhibition, and subsequent MAPK pathway modulation.  Downregulation of DUSP6 mRNA, a downstream MAPK pathway marker, was obsd. in KYSE-520 cancer cells.  Remarkably, simultaneous occupation of both allosteric sites by 1 and 2 was possible, as characterized by cooperative biochem. inhibition expts. and X-ray crystallog.  Combining an allosteric site 1 inhibitor with an allosteric site 2 inhibitor led to enhanced pharmacol. pathway inhibition in cells.  This work illustrates a rare example of dual allosteric targeted protein inhibition, demonstrates screening methodol. and tactics to identify allosteric inhibitors, and enables further interrogation of SHP2 in cancer and related pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWdw7pTS6sOLVg90H21EOLACvtfcHk0lhlUe5NXg0cgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslOgtg%253D%253D&md5=8e4de4c353b9fc196c81e1cb51e367df</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DArgintaru%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGlick%26aufirst%3DM.%26aulast%3DHao%26aufirst%3DH.%2BX.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DKoenig%26aufirst%3DR.%26aulast%3DLaRochelle%26aufirst%3DJ.%2BR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DMcNeill%26aufirst%3DE.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DNishiguchi%26aufirst%3DG.%2BA.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26aulast%3DParis%26aufirst%3DG.%26aulast%3DQuinn%26aufirst%3DC.%2BM.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSendzik%26aufirst%3DM.%26aulast%3DShultz%26aufirst%3DM.%2BD.%26aulast%3DWilliams%26aufirst%3DS.%2BL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DBlacklow%26aufirst%3DS.%2BC.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26atitle%3DDual%2520Allosteric%2520Inhibition%2520of%2520SHP2%2520Phosphatase%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2018%26volume%3D13%26spage%3D647%26epage%3D656%26doi%3D10.1021%2Facschembio.7b00980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR','PDB','5EHR'); return false;">PDB: 5EHR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i35"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00513">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_80412"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00513">10.1021/acs.jmedchem.8b00513</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Top hits from the initial virtual database screening; PAINS results of the top 100 hits from the initial database screening and the ten derivatives of NSC681129; Proton NMR data of <b>1</b>; Proton NMR spectra data of <b>1</b>; NMR results of other derivatives synthesized; HPLC data of all derivatives synthesized (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Complex structures of <b>1</b> with SHP1 and SHP2 (PDB, PDB)</p></li><li><p class="inline">Molecular formula strings of <b>1</b> (CSV)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00513/suppl_file/jm8b00513_si_001.pdf">jm8b00513_si_001.pdf (809.42 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00513&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00513%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00513" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                6MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"66798810de71124c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
